Schachner and Hansen’s Pediatric Dermatology Antonio Torrelo, Angela Hernández-Martín, Elaine C Siegfried, Anne W Lucky, Robert A Silverman, Elena Pope, Karen Wiss
INDEX
Page numbers followed by f refer to figure, fc refer to flowchart, and t refer to table.
A
Abdomen, pigmentary lines of 125f
Abrasions 1628
Abrocitinib 2049
Abscess 74, 1688, 1688f, 1694
labial 460f
metastatic 1738
perianal 1689
Absidia 1871
Absorption, curves of 2074f
Abtropfung 1501
Acanthamoeba 461, 1885, 1886
Acanthaster planci 1617
Acantholysis, suprabasilar 84f
Acantholytic epidermolysis bullosa simplex 287, 644
Acanthosis 74, 537f
nigricans 922, 933, 933t, 934f, 1085, 1138
verrucous 502f
Acatalasemia 1332
Achilles tendon 262f
Acid beta-glucosidase 904
Acidemia 876
methylmalonic 875, 1446
propionic 876, 1446
Acidosis, metabolic 2035
Aciduria
erythematous methylmalonic 876f
methylmalonic 876
mevalonic 836
propionic 876
Acne 33, 764, 840, 1226, 1236f, 1237, 1243
classification of 1224t
conglobata 1237, 1237f
corticosteroids-induced 1242f
cosmetica 1241
cysts 1243f
differential diagnosis of 1229t
excoriée 1238, 1239f
formulation, topical 599f
free nevus 401
fulminans 1224, 1237, 1237f
hormonal therapy for 932
infantile 371f, 1236
inflammatory 1229f
keloidalis 1040f
nuchae 1039, 1203
midchildhood 1236
neonatal 138, 138f, 1235
neonatorum 138
nodular 1243f
occupational 1241
preadolescent 1236
propionibacterium 33, 858, 1118, 1202, 1225
severe 1228f
syndrome 764, 841f
variants 1235
venenata 1241
vulgaris 1230, 2052
Acneiform
eruptions 1671
papules 1866
Acquired immunodeficiency syndrome 458, 459t, 1015, 1278, 1381, 1571, 1765, 1772, 1824, 1923, 1989
Acral erythema, chemotherapy-induced 698, 698f
Acral erythemas 694
Acral hyperkeratosis, focal 275
Acral peeling skin syndrome 240, 643, 645f
Acral pseudolymphomatous angiokeratoma 1005, 1470
Acral skin 17f
Acrocyanosis 123, 694
Acrodermatitis 876
chronica atrophicans 1056, 1717
dysmetabolica 875, 875t
enteropathica 147f, 630, 878, 883, 884f
Acro-dermato-ungual-lacrimal-tooth syndrome 304, 305, 316, 317, 319
Acrodynia 697
Acrokeratoelastoidosis 275, 275f
Acromelanosis 125f
albo-punctata 1157
Acropustulosis 141, 141f
Actinic cheilitis 1552f
Actinic keratoses 1551, 1552, 1552f
Actinic prurigo 1643, 1643f, 1998
Actinodendron plumosum 1619
Actinomadura madurae 1856
Actinomyces 1705, 1709
israelii 1705
pelletieri 1856
Actinomycetales 1736, 1747
Actinomycosis 1705
Actinomycotic mycetoma 1857
Activated partial thromboplastin time 734
Acupuncture 2101
Acute allergic contact dermatitis 600f
Acute cutaneous lupus erythematosus 429, 784
Acute graft-versus-host disease 463, 465f, 466f, 467f, 469, 727
stages of 466t
Acute respiratory distress syndrome 1862
Acyl hydrocarbon receptor 508
Acylceramides 210f
Adalimumab 515, 2044
Adams-Oliver syndrome 184f, 374, 1169, 1169f
Addison's disease 371, 920, 921, 925, 925f, 1057, 1128, 1139, 1138, 1336, 2040
Adenine 56
Adeno-associated virus 2116, 2117
Adenomas, sebaceous 316
Adenomatous polyposis
coli 961
familial 956, 961, 1526, 1586
Adenosine deaminase 448, 755, 842, 847, 2122
deficiency of 699, 842, 842f
Adenosine triphosphate 322, 889, 1062, 1151
Adenosyl-cobalamin cofactor 875
Adenovirus 1446, 1762f, 1767, 1773, 2116, 2117
Adhesives 2070
plaster bandage 600f
Adipocytes
mature 1532f
phagocytosis of 1084f
Adipose lobules, panniculitis involving 1084f
Adipose tissue, tumors of 1538
Adjunctive therapy 590
Adnexae, tumors of 1479
Adrenal disorders 925
Adrenal gland 930
Adrenal insufficiency, primary 1138
Adrenal steroid biosynthesis 931f
Adrenarche, premature 931
Adrenocortical dysplasia homolog 344
Adrenoleukodystrophy 1139
Adverse drug reactions 156, 1664, 1675
classification of 1665t
Advisory Committee on Immunization Practices 1763
Aedes aegypti 171, 1767, 1768
Aedes albopictus 171, 1767, 1768
Aeromonas hydrophila 1614, 1616, 1619, 1620, 1697
African Programme for Onchocerciasis Control 1888
Agalsidase
alpha 904
beta 904
Agammaglobulinemia 444
Agranulocytosis, history of 2054
Aicardi–Goutières syndrome 170t, 695, 745, 841, 847, 1599
Air bag injury 1605
Airway involvement 1363
Alabaster pallor 918f
Alae nasi, hypoplastic 296
Alagille syndrome 963, 964
Alanine
aminotransferase 498
transaminase 1670, 1787, 2054
Albicans 1323
Albinism 1100, 1582
classical oculocutaneous 1098t
deafness syndrome 1154
oculocutaneous 373, 1098, 1098f, 10991101
Albright's hereditary osteodystrophy 59, 941, 1022, 1026, 1028f, 1544
Alcoholism 1691
Alcyonidium
diaphanum 1618
hirsutum 1618
Alemtuzumab 776
Alezzandrini syndrome 1101
Alkaline phosphatase 1670
Alkaptonuria 874
Allelic didymosis 385t
Allelic heterogeneity 61
Allelic twin-spotting phenomenon 1152
Allergen
immunotherapy 591
investigating 601t
Allergic contact dermatitis 43, 49, 107, 598, 600f, 601t, 604f, 605f, 620, 956, 1315f, 2000, 2066f
diffuse 604f
signs of 2066f
symptoms of 2066f
Allergies 239
multiple 289, 289f
Allescheria 1838
Alloknesis promotes 1975
All-trans-retinoic acid 761, 1980, 1981
Allylamines 1987, 1988
Aloe ferox 2098
Aloe vera 2097, 2098
Alopecia 74, 235f, 299, 945, 1167f, 1169f, 1177f, 1631
areata 70, 795, 1187, 1265, 1266, 1266f, 1284, 2004, 2023
congenital 292, 1165
early-onset 1165
lipedematous 1169
mucinosa 910, 1204
neonatal 128f, 1168
nonscarring 1185
patchy 240f, 1168, 1922f
permanent scarring 1828f
postnatal 127
postoperative 1193f
pressure induced 1193, 1610, 1610f
temporal triangular 1168f
temporary diffuse 1186f
totalis 369
traction 1193, 1194f
traumatic 1193
Alpha-1-antitrypsin 969
deficiency 965, 969, 1082, 2122
Alpha-2-antiplasmin 738
Alpha-galactosidase A 903, 904
deficiency 903
Alpha-hydroxy acids 1974
Alpha-interferon 1185
Alpha-linolenic acid 881
Alternaria 1278
Ambiguous genitalia 932f
Amblyomma
americanum 1652
maculatum 1715
Ambras syndrome 1177, 1178f
Amebiasis
disseminated free-living 1886
free-living 1885
neurological free-living 1886
Amebic meningoencephalitis, primary 1885
Amelanotic melanoma 1563
American Academy of Dermatology Guidelines 2031
American Academy of Pediatrics 496, 1763, 1903, 1971
American College of Rheumatology 812, 816f
Amino acid disorders 871
Aminoaciduria 622f
Aminoimidazole-4-carboxamide ribonucleotide 2029
Aminolevulinic acid 897, 1998, 2004
Amniocentesis 153
Amniotic band sequence 186
Amoxicillin 1671f
Amphotericin B 1851, 1987
lipid formulations of 1851
Amplitude modulation 2090
Amputees reactions 1612
Amyloid 912
A 913
light-chain 912, 913
Amyloidosis 912, 913f
classification of 913t
primary 912, 1525
Anagen effluvium 1187
Anal warts, external 1953
Anaphylatoxin 32, 36
Anaphylaxis 707
Anaplasma phagocytophilum 1716
Anaplasmosis, granulocytic 1652
Anaplastic large cell lymphoma 1464f
primary cutaneous 1463
Ancillary diagnostic methods 1562
Ancylostoma
braziliense 1889
caninum 1887
Androgenetic alopecia 1197, 1198f
Androgens 925, 929
excess
causes of 929t
disorders of 929
peripheral metabolism of 931
Androstenedione 930
Anemone stings 1619
Anergic leishmaniasis 1861
Anergy 40
Anesthesia 2105
general 2105
local 2105
Anesthetics 2105
local
injectable 2105
noninjectable 2105
topical noninjectable 2105
Anetoderma 155, 155f, 1048, 1055, 1441f
primary 1056
secondary 1056, 1056f, 1057t
Anetodermic pilomatricoma 1480f
Aneurysms 404
arterial 769
Angelman syndrome 373, 1101
Angiodysplasia 404
Angioedema 74, 702, 705, 711
acquired 712
hereditary 427, 430, 702, 712
Angioendothelioma
endovascular papillary 1379
papillary intralymphatic 1348, 1379
Angiofibroma 1519f
cutaneous 1519
Angiography 1390
Angiokeratoma 1420, 1421f
circumscriptum 1421
corporis diffusum 903, 1421
Angioleiomyoma 1541
Angiolipoma 1540
Angiolymphoid hyperplasia 1007, 1008, 1009f, 1378
Angioma, tufted 741, 1183, 1349, 1350, 1350f, 1376, 1377f
Angiosarcoma 1382
Angiotensin-converting enzyme 703, 989, 996, 1006, 1668, 1808, 2028
Angora hair nevus syndrome 404
Angular cheilitis 1313
Anhidrotic ectodermal dysplasia 1291
Ankyloblepharon 317f
ectodermal
defects 219, 305, 316, 317f
dysplasia 270
Ankylosing spondylitis 820
juvenile 820, 826
Annular elastolytic giant cell granuloma 984, 997
Annular pink-violaceous papules 1007f
Annular urticariform edematous lesions 676f
Anogenital warts 1799, 1953, 1955
Anonychia 1272, 1273f, 1273t, 1291
Anorexia 945
nervosa 1171
cutaneous manifestations of 945t
Antecubital fossa 590
Anterior cervical hypertrichosis 1180, 1180f
Anthralin 508, 1981
Anthrax 1705, 1722
toxin receptor 910
Anti-β2-glycoprotein antibodies 735
Antibiotics 591, 603, 2010, 2041, 2100
oral 1232
topical 1231
Antibody 1010
deficiency 144, 846, 847
mediated diseases 2035
testing 1810
Anticardiolipin 842
Anticoagulant therapy 735
Anticonvulsants 2041
Anti-cyclic citrullinated peptide 822
Anti-desmoglein 663
Antifungals 2018
agents 1988t
griseofulvin 1640
topical 1987
Antigen 47, 49, 50
detection 1947
mapping 91
presentation 39
types of 39f
presenting cells 32, 37, 42, 42f, 465, 724
Anti-gliadin-analogous fusion peptides 678
Antihistamines 590, 1455, 2066f
nonsedating 1975
Anti-inflammatory cytokines 820
Antimalarials 2032, 2034t
drugs, side effects of 2034t
potential uses of 2033t
Anti-malassezia agents 1974
Antimediator drugs, systemic 1456
Anti-melanoma differentiation-associated gene 5 817, 970
Antimicrobial peptides 31, 33, 577
Antimyeloperoxidase 967
Antineoplastic agents 1141
Antineutrophil cytoplasmic antibody 699, 748, 753, 855, 966, 967, 2037
Antinuclear antibody 429, 496, 710, 787, 795, 820, 823, 842, 852, 996, 1049, 1112, 1642, 1674
positive 2011
Antiparasitic agents 1990
Antiphospholipid antibody 788, 1056
syndrome 699, 735, 736f, 787
Antipneumococcal antibodies 313
Antipruritics 1975
Antiretroviral therapy 460
Anti-saccharomyces cerevisiae 957
Antisense oligonucleotides 2116
Antistreptolysin O 1694
Antithrombin deficiency 734
Anti-tissue transglutaminase 960
Antitumor cytolytic T-cell activity 1560
Antitumor necrosis factor 436, 854
alpha agents 2042
Antiviral
drug dosages 2010t
topical 1989
Aortic anomalies 1348
Aortic root diameter 1069
Apert syndrome 1243f
Aphthous stomatitis 848, 1325, 2043
major 1317
minor 1317
recurrent 1317, 1318f
Aplaid syndrome 847f
Aplasia cutis 182f, 1169
congenita 181, 184f, 374, 374t
congenital
diagnosis of 181t, 186
management of 186
Aplastic nevus 1169
Apocrine bromhidrosis 1256
Apocrine chromhidrosis 1256
Apocrine glands 21, 21f23f, 1256
Apocrine miliaria 1256
Apocrine nevus 401
Apocrine sweat glands 23f
diseases of 1250
Apolipoprotein
B 878
C 881
Aponeurotic fibroma 1531, 1531f
Apoptotic cell 31
Apoptotic keratinocytes 533f
Appendages 20
Aquagenic wrinkling 258
Aquaporin 257, 1621
Aqueous crystalline penicillin G 1302
Arachnids 1651
Arboriform vessels 1580f
Arcanobacterium hemolyticum 1778
Arenaviruses 743
Areolar diseases 1257
Argininosuccinate synthetase 875
Arginosuccinic aciduria 1172
Arnica montana 2099
Arnold–Chiari malformation 1054
Arsenic 1622
Artemis, cooperation of 40
Artemisia vulgaris 1633
Arterial capillaries 25f
Arterial catheters 154
Arterial malformations 1387
Arterial tortuosity syndrome 888
Arteriovenous fistula 1347, 1419
Arteriovenous malformation 968, 1347, 1387, 1415, 1417f, 1418t
Arteritis, lymphocytic thrombophilic 700f
Arthralgia 959
Arthritis 825, 827
enthesitis-related 820, 821, 826
juvenile 702
chronic 820
inflammatory 85f, 510
pediatric granulomatous 993
pyogenic 840, 841f
reactive 1326
sexually acquired reactive 1946
systemic juvenile 824f
idiopathic 822
Arthrogryposis 335
Arthropod bites 1649
Arthropod borne diseases 1978
Arylsulfatase
B 908
E 61
Ascher syndrome 1308
Ascorbic acid 742
Ashy dermatosis 1137
Aspartate
aminotransferase 815, 1701t, 2054
transaminase 511, 1670
Aspergillosis 173, 1869, 1870f
allergic bronchopulmonary 775, 1870
Aspergillus 173, 436, 438, 472, 476, 1278, 1851, 1855, 1870, 1987
fumigatus 173
niger 2097
Ataxia-telangiectasia 62, 416, 419f
Atherosclerotic disease 332
Atopic cheilitis 585f
Atopic dermatitis 33, 387f, 450f, 564, 575, 575t, 577, 578t, 580t, 581f583f, 585, 585f587f, 589, 599, 605f, 625, 1253, 1642, 1685f, 1785f, 2000, 2002, 2002t, 2019
classical 585f
diagnostic criteria of 579t
diffuse 585f
features supportive of 586t
Atopic disease 775, 2100
Atopic erythroderma 564f
Atopic eyelid eczema 585f
Atopic folliculitis 585f
Atopic pulpitis 585f
Atopobium 1723
Atopy patch test 109
Atrial myxoma 1128
Atrichia 240f, 1166
congenital 1167
diffuse 1165
isolated 1165
Atrophia maculosa varioliformis cutis 1055, 1055f
Atrophic candidiasis, chronic 1324
Atrophic scarring 318f
Atrophic tongue 343f
Atrophoderma 235f, 1048, 2068
follicular 1049, 1050t
idiopathic 1048f
vermiculata 1049, 1050f
Atrophy 74, 1048
Attacks, acute 713
Attention-deficit hyperactivity disorder 215, 575, 1129, 1975
Auricle, pseudocyst of 1494
Auricular chondritis 856f
Auriculotemporal syndrome 694, 694f
Auspitz sign 94
Australian plant melaleuca alternifolia 2096
Austrobilharzia terrigalensis 1618
Autoeczematization 628, 628f
Autoerythrocyte sensitization syndrome 744
Autoimmune blistering diseases 660, 661, 664, 2037, 2038
Autoimmune bullous diseases 660, 682, 2031, 2037
acquired 162
chronic 674
classic 727
Autoimmune bullous skin disorder intensity score 665
Autoimmune connective tissue diseases 695, 736, 2023
Autoimmune disease 368, 795, 822, 2039, 2047
aggregation of 783
pathogenesis of 2049
Autoimmune disorders 371, 718
Autoimmune hematologic abnormalities 854
Autoimmune inflammatory diseases 2041
Autoimmune polyendocrine syndrome 943, 944t
Autoimmune polyendocrinopathy candidiasis-ectodermal dystrophy 421, 422, 942, 1853
Autoimmune polyglandular syndrome 923, 943f
Autoimmune thyroid disease 795
Autoinflammation 144, 847
Autoinflammatory diseases 759, 847
inflammasome-related 35
Autoinflammatory disorders 843
Autoinflammatory panniculitis 839
Autoinflammatory syndrome 706, 768, 835, 838, 840, 840f, 767, 913
OTULIN-related 839
proteasome-associated 843
Autologous serum skin test 110
Autosensitization 628
Autosomal dominant 256, 264, 355, 374, 417, 443, 737, 836, 879, 890, 1016, 1064, 1066, 1071, 1073, 1145, 1306, 1333
disorder 296, 356, 357, 383t
inheritance 58
skin disorders 383t, 396
segmental mosaicism of 382, 383
Autosomal recessive 262, 266, 273, 355, 374, 416, 417, 737, 738, 835, 879, 890, 1015, 1016, 1061, 1064, 1073, 1145, 1333
congenital ichthyosis 204, 210, 211, 219, 220, 222f, 267, 568f, 1167, 1167f, 1253
disorder 348
genodermatosis 285
hypertrichosis 1178
ichthyosis 1168
inheritance 58
junctional epidermolysis bullosa 386f
keratin 643
keratoderma-ichthyosis-deafness syndrome 266
skin disorders, segmental mosaicism of 384
woolly hair 292
Avena sativa 2097
Axillary freckling 352f, 1129f
Azathioprine 474, 514, 593, 789, 858, 956, 2027, 2028f, 2029t
off-label dermatologic uses of 2027t
potential side effects of 2028t
Azithromycin 2016
B
Bacillary angiomatosis 1722
Bacillus anthracis 1705, 1706
Bacillus Calmette–Guerin 104, 433, 436, 516, 863, 1695, 1705, 1706, 1740, 1780
Bacitracin-polymyxin B ointment 1302
Bacteria 1941
streptomyces 1987
hygroscopicus 1985
Bacterial disease 102
foci of 703
Bacteriological tests 103
Balamuthia 1885, 1886
mandrillaris 1885
Balanitis xerotica obliterans 795
Banal nevus, classic cobblestone pattern of 98f
Bannayan–Riley–Ruvalcaba syndrome 962, 1422
Baricitinib 2049
Barraquer–Simons syndrome 1086
Barsy syndrome 1072
Bart syndrome 374, 642, 649
Bartonella
henselae 472, 1081, 1282
infections 1718
quintana 1723, 1900
Bartonellosis 1721
Bart–Pumphrey syndrome 296
Basal cell 9, 17
carcinoma 315, 340f, 1050, 1482, 1551, 1551f, 1553, 15781580, 2004
criteria for 96
dermoscopy of 1553f, 1580f
eruptive 1554f
layer 18f
nevus syndrome 275, 1579, 1580f, 1581t, 1997, 1998, 2004
diagnostic criteria 1582t
vacuolization 533f
Basal epidermolysis bullosa simplex, types of 642
Basal keratinocyte 23, 644
Basaloid follicular hamartoma 1481, 1483, 1484
Basic fibroblast growth factor 486, 1094
Basophilic cells 1480f
Basophils 31, 36
Bathing suit ichthyosis 222
Bazex–Dupré–Christol syndrome 1051, 1051f, 1166, 1166f, 1171, 1172, 1482, 1551, 1553, 1578f, 1582
Bazin erythema induratum 1081
B-cell 46
activation 47
lymphoma
cutaneous 911, 1467, 2047
mature 1469
pseudolymphoma, borrelia associated 1470
receptor 40
Beach worm 1889
Bead and neck surgery 516
Beau's line 683, 973, 1264, 1265f
Becker's melanosis 1131
Becker's nevus 406, 1131, 1132f, 1182, 2084, 1541
syndrome 406, 407f, 1131f, 1132
Beckwith–Wiedemann syndrome 1310, 1310f, 1569
Bedbugs 1914
nymphal stage of 1914f
Bednar's aphthae 150, 151f
Behçet's arteritis 958
Behçet's disease 530, 749, 759, 767, 842, 960, 1081, 1317, 1330f, 2028, 2035, 2043, 2044
extracutaneous features of 769t
neonatal 148
Behçet's syndrome 763, 848, 1318, 1632
Beighton Scale for Joint Hypermobility 1064t
Benadryl 2066f
Benzophenone 1977
Benzoquinone acetic acid 874
Benzoyl peroxide 1230, 1974
Benzyl alcohol 1902, 1990
Benzyl benzoate 1909
Benzylamines 1988
Berardinelli–Seip congenital lipodystrophy 935
Berlin syndrome 1157, 1157t
Bernard–Soulier syndrome 738t
Beta-blockade 1653
Beta-carotene 1644
Beta-catenin gene 1479
Beta-chemokines 32
Beta-defensins 33
Beta-endorphin 1096
Beta-galactosidase deficiency 907
Beta-glucocerebrosidase 904
Beta-glucuronidase 908
Beta-hexosaminidase 36
Beta-human chorionic gonadotropin 2043
Beta-lactam antibiotic 727, 1690
Beta-lipotropic hormone 1096
Betamethasone 2100
Bevacizumab 969
B-glucan 422
B-hydroxy acids 1974
Bier anemic spots 1810f
Bifidobacterium, strains of 2100
Big toenail, congenital malalignment of 1280, 1280f
Bioflavonoids 742
Biopsy 106
Biotin function disorders 888
Biotinidase 875, 888
deficiency 1446
Birbeck granules, racket-shaped 19f
Birth injury 153
Birt–Hogg–Dubé
disease 1985
syndrome 316, 1481, 1588, 2041
Bisphosphate 41
Biting midges 1650
Bjornstad syndrome 1171
Black dot tinea 1828f
Black hairy tongue 1318
Black heel 1612, 1613f
Bladder diverticula 888
Blaschko's linear hypohidrosis 306
Blaschko's lines 235f, 380, 1048, 1107
Blaschkoid segmental hypermelanoses 1132
Blastomyces 106
adhesin 1861
dermatitidis 1861, 2020
Blastomycosis 1861, 1863f
Blau syndrome 843, 845f, 993, 994f, 996f
Bleach baths 591, 591t
Bleeding 1362
disorders 732, 736, 737
acquired 738, 739
Bleomycin chemotherapy 1136f
Blepharitis 889, 1300
Blepharokeratoconjunctivitis 1300
Blister
formation, planes of 639f
hemorrhagic 338f, 642f
Blistering
dactylitis 682, 1692, 1692f
disorders 685
moderate-to-severe 652f
photodermatoses 685
Bloch–Sulzberger syndrome 143, 308
Blood 1461
brain barrier 2122
chemistry 2012
sampling, fetal 153
streaked stools 621, 1692
urea nitrogen 726, 2015, 2034, 2054
vessel endothelium, neutrophilic infiltration of 83f
Bloodsucking mites 1913
Bloody stools 1435
Bloom syndrome 62, 335, 336, 657, 791
Blue nevi 1128, 1510, 1510f
Blue rubber bleb nevus syndrome 745, 1351, 1364, 1412f
Blueberry muffin 173f, 744, 1572, 1925
Blueberry muffin baby, causes of 170t
Blue-light phototherapy 2083
B-lymphocytes 1776
BN syndrome 407
Bockenheimer syndrome 1414
Body fat, redistribution of 927f
Body lice 1904
Body mass index 487, 945
Body surface area 717, 1461, 1670
total 1601
Bohn's nodules 149, 149f, 1313f
Bone
benign tumors of 1540
cyst 406
Ewing tumor of 1573
hypertrophy 406
marrow
failure 323
transplantation 465, 2118, 2119
morphogenetic protein 1031, 1077
ossification, heterotopic 61
proliferations of 1543
Bonnet–Dechaume–Blanc syndromes 1419
Bony trabeculae, eosinophilic 1028f
Böök syndrome 1332
Borago officinalis 2099
Borderline lepromatous 1118, 1747, 1748
leprosy 1749
Borderline tuberculoid 1119, 1747, 1748
leprosy 1749
Borderline vascular tumors 1378
Borrelia 537
afzelii 692
burgdorferi 692, 1049, 1469, 1470, 1716, 1930
garinii 692
infection 1004
recurrentis 1900
Borrelial lymphocytoma 1717
Bote sign 628
Botryomycosis 1691, 1857
Botulinum toxin 1094, 1251
Bowel syndrome, irritable 2100
Bowen's disease 2004
Brachycephaly 370
Bradycardia 919
Braiding
off scalp 2070
on scalp 2070
Brain 266
edema, cytotoxic 1768
tissue 1169, 1182
heterotopic 192
Branched-chain organic acidurias 876
Branchial arch defects 177t
Branchial cleft anomalies 176, 178f
Breast
abscess 1688
hypoplasia, ipsilateral 1132f
tissue, accessory 195
Brill-Zinsser disease 1711t, 1712
Brittle cornea syndrome 1063
Brittle hair 297f, 329
Brittle nails 1268
Broad-band ultraviolet B 507, 1642, 2000
Brocq pseudopelade 2033
Brodalumab 516
Bromhidrosis, eccrine 1253
Bromo-2-nitropropane-1,3-diol 606, 620
Bronchial anastomotic dehiscence 2041
Bronchiolitis, respiratory 847
Bronchogenic cyst 180, 181f
Brooke–Spiegler syndrome 1482, 1985
Brown facial foundation 2069f
Brown pigmentation, diffuse 1506
Brucella 1730
Brucellosis 1730
Brugia malayi 1695, 1887, 1888
Bruises 1626
B-type natriuretic peptide 1811
Bubostomum phlebotomus 1890
Budd–Chiari syndrome 775
Bulbar conjunctiva, lateral 419f
Bulimia nervosa 945
cutaneous manifestations of 945t
Bullae 73
hemorrhagic 796f
Bullosis diabeticorum 685, 939
Bullous dermatitis artefacta 685, 685f
Bullous pemphigoid 640, 661, 668f, 946
antigen 91f, 645
disease 669
Bunyaviruses 743
Bupivacaine 2105
Bureau–Barriere–Thomas syndrome 270
Burgdorf reaction 698
Burkholderia
cepacia 433
mallei 1733
pseudomallei 1733
Burkitt lymphoma 1469
Burning mouth syndrome 1327
Burns 1601, 1629
abusive 1630
electrical 1603, 1604f
first aid of 1603
friction 1605
mimickers of 1630t
Burow's solution 626
Buschke–Ollendorfs syndrome 1034, 1077, 1177f, 1522
Butyrospermum parkii 2069
C
Café-au-lait 1129
multiple 1129f
spots 359, 941, 942, 1128
Calcineurin inhibitors 474
topical 507, 508, 589, 607, 1112, 1975, 1984
Calcinosis
cutis 156, 337, 1020, 1023
classification of 1021t, 1026t
diagnosis of 1026t
iatrogenic 1021, 1024
idiopathic 1021, 1023
management of 1025
types of 1027t
familial tumoral 1021, 1025
hyperphosphatemic familial tumoral 1025f
Calciphylaxis 972, 1020, 1021, 1024
Calcipotriol 1982
Calcium 789, 2035
modulating cyclophilin ligand 443
Calendula officinalis 2098
Callus 74, 1611f
Calpastatin gene 239
Calvarial defect 1414f
Calymmatobacterium granulomatis 1943
Camphor 1975
Campylobacter
fetus 1326
jejuni 1326
Cancer
chemoprevention 2052
manifestations of 973
treatments for 1141t
albicans 106f, 171, 421, 476, 612, 692, 883, 889, 1698, 1847
diaper dermatitis 619, 619f
esophagitis 1852
infections 1285, 1847
intertrigo 1694
superinfections 444f
Candidiasis 171, 1275f
acute 1323
pseudomembranous 1323
chronic 1324
hyperplastic 1324
congenital 567f, 172f, 1851f
cutaneous 611, 1848, 1849, 1850, 1850t
granulomatous 1850
mucocutaneous 460f
neonatal 171, 1851
systemic 1852
Candle sign 94
Candle syndrome 841, 842, 1085
Caninum 1889
Cantu syndrome 1177
Capillary leak syndrome 464
Capillary lymphatic-venous malformation 1355f, 1395
Capillary malformations 1347, 1350, 1351, 1352f, 1387, 1388, 1389f
arteriovenous malformation syndrome 379, 969, 1364
dermoscopy of 1390f
diffuse 1388, 1392, 1395f, 1450
Capillary nevus, eccrine 402
Capnocytophaga 1662
Caput succedaneum 154
Carbamazepine 1668f
Carbamoyl phosphate synthetase deficiency 875, 876
Carbaryl 1903
Carbon dioxide 1382
lasers 2073
Carbon monoxide 996
Carboxylase deficiency 1281
multiple 888
Carbuncles 1687
Carcinoembryonic antigen 21, 1487
Carcinoid
syndrome 693, 973
tumors 973
Carcinoma
esophageal 272
metastatic 1563
Cardiac anomalies 1348
Cardiac disease 2040
amelioration of 332
Cardiac myxomas 1128
Cardiocutaneous syndrome 288, 288f
Cardiofaciocutaneous syndrome 204, 361, 364
Cardiomyopathy 268
hypertrophic 362
Cardiopulmonary disease 804, 2031
Cardiovascular disease 372, 2039
early 937
Cardiovascular system 1918
Caregiver, role of 2104
Carney complex 1128, 1583, 1584f
diagnostic criteria of 1128t
Carpet tack 1206
Cartilage
benign tumors of 1540
hair hypoplasia syndrome 424
proliferations of 1543
Carvajal–Huerta syndrome 273, 288
Castleman's disease 974
Cat bites 1662
Cataract 335
sectorial 235f
Caterpillars 1651
dermatitis 1651f
Cationic antimicrobial peptides 1683
Cat-scratch disease 1722
Ceftriaxone 2014
Celecoxib 827, 1621
Celiac disease 500, 674, 679, 959, 1316, 1318
Cell
Death
BCL2 associated agonist of 392
subsequent 2120
luminal borders of 23f
membrane 35f
therapy, reported clinical studies of 2118t
Cellular innate inherent immune components 35, 36
Cellulitis 682, 1695, 1695f
bacterial 682
eosinophilic 772
Centella asiatica 1045
Centers for Disease Control and Prevention 1765, 1903, 1924
Centipedes 1651
Central nervous system 122, 164, 183, 229, 311, 355, 404, 406f, 443, 735, 1074, 1130, 1133, 1388, 1439, 1467, 1492, 1503, 1505, 1571, 1628, 1669, 1704, 1772, 1852, 1902, 1918, 2020, 2097, 2122
disease 783
Centruroides 1653
exillicauda 1653
Cephalohematoma 154
Cephalopoda 1617
Cephalosporins 2013, 2014
dosing regimens of 2013t
oral 2013t
potential adverse effects of 2014t
Ceramidase deficiency 908
Ceramide
fatty acid chain of 210f
synthase 210f
Cercarial dermatitis 1617
Cerebral
cavernomas 1387
cavernous malformation 1351
disease 784
dysgenesis 270, 348
Cerebriform
collagenoma 1522, 1523
sebaceous nevus 398f
Cerebro-costo-mandibular syndrome 1543
Cerebro-oculo-facial-skeletal syndrome 335, 340
Cerebrospinal fluid 231, 1707, 1762, 1851, 1886, 1927, 1988, 2009
Cerebrotendinous xanthomatosis 879
Cerebrovascular disease, peripheral 334
Cervical
adenitis syndrome 848, 1325
hypertrichosis, familial 1180
regions, posterior 1766
Cervicitis, mucopurulent 1944
Cervix 1938
Cesioflamea 1510
Cesiomarmorata 1510
Cetirizine 2066f
Ceylonium 1890
Chamomile 2098
Chanarin–Dorfman syndrome 226, 232, 269
Chancre
perimeatal 1919f
tuberculous 1737
Chancroid 1941, 1941f
recommended treatment regimens for 1942t
Charcot–Marie–Tooth disease 331
Chediak–Higashi syndrome 424, 848, 1099, 1101, 1154, 1155, 1156f, 1445
features of 425f
Cheilitis 1314
glandularis 1314, 1314f
Chemical
burns 1605
conjunctivitis 1301
hepatitis 789
injury 155, 1636
artifactual 1637f
Chemokines 36
macrophage-derived 588
Chemotherapy 473, 1560
toxic erythema of 473
Cherry-red papules 1783f
Chest
upper 343f
X-ray 1862
Chevron nails 1265
Cheyletidae 1913
Cheyletiella parasitivorax 1913
Chickenpox 683, 1056f, 1789
enanthem of 1322f
Chikungunya 743, 1767
neonatal 171
virus 171, 1767
Chilblains 1266, 1599, 1599f
lupus
erythematosus 1600f
familial 695, 847
Child abuse 1626
intraoral manifestations of 1631
Child syndrome 233, 234, 236f, 2122
Child's eyelashes, infestation of 1901f
Childhood pemphigus 664
foliaceus 664t, 665
vulgaris 664, 664t
Childhood psoriasis, clinical spectrum of 487t
Children's dermatology life quality index 16, 70
Chime syndrome 241
Chinese herbal medicine 2099, 2100
Chironex fleckeri 1616
Chiropsalmus
quadrigatus 1616
quadrumanus 1616
Chlamydia 104, 528, 2015
associated syndromes 1945, 1946
trachomatis 528, 1326, 1935, 1943, 1944, 1946f, 1956
Chlamydial infections 1950, 1951, 2012
recommended treatment regimens for 1951t
Chloracne 1242
Chlordiazepoxide 2100
Chlorine 2022
Cholangitis, primary biliary 963, 964
Cholesterol
ester storage disease 879
higher total 498
Chondrichthyes 1616
Chondrodysplasia punctate, X-linked dominant 233
Chorionic villus sampling 64, 153, 216
Christ–Siemens–Touraine syndrome 304
Chromate 603
Chromatography-mass spectrometry 877
Chromhidrosis, eccrine 1256
Chrommycetomeosomes 1899f
Chromobacterium violaceum 1614, 1619, 1620
Chromoblastomycosis 1857, 1859, 1860f, 1861
Chromonychia 1276
Chromosomal breakage
analysis 62
syndromes 62
Chromosomal disorder 61, 368
Chromosomes 55, 59f, 1104
Chronic bullous disease 660, 666, 667f, 667t
Chronic cutaneous lupus erythematosus 429, 784
Chronic diseases 790, 815, 825, 2096
management of 2032
Chronic disseminated histoplasmosis 1867
Chronic graft-versus-host disease 344, 465, 467, 468f, 469t, 1552, 2028
Chronic mucocutaneous candidiasis 421, 422, 423f, 1281, 1285, 1285f, 1324, 1848, 1853
subgroups of 421t
Chronic obstructive pulmonary disease 1145, 2051
Chronic suppressive therapy 1959
Chrysanthemum 1901
Churg–Strauss syndrome 753, 754, 967, 2043, 2047
Cicatricial alopecia 311f
Cicatricial pemphigoid 670
Ciclopirox olamine 1988
Cimex lectularius 1914
Circulation 15
Cladophialophora carrionii 1859
Clarithromycin 2016, 2041
spectrum 2016
Clavus 74
Clear cell papulosis 1487, 1488f
Cleft lip 270, 293, 300, 305, 316, 320
syndrome 321f
Cleft palate 266, 270, 293, 300, 305, 316, 319f, 320
syndrome 316, 321f
Cleft syndrome 219
Clindamycin 1231, 1686
Clinodactyly 406
Clobetasol propionate 797
Clostridium difficile 1326, 1729
Clotrimazole 1839, 1987, 2041
Clouston's syndrome 296, 297f, 304, 322, 1043, 1291
Cloves syndrome 1397
Clubbing 1271, 1272t
Clutton's joint 1928
Coagulation cascade 735f
inherited disorders of 737t
Coagulation disorders 2039
Coal tar 1975
preparations 507
Coats plus disease 344
Cobalamin
C defect 1446
metabolism disorders 889
Cobb syndrome 1419
Cocamidopropyl betaine 109, 606
Coccidioides 106, 1862, 1865
immitis 2020
Coccidioidomycosis 1865, 1871
cutaneous 1866f
disseminated 1865
primary 1865
Cockade purpura 752f
Cockayne syndrome 332, 334, 334f, 339, 791, 1168
Coffin–Siris syndrome 1273f
Cogan's syndrome 857
Colchicine 1140, 2034
Colchicum autumnale 2034
Cold
abscess 164f
agglutinins 742, 1598
injury 1637
panniculitis 1081
sores 682
stimulation test 709
urticaria 709
Collagen messenger ribonucleic acid 330
Collagen nevus 1035f
Collagen vascular disease 756, 781
Collagenoma 359f, 1035f
familial cutaneous 1034
Collagenous stroma 1532f
Collarette scales 74
Collodion baby phenotype 1167
Colloid milium 909
Colon cancer, hereditary nonpolyposis 355
Colony-stimulating factors 32
Color adornment products 2065
Coma blisters 685
Combined oral contraceptives 1233
Comedones 1035f, 1227
Common warts 1797, 1798f
dermoscopy of 1798f
Community-acquired methicillin-resistant Staphylococcus aureus 1688, 1690
Complement fixation 1764, 1859
Complement split products 428t
Complete blood count 505, 510, 710, 762, 996, 1461, 2012, 2030, 2054
Complete lymph node dissection 1564
Complex regional pain syndrome 697
Computed tomography 180, 436, 928, 967, 1030, 1360, 1392, 1481, 1670, 1864
Condylactis gigantea 1619
Condyloma acuminatum 1799, 1955f, 1989, 2039
Condylomata lata 1922f
Confetti-like hypopigmentation 360f
Confusion 1660
Congenital alopecia 292, 1165
syndrome 270, 1167
Congenital heart disease 739
diagnosis of 1272t
Congenital melanocytic nevus 100f, 1111f, 1168, 1182, 1182f, 1501, 1503, 1504f, 1505, 1506t, 1556
dermoscopic patterns 1507
syndrome 1503
Conical teeth, eruption of 306f
Conjunctival erythema 722f
Conjunctival telangiectasias 340f
Conjunctivitis 1301, 1302, 1774
allergic 1302
bacterial 1301, 1302
chlamydial 1302
gonococcal 1301, 1937f, 1939
herpetic 1785f
trachoma inclusion 1302
vernal 1302
viral 1302
Connective tissue
diseases 2029, 2037
heritable diseases of 1061
matrix, fibrous 6
nevus 1034, 1077f, 1521, 1522f
fibroblastic 1036f, 1521, 1522, 1523f
Conradi–Hünermann–Happle syndrome 233, 235f, 567
Constitutional mismatch repair deficiency syndrome 354, 1156
Contact allergens 49f, 602
Contact dermatitis 50f, 598, 1315t, 1782
irritant 598
lateral 620f
Contact hypersensitivity 49
elicitation of 50, 50f
induction phase of 49
Contact irritant dermatitis 599f
Contact stomatitis 1314
Contact urticaria 598, 711
immunologic 598
non-immunologic 598
Contiguous gene syndromes 61
Contraception, method of 1944
Conventional systemic therapies 510
Coombs test, negative 736
COPA syndrome 847
Copious fungal hyphae 87f
Copper pennies 1860
Coproporphyria, hereditary 896
Copy number variant analysis 62, 1066
Coral dermatitis 1618
Cord 75
blood 464
transplantation 463
Corneal opacity 2054
Corneal shields 2077f
Corneocyte plasma membrane 210f
Cornification, disorders of 203, 204t, 207t
Cornoid lamellae 298
Coronary artery aneurysm 1811
Coronavirus disease 2019 (COVID-19) 1316, 1807, 1809, 1810f, 1810t
Cortical thymic epithelial cells 40
Corticosteroids 592, 606, 828, 1835f
intralesional 1370
oral 2022t
systemic 723, 804, 1369
topical 503, 588, 589, 1835f, 1972, 1982, 1983t
Corticotropin-releasing hormone 925, 1225
Corynebacterium 1621, 1709
diphtheriae 1708
minutissimum 101, 1709, 1836
tenuis 1709
Cosmetic 1976, 2065, 2066t, 2067t, 2069t
removal 2068
selection 2066
treatment 2065
Costello syndrome 361, 363, 363f
Costimulatory molecule 41f, 42
role of 42f
COVID toes 1809f
Cowden disease 1319, 1985
Cowden syndrome 1422, 1483, 1526, 1546, 1587, 1589t
Coxiella burnetii 1715
Coxsackievirus 622, 683, 684, 1302, 1320, 1774
B 818
Crab lice 1904
Cranial fasciitis 1527
Cranial meningoceles 1169, 1182
Cranial radiation therapy 1606
C-reactive protein 739, 762, 801, 822, 823, 835, 855, 1010, 1697, 1810
Creatine kinase 919
Creatine phosphokinase 815, 1026, 1670, 2050
Crest syndrome 803
Crimean-congo virus 743
Crohn's disease 622, 754, 1081, 1318, 1525, 1632, 1943, 2013
cutaneous 611
diagnosis of 769
metastatic 956, 957f
Cross syndrome 1526
Crotalus horridus 1660
Crotamiton 1910
Crotonyl-N-ethyl-O-toluidine 1910
Crust 74
Cryofibrinogenemia 742
Cryogen spray units 2075
Cryoglobulinemia 695, 699, 742, 855t
Cryoglobulinemic vasculitis 2047
Cryoglobulins 1598
Cryoproteinemia 854
Cryopyrin-associated periodic syndrome 35, 702, 835, 837
Cryotherapy 1589
Cryptococcomas 1871
Cryptococcosis 1868
Cryptococcus 439, 106, 1695, 1987
gattii 1868
neoformans 1868, 2020
Cryptorchidism 266, 1037
Ctenocephalides felis 1712
C-type lectin receptors 33
Cupping 1622, 1632
Curly hair-ankyloblepharon-nail dysplasia syndrome 317
Curry–Jones syndrome 1482
Cushing's disease, skin manifestations of 927
Cushing's syndrome 927f, 1208, 1984
Cutaneous anaplastic large cell lymphoma 1463
Cutaneous lymphoid hyperplasia 1004, 1005f
causes of 1004t
Cutaneous lymphoid infiltrates 1004t
Cutaneous mastocytosis 1449
diagnostic criteria for 1452, 1453t
Cutaneous mosaicism 377
mechanisms of 379
Cutaneous tuberculosis 1737
classification of 1737t
peculiarities of 1740
Cutaneovisceral angiomatosis 1364, 1422
Cutibacterium acnes 1225, 2090
Cuticle loss 374
Cutis laxa 1070, 1071t
X-linked 1171
Cutis marmorata 123, 699
physiologic 124f
telangiectatica congenita 374, 1388
Cutis tricolor 384f, 1152, 1152f
parvimaculata 385, 1153f
Cutis verticis gyrata 1040, 1041, 1041f
congenital forms of 1169
Cyanocobalamin 603
Cyclic adenosine monophosphate 942
Cyclic neutropenia 848, 1318, 1324
Cyclists nodules 1612
Cyclooxygenase 2098
inhibitors 1621
Cyclophosphamide 789, 858, 2047
Cyclospora 528
Cyclosporine 512, 592, 626, 848, 858, 1751, 2025, 2026t
drug interactions 2026t
Cylindroma 1484
Cynergy multiplex 2077, 2080
Cyproterone acetate 932
Cyst 75, 1228
blue-brown 1493f
epidermal 1581, 1586f
epidermoid 1479, 1488, 1489f
hemispheric 1489f
lymphomesenteric 1582
multiple epidermal 1582
pilonidal 1493
preauricular 178f
walls 1239
Cystathionine B-synthase 873
Cysteine 351
Cystic fibrosis 258, 884, 965, 1145
Cysticercosis 1892
Cysticercus cellulosae cutis 1892
Cytidine deaminase, activation-induced 444
Cytochrome P450 2009
Cytokine 32, 36
based cellular differentiation 40
genes 2022
proinflammatory 35f, 1037
receptors, classes of 32f
Cytomegalovirus 170, 461, 476, 743, 1325, 1446, 1670, 1722, 2032
infection
acquired 1778
congenital 170f
Cytophagic histiocytic panniculitis 1083
Cytoplasm 18f
eosinophilic 23f
Cytosine 56
Cytosolic glucocorticoid receptor 2022
Cytotoxic T lymphocytes 50, 684
associated antigen 424, 829, 1560
D
Dabska tumor 1379
Dactylitis 1282, 1282t
Dakin's solution 317
Dapsone 2035, 2036t
hypersensitivity syndrome 2036
potential uses of 2036t
Darier's disease 80, 84f, 241, 242f, 1270f, 1981, 2004
Darier's dyskeratosis follicularis 1269
Darier's nail disease 242f
Darier's sign 94, 94f, 1470
Darier–Gottron syndrome 269
Darier–White disease 241
Dark cells 21
D-dimer 1810, 1811
De novo ceramide pathway enzymes 210f
Deafness 1928
syndrome 1167
Dechaume–Blanc syndrome 1419
Deep fungal infections 1855
Deep perivascular lymphocytic infiltrate 536f
Deep vein thrombosis 733, 787
Dehydroepiandrosterone 929
sulfate 929, 1199, 1225
Delivery system 2073
Delta wing sign 1909f
Demodex 461, 1239, 1241, 1911
folliculorum 1911
mites 1240
Demodicosis 1240, 1241f, 1911, 1912f
Dendritic cells 19, 31, 38, 43, 49f, 476, 784
Dendrocyte medallion hamartoma 1523
Dennie–Morgan sign 586f
Dense-core granules 5
Dental
abnormalities 311f
alveoli 1864
anatomy 1306
lamina cysts 149
Deoxyribonucleic acid 4, 15, 5558, 166, 210, 287, 332, 416, 429, 447, 655, 718, 1118, 1190, 1263, 1551, 1579, 1623, 1823, 1980, 2089
liposome-complex 2116
probes 1948
replication 57, 58f
single stranded 1768
transcription 56
Derma T cells 2000
Dermacentor variabilis 1652
Dermal aplasia 386
Dermal atrophy 798f
Dermal dendritic cells 38, 50, 598
Dermal duct nevus 402
Dermal epidermal junction 5, 13f, 18, 639
function 23
structure 23
Dermal fibroblasts 2117
Dermal fibroma 1523
Dermal function 23
Dermal granulomas, noninfectious 983
Dermal hypertrophies 1034
Dermal hypoplasia, focal 60, 305, 313, 314f, 1051, 1053f
Dermal inflammation 79f
Dermal melanocytosis 905f, 1133t, 1510
congenital 1133, 1134f
primary circumscribed 1133
Dermal melanoses 1136
Dermal nodule 1530f
Dermal papilla 10, 25f, 81f, 85f, 677f, 1798f, 1802f
edematous 1436f
Dermal structure 23
Dermal telangiectasia 81
Dermanyssus gallinae 1913
Dermatitis 585f, 1621, 2066
acute spongiotic 81f
aquatic 1617
artefacta 1635, 1636f
chronic contact nickel 600f
extensive seborrheic 565f
herpetiformis 85f, 660, 674, 676f
incontinence-associated 614
infective 633, 634f, 634t
interface 1675, 1781
lip-lickers 1240
mild nummular 626f
neglecta 1638, 1638f
nummular 583f, 625, 626f
papillaris capillitii 1039
perianal 961f
periorificial 1240
severe 239, 289, 289f, 586t
streptococcal 585f
Dermatofibroma 1481, 1520, 1521f
Dermatofibrosarcoma protuberans 1567, 1568f, 1861
Dermatologic diseases 2022, 2023, 2041
multiple 2041
Dermatology 2033t, 2036t
Dermatomyofibroma 1481, 1521, 1521f
Dermatomyositis 811, 1020, 1083, 1121, 1262f, 1998
amyopathic 788
juvenile 811, 817, 818, 1121, 1121f
Dermatopathology
basics of 79
pediatric 80
Dermatophilus 1709
Dermatophyte 1823, 1839
infections, nomenclature for 1824f
natural habitat of 1823t
subcutaneous 1839
test media 1829
treatment of 1841
Dermatophytid reaction 628
Dermato-pulmonary syndrome 969
Dermatoscopy, ABCD rule of 97
Dermatosis 1057t, 1283
acute febrile neutrophilic 143, 759
arthritis syndrome 959f
bowel-associated 959
bullous 652, 682, 960
chronic atypical neutrophilic 333, 839, 842
inflammatory 461
neutrophilic 759
paraneoplastic 973
pigmented purpuric 741
syndrome 839
vesicular 144, 145f
Dermis 996f
complex structural organization of 9f
diseases of 981
reticular 24f
superficial 79f
Dermoepidermal junction 664, 1501, 2118
Dermographism 94
symptomatic 707, 708
Dermo-hipodermal junction 755f
Dermoid cyst 190, 191f, 1481, 1491, 1492f
Dermopathy
diabetic 938
restrictive 346, 807
Dermoscopic melanoma-specific structures 1512
Dermoscopy 95, 1512f
score, total 98
Desanctis-cacchione syndrome 2004
Desmocollin 2 288
Desmoglein 577
cleavage of 84f
Desmoid fibromatosis 1526
Desmoid tumors, occurrence of 1586
Desmoplakin 285, 288, 577, 640f
Desmoplastic trichoepithelioma 1482, 1483, 1483f
Desmosomal disorders 207
Desmosomal proteins plakophilin-1 640f
Desmosomal skin pathology 288f
Desmosome 660f
cell-cell contacts 285f
inherited disorders of 284
Desquamated cells 10
Destruction plus congestive cardiac failure 1416
Deubiquitinase 839
Deuteromycetes 1869
Dexamethasone 2023, 2100
Diabetes mellitus 497, 499t, 937, 938t, 939, 940, 984, 1085, 1691, 2038
insulin dependent 937
noninsulin-dependent 939f
type 1 499, 937, 985
type 2 267, 333, 372, 984
Diacylglycerol 41, 846, 1096
Diaper area
care of 1976
eruption 622f
Diaper dermatitis 611, 612, 1850
distribution of 615f
severe chronic irritant 615
Diaper rash 611
Diapering methods, early 612
Diarrhea 926f, 2100
acute infectious 2100
Diascopy 95, 95f
Diazolidinyl urea 606
Didymosis 384
Diethylcarbamazine 1888
Diethyltoluamide 1718
Dietzia papillomatosis 1143
DiGeorge syndrome 436, 440
Digital constriction bands 262
Digital fibroma, infantile 1528
Digital herpes simplex 1284
Digital infantile fibromatosis 1529f
Dihydrorhodamine 434
Dihydrotestosterone 932, 1178, 1225, 1977
Dihydroxyindolecarboxylic acid 1095
Dihydroxyphenylglycol 887
Dimercaptosuccinic acid 1623
Dimethicone 1903
Dimethyl sulfoxide 1829
Dimethylaminopropylamine 606
Dimethylglyoxime-ammonia 603
Dimorphism-regulating kinase-1 1861
Dinitrochlorobenzene 1192, 1981
Diphenylcyclopropenone 1192, 1981
Diphtheria, cutaneous 1708, 1708f
Diprolene 1982
Direct bilirubin 1670
Direct fluorescent antibody 106
Direct immunofluorescence 674, 677, 786, 841, 1764
microscopy 88
technique 660
Direct microscopic examination 105
Direct smear fluorescent antibody test 1947
Dirofilaria immitis 1910
Discoid eczema 585f
Discoid lupus erythematosus 1203, 784, 1206, 1206f
lesions 785f
erythematous 785f
treatment of 2032
Discoid lupus lesions 786
Disease-modifying antirheumatic drugs 1866
Disialoganglioside 1573
Disseminated actinic superficial porokeratosis 245f
Distal interphalangeal finger joints 812
Distal onycholysis 493f
Distal psoriatic arthritis 826f
Distinct syndrome 790
Dithranol 1981
Dog bites 1662
Dogger bank itch 1618, 1619
Dominant dystrophic epidermolysis bullosa 640, 649, 2116
Donovanosis 1942
Dopamine beta-hydroxylase 887
Doppler ultrasonography 827
Dorfman-Chanarin syndrome 233f, 300
Dormancy 1416
Double lip 1308
Down syndrome 61, 142, 368, 369f, 920, 1040f, 1310, 1316, 1485f
Doxorubicin 2047
Doxycycline 1203, 1640, 2012
therapy 1275f
D-penicillamine 805, 886
Dracunculiasis 1893
Dracunculus medinensis 1893
Drosophila melanogaster 385
Drug hypersensitivity 110
syndrome 1668, 1669t
Drug interactions 2010, 2028t, 2036t
Drug rash 462, 563
Drug reactions 565, 1664
clinical manifestations of 1668t
cutaneous 462
diagnosis of 1676t
pharmacogenetics of 1666t
Drug therapy 679, 2023
Drulia uruguayensis 1617
Dry lusterless hair 918f
Dual-energy X-ray absorptiometry 2025
Ductal mammary ectasia 1495f
Dunnigan syndrome 1086
Duodenale 1889
Dupilumab 593, 2048
Duplication syndrome 55, 61
Dupré-Christol syndrome 1490
Dusky plaques 1710f
Dysbetalipoproteinemia, familial 882
Dyschromatosis 1145t, 1157
infection-related 1157
nutritional 1158
symmetrica hereditaria 1150, 1150f
types of 1157
universalis hereditaria 1151
Dyschromia 1150, 1153f
central 798f
Dyschromic amyloidosis cutis 1158
Dyshidrosis 626
Dyshidrotic eczema 585, 585f, 626, 627f
Dyskeratosis
congenita 323, 324, 338, 341, 343f, 1153, 1154f, 1332
hereditary benign intraepithelial 1327
Dyslipidemia 498, 937
Dysphagia 811
Dyspigmentation, postinflammatory 2067
Dysplasia
fibrous 61
hereditary mucoepithelial 1330, 1330f
low grade 1562
terminal osseous 386f
Dysplastic nevi 101f, 1511
Dysraphism 189f
skin manifestations of 190f
Dystrophic calcinosis cutis 1020, 1021
lesions of 1022f
Dystrophic epidermolysis bullosa 639, 640, 648, 649, 650f, 655, 1016, 2116
types of 649t, 650
Dystrophic nails 315f
Dystrophy 647f
congenital fascial 806, 807f
D-zone test 1690
E
Ear
infection 628f
lobe, non-cartilaginous 856f
pinnae hypertrichosis 1181
Ebola virus 743
Ecchymosis 75
Eccrine gland 22f, 25f
diseases of 1250
ducts 21f, 22f
Echinococcus 1892
granulosus 1892
Echinoderms 1617
Echoviral infection 1774f
Echovirus 1782
Econazole 1839, 1987
Ecotropic viral integration site 436
Ectasias, multiple 1396f
Ecthyma 1691
gangrenosum 474f, 1445f, 1725, 1725f
Ectodermal derivative impairment 323
Ectodermal dysplasias 5, 270, 285, 286f, 293, 300, 303306, 313, 316, 321f, 322, 384, 640, 1157, 1166, 1167t, 1288
anonychia in 1273f
classification of 304t
Ectodermal mucosa 1556
Ectodysplasin 5, 304, 305
Ectonucleotide pyrophosphatase-phosphodiesterase 276, 1062
Ectrodactyly 305
ectodermal
defects 300
dysplasia 305, 316, 320
Eczema 573, 585f, 625
acute dyshidrotic 627f
area and severity index score 1985, 2049
asteatotic 632, 633f
chronic dyshidrotic 627f
coxsackium 579, 1774
craquelée 632, 633f
flexural 582f
follicular 585f
forms of 625
herpeticum 587f, 1785f, 1786
lichenified 439f
metabolic 630
mild but diffuse 581f
nummular 625
papular 1782
perinasal 581f
post-traumatic 629, 629f
psoriasis overlap 489
severe 581f, 583f
typical perioral 581f
Eczematous diseases 2028
Edaradd gene 304, 305
Edema 154, 812
acute hemorrhagic 751, 751f, 752f
blister 685, 685f
factor 1706
hereditary angioneurotic 960
vasogenic 1768
Edward syndrome 61, 370
Ehlers–Danlos syndrome 744, 1022, 1045, 1063t, 1065f
Ehrlichia 1716
chaffeensis 1716
ewingii 1716
Ehrlichiosis 1716
human monoyctic 1716
Eikenella corrodens 1662
Eipdermolysis bullosa 240
Elapidae 1659
Elastic fiber synthesis 1074
Elastic tissue nevus 1036f
Elastoma 1036f
Elastosis perforans serpiginosa 1015, 1017, 1017f, 1067, 1077
Elbow flexures 581f
Electra pilosa 1618
Electrocardiogram 1670, 1884, 2033, 2100
Electrocardiographic conduction defects 1128
Electrocardiography 362
Electroencephalography 155, 2100
Electrolysis 932
Electrolyte
disorders 2035
imbalance 300
Electromyogram 1670, 2100
Electromyography 813
Electron
energy loss spectroscopy 989
microscopy 91
Electrosurgery 1989
Elejalde syndrome 1102, 1103
Elementary body 1945
Embryonal tooth development 922f
Emery–Dreifuss muscular dystrophy 331
Emollients 605, 633, 1974
Emopamil binding protein 233
En coup de sabre 799, 1207
Enamel defects 360f
Encephaloceles 192, 1169, 1182
Encephalocraniocutaneous lipomatosis 184, 1168, 1538
Encephalopathy, hypoxic ischemic 156
Encephalotrigeminal angiomatosis 1391
Encoding anthrax toxin receptor 2 1527
Endemic typhus 1712
Endemicum 1119
Endocarditis 1727, 1939
Endocrine
abnormalities, multiple 942
cutaneous manifestations of 918
disorders 943, 2047
neoplasia, multiple 359, 913, 1034, 1333, 1519, 1546, 1588
Endocrinopathy 1251
Endoplasmic reticulum 39, 266
Endorphin 1096
Endothelial cells 1382f
epithelioid 1382f
Endothelin 1094, 1623
Endotracheal intubation 154
Energy
based devices 2072, 2072f
dispersive X-ray analysis 989, 990
fluence 2074
Engraftment syndrome 465
Entamoeba histolytica 1729
Enterobacter 1728
Enterobacteriaceae 1698
Enterobiasis 1893
Enterobius vermicularis 1304, 1893
Enterococcus faecalis 2097
Enteropathy 423, 445
Enteroviral exanthems 1774
Enterovirus 683, 1320, 1767, 1773, 1775t
infection 1773
Enzyme 837
cystathionine beta-synthase 735
defects 207, 208
dihydrofolate reductase 2017
immunoassay 1706, 1766, 1866, 1929, 1948
linked immunosorbent assay 166, 660, 674, 787, 967, 1711, 1721, 1857, 1889, 1948
replacement therapy 904, 2115, 2120, 2121t, 2122
Eosin stain 23f
Eosinophil 31, 36, 43, 85f
cationic protein 36
derived neurotoxin 36
rich dermatoses 770t
Eosinophilia 462, 563, 1007, 1008, 1378, 1668
myalgia syndrome 804, 805
Eosinophilic diseases 759, 770
Epicutaneous test 600
Epidemic typhus 1711
Epidermal acanthosis 80f
Epidermal appendages, development of 4
Epidermal dermal junctions 2116
Epidermal growth factor receptor 273, 1671
Epidermal hypermelanoses, primary circumscribed 1127
Epidermal nevus 273, 390, 393, 396, 397f, 404, 405, 2086f
epidermolytic 394f
group of 390
syndrome 390, 403, 404t
Epidermis 4f, 210f
cysts of 1479, 1488
embryonic 6f
keratinization of 9f
necrotic 725f
overall organization of 13f
papillomatous 218f
tumors of 1479
type lipoxygenase 3 225
Epidermodysplasia verruciformis 1553, 1577, 1803
Epidermolysis bullosa 80, 91, 144, 146, 185, 343, 374, 639641, 643f, 892, 1152f, 1251, 1553f, 1908f, 2099, 2115
acquisita 661, 669, 669f, 670f
diagnosis of 655
hereditary 162
management of 653
nevi 646
pruriginosa 652, 653f
simplex 257, 639643, 644f, 645, 1151
classification of 641t
pathophysiology of 644
superficialis 644
Epidermolytic ichthyosis 146, 147f, 203, 204, 215, 257
superficial 204, 211, 215, 218f
Epidermophyton 1823
floccosum 1836
Epidermotropism 1435
Epigenetic disorders 63
Epilepsy, myoclonic 374, 1539
Epiluminescence microscopy 95
Episodes, stroke-like 374
Epithelial cells 4, 1973
superficial 1285f
Epithelial membrane antigen 21, 1487, 1527
Epithelioma, sebaceous 316
Epithelium 2119f
Epsilon-aminocaproic acid 432
Epstein's pearls 149
Epstein–Barr virus 416, 449, 742, 997, 1010, 1325, 1444, 1461, 1571, 1670, 1722, 1762, 1777, 1778, 1989
infection 1776, 1777
Epulis, congenital 150
Eraser challenge 1635
Eratigena agrestis 1656
Erdheim–Chester disease 1439
Erosion 74, 150
Erosive perianal dermatitis 615, 616f
Eruption 75, 1674
cysts 150
exanthematous 1667
pustular 1671
urticarial 1669
Eruptive vellus hair cysts 1183, 1484, 1491, 1492f
Erysipelas 682, 1694, 1694f
Erysipeloid 1707, 1708f
leishmaniasis 1882
Erysipelothrix 1707
rhusiopathiae 1707
Erythema 75, 153, 218f, 310f, 585f, 691, 859f, 1434f
annular 691, 692
annulare centrifugum 691, 1833
type of 691f
chronicum migrans 691, 692, 692f, 693t
elevatum diutinum 960
induratum 1739, 1740
infectiosum 1761, 1768, 1769, 1769f
local 348f
marginatum 691, 693, 693f
migrans 1716, 1717
mild 1645f
multiforme 671, 683, 684, 786f, 717, 718f, 720f, 1606, 1642
classification of 717
lesions 1810f
neonatorum 123
nodosum 72f, 960, 1080f
leprosum 1081, 1751
perianal 1693f, 1703
perinatal 1703, 1703f
periocular 791f
periorbital 844
petechial 1771f
purpuric 725f
toxicum 134, 137f
neonatorum 134
widespread 1702f
Erythrasma 1709, 1709f
Erythrocyte sedimentation rate 529, 720, 739, 762, 788, 801, 822, 823, 835, 1010, 1598, 1810, 2043
Erythroderma 75, 218f, 223f, 290f, 448f, 563
causes of 563t, 564
diffuse 147f, 569f
evaluation of 569
management of 569
mild 568f
severe 839f
Erythrodermrittle hair, congenital 348f
Erythrodontia 891f
Erythrokeratoderma, progressive symmetric 221, 268
Erythrokeratodermia 295f
cardiomyopathy syndrome 290, 290f
variabilis et progressiva 269, 295
Erythromelalgia 696, 697f
Erythromycin 1203, 1231, 2015, 2041
Erythropoietic porphyria, congenital 890, 891f
Escherichia coli 103, 171, 1238, 1687, 1728, 1886
Esthetic products 2065
Estimated gestational age 3, 6f, 10
Estradiol 930
Estriol, unconjugated 65
Estrone 930
Estuary dermatitis 1618
Etanercept 514, 2043
Ethylenediaminetetraacetic acid 61
Eumycotic mycetoma 1857
European Academy of Allergy and Clinical Immunology 108
European American Lymphoma Classification 1459
European Competence Network on Mastocytosis 1453
European League Against Rheumatism 770, 812, 816t
European Medicine Agency 2049
European Pressure Ulcer Advisory Panel 1608, 1608t
European Standard Series of Contact Allergens 108t
Ewing's sarcoma 1573
Ewing's tumor, extraosseous 1573
Ex vivo gene therapy 2117
Exanthem 75, 1761
subitum 1771
classic childhood 1761
Exanthematous pustulosis, acute generalized 727, 1656, 1672, 1672
Excoriation 74
Exfoliants 1979
Exfoliative scales 74
Exogenous physiologic stratum corneum lipids, optimized ratio of 1975
Exophiala 1278
gougerotti 1859
Exophytic nevus 2068
Exostosis, subungual 1543, 1543f
Extensive chondrodysplasia punctata 235f
Extensive molluscum contagiosum 448f
infection 1806f
External genitals, atrophy of 796f
Extracellular lipid deposition 14f
Extracellular matrix 32, 344
protein 795, 909, 1075
Extracellular signal regulated kinase 36
Extracorporeal membrane oxygenation 154
Extragenital lichen sclerosus 1120f
Extragenital warts 1957
Exudative eczematous plaques 626f
Eye
anomalies 1348
infection, herpetic 1786
Eyebrows 348f, 364f, 1051f
dermoid cyst of 191f
loss of 338f
Eyelashes 338f
pediculosis of 1301
Eyelid
apocrine cysts, multiple yellowish 315
coloboma 406f
cysts 316f
multiple 315
infection, primary herpetic 1785f
lower 369f, 1369f
Eyeliner sign 396
F
Fab’ fragment antibody 828
Fabry disease 697, 903, 904f, 2122
Facial
afro-caribbean childhood eruption 1240
angiofibroma 358f, 2123f
aseptic granuloma, idiopathic 1239, 1240f, 1489
asymmetry 2068
dysmorphism 1181
edema 1238
erythema 465f, 693
hemiatrophy, progressive 799
hyperpigmentation, idiopathic 1138, 1138f
lentigines 1584f
papules 1780f
psoriasis 487, 489f
vitiligo 1111f
warts 439f
Familial chylomicronemia syndrome 881
Familial cold autoinflammatory syndrome 417, 709, 837
Fanconi anemia 62, 1552
Farber
disease 908
lipogranulomatosis 908
Farnesyl diphosphate synthase 244
Fas ligand activate cytotoxic T cells 1666
Fasciitis
eosinophilic 801, 804
intravascular 1528
necrotizing 1697, 1697f
nodular 1527, 1528f
Fat
metabolism 1086
necrosis, subcutaneous 86f, 156, 807, 1082, 1082f
Fatal disease 783
Fatty acids 210f
essential 2099
free 1225
very-long-chain 241, 1139
Fatty aldehyde dehydrogenase 211, 229
Fatty liver disease, nonalcoholic 499
Favus tinea 1828f
Feather hydroid 1615
Felon 1285
Femur 415f
Fermitin family homolog 269, 640, 657
Ferritin 1810
Ferrochelatase 892
Fetomaternal transfusion syndrome 744
Fever 926f, 1237f
acute rheumatic 693, 693f
enteric 1728
low-grade 1780
rat-bite 1727, 1732, 1732f
rheumatic 1727
spotted 1715
Fexofenadine 1975
Fibrillary myxoid stroma 1545f
Fibrinogen 1810
Fibroadipose vascular anomaly 1414
Fibroblast 36, 2089, 2117
growth factor 1025, 1357
receptor 390, 396, 403, 1243
Fibrodysplasia ossificans progressiva 1029, 1030, 1030f
Fibrofolliculoma 316, 1481, 1588
Fibroma 1533, 1861
hereditary 2041
periungual 360f
ungual 359
Fibromatosis
colli 1525
pseudosarcomatous 1527
superficial 1524
Fibrosarcoma 1567, 1569, 1570f
Fibrotic skin disease 806
Fibrous cephalic plaques 359f
Fibroxanthoma, atypical 1571
Fibulin 888, 1071
Fifth disease 1769f
Figurate erythema 691, 824f
Filaggrin
gene 15, 576
mutations 586f
Filariases 1887
Filoviruses 743
FILS syndrome 420
Fingertip, psoriasis of 493f
Fire ants 1649
Fissure 75
painful 796f
Fissured tongue 1309, 1309f
Fistula 75
Fitz–Hugh–Curtis syndrome 1936
Fixed drug eruption 683, 1140, 1666, 1673
Flaccid blister 84f
Flagellate dermatitis 1136, 1136f
Flaky paint dermatosis 1122f
Flat warts 1799, 1800f
Flaviviridae 1768
Fleas 1650
Flexural comedones 1487, 1488f
Flice-inhibitory protein 1961
Fluconazole 1842, 1854, 2020
Flucytosine 1854
Fluorescein isothiocyanate 1947
Fluorescence in situ hybridization 61, 213, 372, 449, 1505, 1562, 1723
Fluorescent treponemal antibody 788
absorption 166, 1119
Fluorine 2022
Fluorouracil compounds 1552, 1554
Flynn–Aird syndrome 333
Focal facial dermal
dysplasia 1182
hypoplasia 1055
Folinic acid 2031
Follicle center lymphoma, primary cutaneous 1467
Follicle-stimulating hormone 924
Follicular hyperkeratosis, prominent 212f
Follicular mucinosis, idiopathic 1473f
Folliculitis 1806
bacterial 1687
decalvans 1200, 1201, 1201f
gram-negative 1238, 1728, 2052
keloidalis 1039
nuchae 1039
Fonsecaea
compacta 1859
monophora 1859
nubica 1859
pedrosoi 1859
Food
allergy 576
assessment of 578t
interactions 2011
Foot
dermatitis 605f
dorsum of 256f
Fordyce spots 1309, 1309f
Forefoot eczema 585f
Foreign body 1302
granulomas 988, 989t
reaction 1481
Foreskin cyst 194f, 1494, 1494f
Forkhead box transcription factors 392
Formal eczema action plans 588
Forme fruste 1490
Formylglycine-generating enzyme 232
Fortuitum 991
Fossae, cutaneous 188
Fournier's gangrene 1697
FOXC2 gene 924
Fox-Fordyce disease 1256
Fragile X syndrome 60
Fragrances 604
Francisella tularensis 1731
Freckles 340f, 1127
Free testosterone 1199
Freund's leukemia integration site 1383
Frey syndrome 694
Friction blisters 686, 1612
Frictional lichenoid dermatitis 1611, 1611f
Frostbite 1266, 1597
Frostnip 1597
Fumarate hidratase 1571
Fumaric acid esters 512
Fungal
cultures 105
dermatitis, invasive 1851
hyphae 105f
infections 1285, 1822
neonatal infections 171
Furuncles 1687
Furunculosis 1806
Fusarium 472, 1838, 1987
sepsis, necrotic nodule of 1855f
Fusidium coccineum 1986
Fusion inhibitors 462
Fusobacteria 1323
Fusospirochetal gingivitis 1322
Futcher's line 1131f
G
G protein signal transduction, disorders of 941
Galactosialidosis 1446
Gallop rhythm 864
Gamasidae 1913
Gamete formation 59f
Gamma
aminobutyric acid 1902
carboxyglutamate 1062
delta T-cell lymphoma
cutaneous 1467
primary cutaneous 1467f
globulin 2037
secretase protein complex 764
Ganglioneuroma 1546
Gangliosidosis 905
Gangrene 75, 1694
Gardner fibroma 1526, 1587
Gardner syndrome 961, 1582, 1586, 1586f
Gardner–Diamond syndrome 744
pathogenesis of 744
Gardnerella vaginalis 528, 1723
Gastrointestinal disease 500, 956
Gastropoda 1617
GATA2 deficiency 1085
Gaucher disease 904, 2120, 2121
Gel electrocardiogram 155
Gene 56
carriers 58
conversion 2120
disorders, single 55, 65
gun 2116
mutation
database 63
single 57
serping 712
simplified structure of 56f
testing 62
therapy 55, 2115
approach 2117fc
Genetic 486, 1099, 1505
disease 5, 56f, 807, 1291, 2123
oral manifestations of 1327
disorders 59, 923t, 1098, 2116, 2123
dyschromatoses 1150, 1153
information, packaging of 55
mutations 60
nail disorders 1286
skin disorders 2115
syndromes 1050t
testing 63
tumor prone syndromes 1577, 1577t
Genital herpes simplex 1305
virus infections 1958, 1958f
Genital mucous membranes, disorders of 1303
Genital region, primary herpetic infection of 1786
Genital ulcer 857, 968
acute 1305
disorder 1942
Genital warts 1953f
external 1953, 1955
Genitalia
abnormal 1128
anatomy of 1304f
Genodermatosis 1166, 2120t
Genomic hybridization 1505, 1562
Geographic tongue 1315, 1316f
Germ tube formation 106f
Germinative cells 1261
Germline
GJB2 disorder 297
rasopathies 351, 361
Gerodermia osteodysplastica 1073, 1074
Gianotti–Crosti
lesions 1774
syndrome 72f, 461, 461f, 1780f, 1782
Giant cell
fibroblastoma 1567
multinucleated 37, 996f
tumor 1533
Giant collagenoma 1036f
Giant congenital melanocytic nevus 2112f
Gingival fibromatosis 1525
hereditary 1525
idiopathic 1525
Gingival overgrowth, drug-induced 1525
Gingivitis 1025f
acute necrotizing ulcerative 1322
desquamative 1317
Gingivostomatitis 1320
herpetic 1321, 1321f, 1785f
Glands 21
eccrine 22f, 25f
Glassy membrane 20f
Glaxosmithkline 1986
Globular halo nevus, involution of 1511f
Glomangioma 1412
Glomerular filtration rate 1670, 2035
Glomerulonephritis 1694
postinfectious 650
Glomuvenous malformation 1351, 1364, 1387, 1412, 1413f
Glossitis 889, 1316, 1785f
idiopathic 1317f
Glucocorticoids 474, 848, 881, 925, 1811, 20232025
potencies of 928f
stress doses of 926t
systemic 2022
therapy 2023, 2024
Glucocorticosteroids 2022
Glucose
6-phosphate dehydrogenase 666, 2017, 2034, 2036
tolerance tests 937
transporter 1357, 1362, 1373
Glucosylceramide 227
Glutamic oxaloacetic transaminase 1026
Glutamic pyruvic transaminase 1026
Glutaric acidemia 875, 876
Glutaryl-CoA dehydrogenase 875
Glutathione-S-transferase 2027
Gluten-free diet 674, 679
Gluten-sensitive enteropathy 678
Glyceryl trinitrate 696
Glycogen synthase kinase-3 392
Glycolic acid 227, 1974
Glycosaminoglycans 32, 905, 2122
Glycosylation, congenital disorders of 888, 1074
Glycyrrhiza glabra, root of 2098
Gnathostoma 1888
spinigerum 1888
Gnathostomiasis 1888
Gobello syndrome 404, 406, 406f
Goeckerman therapy 510f
Goeminne syndrome 1037
Göhlich–Ratmann syndrome 1526
Goldenhar syndrome 1543
Golf tee hair appearance 1177f
Golgi apparatus 887
Goltz syndrome 313, 314f, 1319
Gomez–Lopez–Hernandez syndrome 1167
Gonadal dysgenesis 922, 924f, 924t
Gonadal mosaicism 355
Gonadotropin-releasing hormone 932
Gonionemus vertens 1616
Gonococcal infection 1939, 1940, 1949
disseminated 1936, 1937f, 1939, 1940
uncomplicated 1938
Gonorrhea 1937
Gonyaulax breve 1619
Goodpasture's syndrome 966
Gorlin's syndrome 275, 1489, 1554f, 1580f, 2004
Gottron's papules 811
Graft-versus-host disease 437, 465, 467f, 469f, 566, 775, 801, 1255, 1329f, 1606, 2119
vitiligoid chronic 470f
Gram-negative bacteria 1718, 1719t, 1723, 1985
Gram-positive bacteria 1703, 1704t
Granular cell 18
tumor 1546
Granular keratinocytes, acantholysis of 84f
Granular parakeratosis 552, 553f
Granulocyte 50f
colony-stimulating factor 464, 759, 1325, 1606
Granuloma 843
allergic foreign body 989
annulare 938, 939, 983, 984, 987f, 988, 1016, 1081
classic 83f
disseminated 2033
management of 988t
papular umbilicated 986f
subcutaneous 986f, 1081
cutaneous noninfectious 449f
gluteale infantum 620, 620f, 1850
inguinale 1918, 1942, 1943t
necrotizing palisading 966
nonallergic foreign body 989
umbilical 152, 152f, 194
Granulomatosis 753, 956, 965967, 1328
diagnosis of 967t
eosinophilic 754
lymphomatoid 997
Granulomatous disease, chronic 432, 433, 433t
Granulosis rubra nasi 1255
Graves’ disease 920922, 1056
Gray patch tinea 1827, 1828f
Green nail syndrome 1724
Greither's palmoplantar keratoderma 262f
Griffiths’ classification 550t
Griscelli syndrome 425t, 848, 1098, 1100, 1102, 1103f, 1155, 1156f, 1445
Griseofulvin 2018
therapy, potential adverse effects of 2019t
Growth hormone 922
deficiency 922
disorders 922
excess 922
primary 922
Guanine 56
Guanosine triphosphate 433, 1026
Guillain–Barré syndrome 1708, 1791
Gunther disease 336, 341, 890
Gustatory erythema 694
Guttate psoriasis 491, 491f, 502, 503f
Gyrate erythemas 691
H
H syndrome 374, 843, 1139, 1139f, 1182
H1 antihistamines 1455
Haemophilus ducreyi 1941
Haemophilus influenzae 164, 429, 438, 460, 1696, 1727, 2016
infection 164
type B 990, 1695
Hailey–Hailey disease 243
Haim–Munk syndrome 268
Hair 1163
acquired progressive kinking of 1177
camouflage techniques 2069
counts 113
cutting 1638
cycle changes 127
disease 113, 114t
disorders 1165
feathering 113
findings 533
follicle 8f, 20, 20f, 21f, 25f, 677f, 1436f, 2074f
bulb of 20f
light of 20f
nevus 399, 402
growth window 113
integration systems 2070
invasion 1826t
loss
classification of 1185
disorders, acquired 1185, 1200
morphology 10f
multiple 1481f
patterns 127
pull test 113
removal 2087t
shaft 10, 114, 114f, 1899f
abnormalities 1170
thinning 929f
transverse sections of 20f
typical thinning 929f
uncombable 1174, 1175f
Hairpieces 2070
Hairy cutaneous malformations 1180
Half-and-half nails 1277f
Half-buried horizontal mattress sutures 2108
Hallermann–Streiff syndrome 335, 1169
Hallopeau acrodermatitis continua 494
Hallux nail 1280f
Halo nevi 1510
Haloclava producta 1619
Halt disease 2122
Hamamelis virginiana 2099
Hamartoma
eccrine angiomatous 402, 1183, 1484
fibrous 1527, 1531, 1532f
meningothelial 1544
neuromuscular 1544, 1545f
precalcaneal fibrolipomatous 1524f
syndrome 404, 1422
multiple 1587
Hand
atopic dermatitis 583f
dorsum of 720f
eczema 583f
Hand-foot
mouth
buttock syndrome 622
disease 683, 683f, 1265, 1320, 1773, 1774f
skin reaction 698
Hansen's disease 1746, 1750
Hantavirus 743
Hapalochlaena 1617
Hapalonychia 1269f
Happle–Tinschert syndrome 1484
Harlequin ichthyosis 221, 227, 228f
Hartnup disease 875
Hartnup disorder 877
Hashimoto's thyroiditis 920
Hashimoto–Pritzker disease 142, 745
Hay–Wells syndrome 219, 316, 1291
Head lice 1903
family of 1898f
Hearing loss 843
Heart
anomalies 843
disease, congenital 739
failure, congestive 919, 2045
monitoring, fetal 153
Heat urticaria 710
Helicobacter pylori 739
Heliotrope eruption 811
Helminthic
diseases 1887, 1891
infections 775, 1880
Helminths 476
Hemangioendothelioma 1381, 1381f
epithelioid 1383
pseudomyogenic 1381
Hemangioma 1347, 1348, 1363
congenital 1348, 1363, 1373, 1374, 1375f, 1376, 2122
epithelioid 1007, 1373, 1378
gepatic 1363
lobular capillary 1378
multifocal infantile 1363
multiple infantile 745
noninvoluting congenital 1348, 1349, 1349f, 1373, 1375
periocular infantile 1363
segmental infantile 1349f
ulcerated infantile 2081f
verrucous 1355, 1413, 1413f
Hematologic diseases 695
Hematoma 75
subungual 1275f
vulvar 1613
Hematopoietic stem cell transplantation 313, 323, 463, 907, 1471, 2120
Hematopoietic system, diseases of 1429
Hematoxylin 23f, 1417f
Hemidysplasia, congenital 380, 386, 395, 395f, 403
Hemihypertrophy 1182, 1355f
Hemivertebrae 406
Hemochromatosis 940, 964
hereditary 964
Hemoglobin 2075
Hemolytic disease 145
Hemophagocytic lymphohistiocytosis 824, 848, 1083, 1444, 1445f
Hemophagocytic syndrome 1466
Hemophagocytosis 1435
Hemophilia
A 737
B 737
Hemorrhage 1352f
splinter 1275f
subconjunctival 153
subungual 1276t
Hemorrhagic disease 738
Hendersonula toruloidea 1838
Henoch–Schönlein purpura 417, 575, 686, 686f, 749, 749f751f, 1727
Heparan sulfate proteoglycan 6
Heparin, low-molecular-weight 740
Hepatic disease 739
Hepatic disorders 2039
Hepatitis
B
reactivation 2048
virus 1057, 2038
C virus 461, 1325, 2038
Hepatocyte growth factor 1094
Hepatorenal syndrome 2017
Hepatosplenomegaly 417, 443, 447, 824, 843
Hepatotoxicity 2045
Heredopathia atactica polyneuritiformis 230
Hermansky–Pudlak syndrome 848, 1098, 1099, 1101
Hernia
inguinal 888
umbilical 918f
Herpangina 1320, 1774
Herpes genitalis
first episode of 1959t
recurrent 1960
Herpes gestationis 946, 947
neonatal 146
Herpes labialis 1786, 1989
Herpes simplex 162, 648, 682
infection 1302, 1783
disease, recurrent episodes of 1960
infections, treatment of 1788t
Herpes zoster 683, 1303, 1792
infection 1793f
ulcerating 461f
Herpesviridae 1783
Herpetic whitlow 1284, 1785f, 1786
Herpetiform ulcers 1317
Herringbone 1265
Heteroplasia, progressive osseous 942, 1026, 1027, 1028f
Hexachlorophene 1972
Hexylene glycol urea 1982
Hibernoma 1540
Hidradenitis
eccrine 1610
suppurativa 764, 840, 1237, 1488, 1857, 2042
Hidrocystoma 1493, 1493f
eccrine 81f
Hidrotic ectodermal dysplasia 322, 323f
Highly active antiretroviral therapy 936, 1824
High-voltage accidental electrical injuries 1604
Higoumenaki's sign 1928
Hirschsprung's disease 956, 960, 961f
Hirsutism 932, 1208
Histiocytic pseudorosettes 1010
Histiocytoma
angiomatoid fibrous 1569
malignant fibrous 1569, 1572
Histiocytosis 1006
benign cephalic 1441, 1442f
congenital 162
Histogenesis 121, 1099
pathology 1930
Histoplasma 106, 1867
capsulatum 1866, 2020
Histoplasmosis 1866, 1867, 1871
acute disseminated 1867
cutaneous 1867
primary 1867
secondary 1867
Hobo spiders 1656
Hodgkin's disease 1204, 1464, 1472
Hodgkin's lymphoma 974, 1272, 1546
Hodgkin's syndrome 316
Holocarboxylase synthetase 888
Holothuroidea 1617
Homeopathy 2101
Homocysteine 873
total 873
Homocystinuria 735, 873
Hormodendrum pedrosoi 1859
Hormonal therapy 1234
Hormone
adrenocorticotropic 922, 1096, 1128, 1671, 2025
lipotropic 1096
luteinizing 930, 1199
sensitive lipase 1086
Hortaea werneckii 1855
Host defense proteins 31, 33
Hot tub folliculitis 1620
Howel–Evans syndrome 272
Hoyeraal–Hreidarsson syndrome 344
Human chorionic gonadotropin 948
Human embryonic skin, transmission electron micrograph of 6
Human herpesvirus 530, 1007, 1381, 1444, 1446, 1668, 1762, 1772
Human immunodeficiency virus 140, 171, 423, 458, 460f, 461f, 505, 511, 526, 724, 739, 770, 983, 984, 1004, 1010, 1057, 1233, 1278, 1469, 1571, 1579, 1687, 1765, 1918, 2009
infection 1923, 1937, 1950, 1960
Human leukocyte antigen 19, 244, 528, 674, 718, 724, 783, 796, 817, 820, 822t, 941, 1190, 1319, 1643, 1666
Human papillomavirus 237, 275, 461, 530, 990, 1197, 1319, 1577, 1796, 1953, 1954, 1989
vaccination 1956
Hunter syndrome 907, 1034, 2116, 2121
Huriez syndrome 266
Hurler–Scheie, Scheie syndrome 2121
Hutchinson's teeth 1927, 1928f
Hutchinson–Gilford progeria syndrome 329, 330f, 331f, 1016, 1034, 1087, 1168
Hyaline fibromatosis
juvenile 1525, 1526
syndrome 910, 910f, 1526, 1527f
Hyaline material, deposits of 1527f
Hyalinosis
cutis et mucosae 1332
infantile systemic 1526
Hydration 2038
Hydroa vacciniforme 685, 686, 892, 1465, 1644, 1644f, 1998
Hydrocortisone 2022, 2023, 2100
acetate 606
powder 1972
Hydrous magnesium silicate 1976
Hydroxy vitamin D 591
Hydroxylase deficiency 931
Hydroxypregnenolone 931
Hyperandrogenism 937
Hypercholesterolemia 879, 880f
familial 878, 882
Hyperchromatic nuclei 1530
Hypercoagulable states 733
Hyperemia, cutaneous 1183
Hypereosinophilic syndrome 770, 774
Hyperglobulinemic purpura 743
Hyperhidrosis 1250, 1251f
profuse 1251f
Hyperimmunoglobulin
D syndrome 836f
E syndrome 140, 437, 439f, 772, 1324
M syndrome 444, 444f
Hyperimmunoglobulinemia D 417, 836
Hyperkeratinization, follicular 1225
Hyperkeratosis 218f, 318f, 585f, 1798
epidermal 146
epidermolytic 215
massive 218f
mild 218f
periungual 271
severe 218f, 256f
subungual 493
Hyperkeratotic follicular papules 1241f
Hyperlipidemia 497
familial combined 878, 881
mixed 882
Hyperlipoproteinemia 878, 881, 882
Hypermelanoses, nonblaschkoid segmental 1132
Hyperorthokeratosis 533f
Hyperphenylalaninemia 871
Hyperpigmentation 310f, 1133f, 1136f, 1145t, 1151
chemotherapy-induced 1141t
cutaneous 2069t
disorders 1127
familial progressive 1142, 1151
miscellaneous disorders of 1142
mucocutaneous 1585
multiple small 71f
peripheral 798f
postinflammatory 79f, 1129, 1136
progressive 1142
stage 309
Hyperplasia
congenital adrenal 926, 931
epidermal 1016f
focal epithelial 1319
sebaceous 1487, 1487f
Hypersensitivity
syndrome 2029, 2036
vasculitis 1727
Hypertelorism, ocular 1128
Hypertension 497, 498, 937, 2038
intracranial 2054
Hyperthyroidism 920
Hypertrichosis 895f, 11771179, 1179t, 1182, 1183
Cantu syndrome consists of 1177
cubiti 1181f
diffuse 1177
drug-induced 1178, 1180f
lanuginosa 1177
localized 1180, 1182
prepubertal 1178
primary 1177
secondary 1178
X-linked
dominant 1178
recessive 1178
Hypertrichotic plaques 843
Hypertriglyceridemia 878, 882, 2054
Hypertrophic scars 1035, 1038f, 1791f, 2068
management of 2111f
Hypertrophy 75, 2068, 2079f
Hyperviscosity syndrome 695
Hypoadrenalism, causes of 926t
Hypoalbuminemia 1810
Hypocomplementemia 513
Hypocomplementemic urticarial vasculitis syndrome 753
Hypodontia 306
nonsyndromic 303
Hypoglycemia 122, 685
Hypoglycemics, oral 2020
Hypogonadism 843
Hypogranulosis 502f
Hypohidrosis 300, 305
Hypohidrotic ectodermal dysplasia 304, 305, 306f, 307, 307f, 312
classic 305
diagnosis of 306f
Hypomelanosis 1117
drug-induced 1116
infectious 1118
progressive 1117
Hyponychia congenita 1291
Hyponychium 21
tumors of 1264f
Hypopigmentation
acquired 1116
disorders of 1109
diffuse 1100
disorders of 1098
familial progressive 1151
localized 1185
perifollicular 100f
streaks 310f
transient 607f
Hypoplastic hyperconvex toenails 924f
Hypotension 1660
Hypothermia 122
Hypothyroidism 882
acquired 919f
congenital 918, 918f, 1310
Hypotrichosis 291293, 305, 11651169
congenital 1166, 1166f
localized autosomal recessive 292
severe neonatal 1167t
simplex 291
Hypoxanthine guanine phosphoribosyl transferase 2027
Hypoxia inducible factor 1357, 2051
I
Ichthyoses 203, 210f, 1974
nonsyndromic 204, 211
syndromic 204, 229
Ichthyosiform
disorders 1981
erythroderma 2122
bullous congenital 146
classical congenital 222f
congenital 204, 211, 219, 225, 1167
nonbullous congenital 225
lesions, segmental 235f
nevus 380, 386, 395, 403
scales 74
Ichthyosis 204, 210, 216, 220, 232, 240, 241, 264, 270, 299, 300, 329, 348, 1167, 1168, 1979
acquisita 973, 974
congenita 269, 1043
follicularis 240f, 1167
alopecia, and photophobia syndrome 266
foundation for 225
hands 212f
hyperproliferative 209
phenotypes 15
prematurity syndrome 241
types of 210f
vulgaris 211, 212f
typical histology of 212
X-linked recessive 203, 212f
Id reaction 628
Idiopathic skeletal hyperostosis, diffuse 2053
Imidazoles 1987, 1988
Imiquimod 1552, 1957
Immersion foot 1598
Immune
complex
disease 754
small vessel vasculitis 749
deficiency syndrome 312, 1688
dysregulation 144, 423, 426t, 445, 846, 847
mediated disorders 33
reconstitution inflammatory syndrome 458
surveillance 45
thrombocytopenic purpura 739
Immunity
cell-mediated 1750
cutaneous 31
herd 1761
Immunization 1792
Immunobullous diseases 2028
Immunochromatographic test 1888
Immunodeficiency 307, 413, 440, 1291, 568, 2043
disease, primary 415, 416, 2123
disorders
primary 415t, 418t
treatment of 2122
iatrogenic 1579
severe 449f
syndromes 1168
Immunodysregulation polyendocrinopathy enteropathy X-linked syndrome syndrome 440
Immunoelectrophoresis 1859
Immunoflourescence 88, 787, 947
assay 1710
Immunoglobulin 47, 416, 438, 443, 749, 1009, 2037
A 48, 80, 336, 420, 500, 674, 1266, 1277
deficiency 440
D 48, 837
deficiency disorders, primary 441t
G 37, 48, 91, 146, 661, 785, 947, 1664
M 47, 48, 336, 533, 821, 822, 1057, 1930
vasculitis 749
Immunohistochemistry 87, 1376
Immunopathology 413
Immunoreactive trypsinogen 966
Immunoregulatory T-cells 18
Immunosuppressants 2022
Immunosuppression
acquired 458
iatrogenic 473
systemic 500
Immunosuppressive
agents 474
drugs 2022
T cells 40
therapy 1113
Immunotherapy 591
Impetigo 1684
bullous 84f, 682, 1685f
herpetiformis 948
neonatorum 162
nonbullous 162f, 1684f
In vitro fertilization 65
In vivo technology 2117
Inadequate corticosteroid therapy 812
Incontinentia pigmenti 59, 84f, 143, 143f, 308, 310f, 311, 311f, 1101, 1145, 1291
features of 311
neurologic features of 311
skin features of 309
Index finger, congenital onychodysplasia of 1290, 1290f
Indirect hemagglutination assay 1736
Indirect immunofluorescence 660, 674
microscopy 90
Indomethacin 2100
Infantile hemangioma 1348, 1357, 1358, 1360, 1362f, 1364, 1366, 1369, 1373, 1530, 2080, 2081t
anatomic location of 1360t
differential diagnosis of 1361t
management of 1366
risk stratification of 1367t
superficial 1349f
Infections 621, 939, 1363, 1807
aquatic 1619
bacterial 162, 682, 893f, 1683
catheter-associated 1845
cutaneous 459
enteroviral 1727
herpetic 1786
mycobacterial 1621
neonatal 1949
perinatal 1961
protozoal 1880
recurrent 419t
secondary bacterial 581f
Infectious diseases 45, 102, 162, 566, 2072
Inflammation 1225
laboratory evidence of 1810
Inflammatory airway diseases, chronic inducible 44
Inflammatory bowel disease 500, 764, 826, 827, 956, 1081, 1104, 2013, 2042, 2054
Inflammatory diseases 564, 1313, 2042, 2072
pathogenesis of 2049
treatment of 2025
Inflammatory disorders 33
Inflammatory linear verrucous epidermal nevus 394, 395f, 535, 536, 536f
Inflammatory skin disease, treatment of 2022
Infliximab 515, 2042
Influenzae infection 1728f
Infraorbital dennie 579
Ingrown nails 1279
Injury
aquatic 1614
extravasation 155
neonatal 153
nonaccidental 736
physical 1635
postnatal 154
prenatal 153
severe 926t
Innate lymphoid cell 36
Inner luminal cells 23f
Inner root sheath system 20f
Inosine monophosphate dehydrogenase 2031
Inositol trisphosphate 846, 858
Insect 1649
bite 683, 683f, 1650f
reaction 1650f
Insulin 939
like growth factor 922, 1225, 1357
resistance 882, 937t
disorders of 933
syndromes 934
Intellectual disability 1041
Intense erythema 1434f
Intense pulsed light 2074, 2081, 2089
Intensive care unit 1608, 1811
Intercellular adhesion molecule 210, 445, 1202, 1980, 2043
Intercellular desmosomes 80f
Interdigitale 1286
Interferon 32, 436, 983, 2039
alpha 784, 1379
genes, stimulator of 840, 841
Interfollicular keratinization 4f
Interleukin 19, 32, 43, 210, 290, 438, 530, 630, 817, 820, 835, 858, 958, 983, 1007, 1190, 1225, 1324, 1810
receptor antagonist, deficiency of 486, 838f, 839
Interphalangeal joint 275f, 1025f
proximal 1599
Interstitial granulomatous
dermatitis 825, 827
drug reaction 827
Intracellular cobalamin transport 1142
Intracytoplasmic sperm injection 65
Intradermal skin test 110
Intraepidermal neutrophils, spongiform pustular’ distribution of 502f
Intrauterine
device 1227, 1850
epidermal necrosis 148
growth restriction 1771
herpes simplex virus infection 167f
Intravascular coagulation
disseminated 733, 739, 1656
localized 1396
Intravenous amphotericin B 1987
Intravenous immunoglobulin 290, 313, 663, 711, 723, 818, 848, 967, 1446, 1771, 1811, 2037, 2038
off-label dermatologic uses of 2037t
Inversa recessive dystrophic epidermolysis bullosa 650
Involucrin 257
Iodine 2040
Iris 314
Irritant diaper dermatitis 611, 613, 614, 615f
clinical features of 614
differential diagnosis of 616
epidemiology of 614
management of 617
pathogenesis of 617
prevention of 618
severe 615f
treatment of 618
Isohemagglutinin 313
Isothermal amplification, loop-mediated 1796
Isothiazolinone 2066
Isotretinoin 1234, 2051
Itch
scratch cycle 1975
types of 2066f
Itchy papules 627f
Ito hypomelanosis 1101
Ito nevus 1134, 1135f
Itraconazole 1640, 1842, 1854, 2019, 2041
Ivermectin 1902, 1910
Ixodes 1652
J
Jacquet's diaper dermatitis 615, 616f
Jadassohn sebaceous nevus 1169
Janus kinase inhibitors 593, 2049
Jaundice, physiologic 125
Jaw cysts 1581
Jellyfish tentacles 684f
Jessner's lymphocytic infiltration 785, 1006
Jewels, cluster of 666
Job syndrome 140
Jogger's nipples 1614
Joint laxity 888
Junctional epidermolysis bullosa 7, 639, 640, 645, 646, 647f, 2117
pathophysiology of 647
subtypes of 646t
Juvenile idiopathic arthritis 693, 788, 818, 820, 822t, 968, 1673
characteristics of 823t
clinical syndromes of 822
heterogeneity of 820
treatment of 827
Juvenile idiopathic inflammatory
myopathies 816t
myositis 817
Juvenile systemic sclerosis 801, 802, 803f
diagnosis of 803t
K
Kala-azar 1871
Kaposi's sarcoma 462, 974, 1381, 1723, 2041
AIDS-associated 2039
Kaposiform hemangioendothelioma 741, 1349, 1350, 1350f, 1376, 1378, 1379f, 1380f
Kasabach–Merritt phenomenon 732, 741, 1349, 1376, 1379, 2039
Katayama syndrome 1892
Kawasaki's disease 530, 611, 749, 858, 859f862f, 1271, 1446
incomplete 862
treatments 1811
Kawasaki's syndrome 2037
Kayser–Fleischer rings 885
Kearns–Sayre syndrome 374
Keloid 1035, 1038f, 1520, 1857, 1861
scar 1520f
spontaneous 1037
treatment of 1039t
Keratin filaments 8f, 209
Keratinization
disorders of 2051, 2052
follicular 4f
Keratinocyte 18f, 35, 49, 49f, 210f, 286f, 2048, 2117
apoptosis 536f
cells, mature 17
Keratinocytic nevus 390, 396
epidermolytic 394
linear 392
nonsegmental 396, 396t
syndromes 404
Keratinopathic ichthyoses 204, 215, 218f
Keratitis 857, 1167, 1785f
ichthyosis-deafness syndrome 204, 267, 269, 270f, 294, 294f, 297, 567
interstitial 1928
Keratoconjunctivitis 889
Keratoderma 270, 348
aquagenic 1621
blennorrhagica 529f
focal palmoplantar 270, 271
hypotrichosis-leukonychia totalis syndrome 270, 298, 298f
mutilating 264
perianal 267
sclerosing 269, 1043
Keratohyalin granules 17
Keratolysis
exfoliativa 632, 633f
pitted 1709, 1710f
Keratosis 75, 241
follicular 212f, 214
follicularis 241
spinulosa decalvans 240, 1051, 1200
lichenoides chronica 538, 538f
linearis 269, 1043
palmoplantaris varians 271
pilaris 586, 586f
atrophicans 1050, 1051f, 1173, 1200, 1201t
decalvans 1051
Ketoacidosis, diabetic 685
Ketoconazole 1987, 2019
shampoo 1847
Kidney
disease 2021
chronic inducible 2030
injury, acute 1811
Kikuchi's disease 1010, 1011f
Kikuchi's syndrome 1290
Kikuchi–Fujimoto disease 1010
Kimura's disease 1007, 1008t
Kinase deficiency 440
Kindler syndrome 344, 344f, 345, 639, 639f, 656, 656f
Kinky hair syndrome 1171
Klebsiella 1687, 1728
granulomatis 1943
pneumoniae 1694
Klein–Waardenburg syndrome 1105
Klinefelter syndrome 60, 309, 372, 1243
Klippel–Trenaunay syndrome 1355f, 1395, 1396f
Knee, geographic patch on 1396f
Knot tying 2107
Knuckle
pads 256, 1525f
sign 371
Kobberling syndrome 1086
Köbner phenomenon 78, 78f, 1806f
Koenen tumors 359, 360f
Koilonychia 1270f
Koplik's spots 1763, 1763f
KRT9 gene 219
Kwashiorkor 949, 950f, 1121, 1122f
dermatosis of 1122
Kyphoscoliosis syndrome 335, 1180
Kyphosis 335, 406
Kyrleśs disease 1015, 1016, 1018
Kytococcus sedentarius 1709
L
Labial telangiectasias 969f
Lacerations 154, 1628
intrapartum 154
Lacrimal gland dysfunction 300
Lactate dehydrogenase 588, 736, 1026
Lactic acid 227, 1974
dehydrogenase 1810
Lactic acidosis 374
Lactic dehydrogenase 815
Lamellar ichthyosis 204, 211, 212f, 219, 1167, 2115
phenotype 222
classical 222f
Lamina densa 23, 639f
Lamina lucida 6, 23, 639f
Langerhans cell 3, 10, 18, 19, 19f, 37, 49, 49f, 50, 718, 1431, 1438, 1975
histiocytosis 142, 1328, 1431, 1432, 1438, 1329f, 1434f, 1435f
congenital 142, 143f
cutaneous manifestations of 1431
Lanolin 605
Laron syndrome 922
Larva migrans 1889, 1890f
cutaneous 1889
Laryngo-onycho-cutaneous syndrome 646, 647
Laser
ablation 969
cooling systems 2075
hair removal 2087
light, properties of 2073f
medium 2073
modalities 1370, 2088
settings 2074
system, elements of 2073f
tattoo removal 2085
therapy 932, 2072, 2073, 2075
indications for 2077
Last cuticle sign 94
Laterothoracic exanthema, unilateral 1777, 1781, 1782f
Latrodectus genus 1654
Latrodectus mactans 1654
Laugier–Hunziker syndrome 1584, 2085, 2085f
Laurence–Moon–Biedl syndrome 1274
Lavandula officinalis 2098
Lawrence syndrome 1086
L-dihydroxyphenylalanine 1099
Lebrikizumab 594
Lebrunia danae 1619
Lectin pathway 32
Led therapy 2089
Leg herniations 1613
Legius syndrome 352, 361, 374, 1129
Leiomyomatosis, hereditary 1541
Leiomyosarcoma 974, 1567, 1571
Leishmania 104, 1880, 1881, 1885
donovani 1118
major 2020
recidivans 1881, 1882
Leishmaniasis 1883f, 2005
atypical cutaneous 1882, 1882t
clinical forms of 1881t
cutaneous 87f, 1880, 1885t
diffuse cutaneous 1880, 1881, 1883
disseminated 1883
eczematous 1882
localized cutaneous 1880, 1881
mucocutaneous 1881, 1883
neonatal 1882, 1883f
pediatric cutaneous 1882
verrucous 1882
cutaneous 1883f
Lentiginoses 1128
Lentigo simplex 1128
Lentivirus 2117
Lenz microphthalmia syndrome 1543
Leopard syndrome 362, 363f, 1128, 1546
Leprechaunism 934
Lepromatous disease 1748, 1750
Lepromatous leprosy 1118, 1749, 1749f, 1861
Leprosy 1119, 1746
classification of 1748f
indeterminate 1119f, 1748, 1748f
presentation of 1749
Leptospira interrogans 1736
Leptospirosis 1736
Lesch–Nyhan syndrome 1282
Lesions
cutaneous 189t, 725
eczematous 585f
herpetic 1786
inflammatory 1236f
linear arrangement of 298f
multiple hypopigmented 1108f
necrotic 750f
nodular 1859
papular 1166
psoriatic 78f
ulcerated 1745f
urticarial 705f
Lethal factor 1706
Leucovorin 2031
Leukemia 470f, 895f, 1329f, 1459, 1470
acute 1471, 1912f
lymphoblastic 882, 1471
lymphoid 1471f
megakaryoblastic 370
myeloid 370, 436, 1130, 1470, 1471
myelomonocytic 1471
chemotherapy for 473f
congenital 1471
cutis 1459, 1470
congenital 1472f
juvenile myelomonocytic 352, 1470
mixed lineage 1471
neonatal 1471
Leukemoid reactions 1471
Leukocyte 36
adhesion deficiency 46, 445, 445f
function 46
migration 2044
vacuoles 299
Leukocytoclastic vasculitis 83f, 417, 686, 748, 755, 755f, 756t, 959
Leukoencephalopathy, progressive multifocal 2032
Leukonychia 1276
classification of 1277
hereditary 1277f, 1292
partial diffuse 1277f
spotted 1277f
Leukoplakia 1334f
oral 324f, 343f
Leukotriene 36, 229
Lhermitte–Duclos disease 1422
Lice 1898
Lichen
nitidus 539, 539f
planopilaris 1205, 1205f
planus 82f, 530, 531f, 533f, 534, 1316, 1781, 2028
annular 533f
histopathology of 533f
oral 2033
papules of 533f
pemphigoides 666, 671
ungual 1267f, 1284, 1284f
sclerosus
disease 795, 796f, 1304, 1305, 1305f
et atrophicus 1120
scrofulosorum 1739
simplex chronicus 631, 631f
spinulosus 540, 540f, 585f
striatus 534, 535f
histopathology of 536f
Lichenification 581f
Lichenoid 82, 548
dermatitis, annular 537, 691
drug eruption 1781
inflammatory process 536f
Licorice 2098
flavonoid 2098
Lidocaine 1807, 2105
Ligase chain reaction 1948
Lightbulb sign 579
Light-emitting diode 2072, 2083
Lightning injuries 1604
Limb
defects 380, 386, 403
nevus 395
upper 1882f
Limb–Mammary syndrome 304, 305, 316, 321
Lindane 1902, 1909
Linear IgA disease 91f, 2035
Linear skin defects 386
Linear ubiquitin assembly chain, components of 840
Linoleic acid 881
Linuche unguiculata 1618
Lip
lentigines 1584f
lower 149f
mid-upper 1309f
pits, congenital 187
swelling 957f
thick everted 306f
Lipase maturation factor 881
Lipids
epidermal 10
laden macrophages 1084f, 1441f
Lipoatrophy 1084f
Lipoblastoma 1540
Lipoblastomatosis 1540
Lipodermoid 406f
Lipodystrophia centrifugalis abdominalis infantalis 1085
Lipodystrophy 333, 839, 842, 844, 935, 936t, 940, 1080, 1085, 1086
acquired
generalized 1086
partial 1086
congenital generalized 1086
familial partial 331, 935, 1086
local 939
multifocal 812
syndrome 333
panniculitis induced 843, 1085
Lipofibromatosis 1527, 1527f, 1540
Lipogranulomatosis, disseminated 908
Lipoid proteinosis 909, 1332
Lipoma 1539
multiple 1539t
Lipomatosis 1539
Liponyssoides sanguineus 1715
Lipopolysaccharide 45, 1936
Lipoprotein
cholesterol
low high-density 937
low-density 937
high-density 2050, 2054
intermediate density 879
lipase 881
low-density 498, 878, 1200, 2050, 2054
metabolism, disorders of 878
very-low-density 881, 937
Liposarcoma 1571
Lipoxygenase system 2098
Liquid nitrogen 1989
Liquor carbonis detergens 1980
Listeria 1707
monocytogenes 164, 460, 476, 1707, 1727
infection 164
Little toe, double nail of 1290
Livedo racemosa 825
Livedo reticularis 698, 698f, 699, 699t
idiopathic inflammatory 699
physiologic 699
Liver
disease 824, 884, 963, 2021, 2034, 2054, 2122
history of 2019
severe 739
function tests 2012
Loa loa 1887
Lobar panniculitis 86f
Lobomycosis 1861
Local anesthetics, eutectic mixture of 2075, 2105
Localized alopecia syndromes 1168, 1169
Locus heterogeneity 61
Loeys–Dietz syndrome 1050, 1069, 1491f
Löfgren's syndrome 971
Longer disease 795
Loose anagen hair syndrome 1196, 1197f
Loricrin keratoderma 255, 264, 265f, 1043
Loricrin mutations 264
Lower lip 149f
congenital fistulae of 1306
sucking calluses in 150f
Loxosceles 1655
reclusa 1655f
spiders 1655
Lucio's phenomenon 1751
Lucky luke dermatitis 620, 620f
Lucky syndrome 1157
Lumbar syndrome 1364, 1365, 1366f
Luminal cells 21
Luminal neutral amino acid 875
Lung disease
interstitial 817, 965, 2041
severe chronic 336
Lupoid leishmaniasis 1882, 1882f
Lupus erythematosus 429, 509, 670, 783, 787f, 1020, 1057, 1121, 1328, 1600f, 1642, 1674, 1998, 2028
linear 786f
neonatal 70, 664, 692, 790, 791f
panniculitis 1082
subacute cutaneous 111f, 429, 784, 2043
tumidus 785
Lupus
panniculitis 1082, 1083f
tumidus 785f, 787f
vulgaris 1739, 1739f
Lyme arthritis 1717
Lyme borreliosis 1470
Lyme carditis 1717
Lyme disease 530, 693f, 693t, 1652, 1716, 1978
disseminated 692
early disseminated 692
erythema migrans of 1717f
Lymph node 1461
regional 49f
Lymphadenopathy 417, 443, 447, 1237f
Lymphangioendotheliomatosis, multifocal 745, 1364, 1422
Lymphangitis 1694, 1695
nodular 163
Lymphatic filariasis 1888
Lymphatic malformation 149, 1347, 1352, 1392
Lymphedema 1387
bilateral 372f
Lymphocyte 83f, 1084f, 1436f
antigen, cutaneous 46, 49, 50
function antigen 445
small accumulations of 1462f
specific protein tyrosine kinase 41
trafficking 45
Lymphocytic infiltrate 786
Lymphogranuloma venereum 1918, 1951, 1952t
Lymphoid
cells 31
tissues 31
Lymphoma 1239, 1459, 1465
marginal zone 1468
primary cutaneous 1459
systemic 1469
Lymphomatoid papulosis 547, 1463, 1465f
subtypes of 1466
Lymphopenia 1810
Lymphoplasmacytic plaque 1009
Lymphopoietin, thymic stromal 577, 588
Lymphoproliferation 426t
Lymphoproliferative disorder 1465
Lymphotoxin alpha 2044
Lyngbya majuscula 1617
Lysine catabolism, disorders of 876
Lysosomal acid lipase 879
deficiency 2122
Lysosomal enzyme alpha-l-iduronidase 905
Lysosomal storage
disease 903, 2120
disorders 2115, 2121t
Lysosome 2120
M
Macrocystic lymphatic malformation 1352f
Macroglossia 918f, 1310
primary causes of 1310t
secondary causes of 1310t
Macrolides 2015
Macrophage 31, 37, 43, 50f
activation syndrome 822, 824, 1444
Macular dystrophy
juvenile 293, 1166
syndrome 305
Macular erythema 1239
Macular pigmentation, idiopathic eruptive 1136, 1137
Macules 71f
bilateral depigmented 1111f
erythematous 137f, 683f
hypomelanotic 357
hypopigmented scaling 1433f
large hyperpigmented 1130f
multiple hyperpigmented 1109f
red-brown 1442f
Maculopapular
drug reaction 1667
exanthem 1667f, 1762f
rash 1667
MaCune–Albright syndrome 61, 354, 920, 942, 942f, 1130, 1130f, 1156
Madurella mycetomatis 1856, 1857
Maffucci syndrome 1414
Majocchi's granuloma 86f, 106
Malar rash 784f
Malassezia 526, 138, 1235, 1843, 1846, 1854, 1987, 2068
furfur 1118, 1142, 1242, 1256, 2020
globosa 1118, 2097
infections 1843
sympodialis 1118
Malathion 1902
Malformations
congenital 1582
venous 1350, 1387
Malignancies
hematologic 958
hematolymphoid 1464
Malignant melanoma 1574
dermoscopy of 1557f
Malnutrition, severe acute 1121
Malouf syndrome 331
Mammary duct ectasia 1257, 1257f, 1495
Mandible, relative protuberance of 1928
Mandibuloacral dysplasia 331, 935
Mansonella
ozzardi 1888
streptocerca 1888
Maple syrup urine disease 875
Maquas 1622, 1633
Marasmus 950, 950f
Marburg virus 743
Marfan syndrome 735, 1067, 1069, 1070
arachnodactyly in 1068f
Marie Unna hypotrichosis 1166
Marinesco–Sjögren syndrome 1173
Maroteaux–Lamy syndrome 908, 2121
Marshall's syndrome 763, 1076
Mass reduction 1768
Mast cell 31, 36, 43, 1449, 1453f, 1455, 1975
activation syndrome 2047
biology 1449
leukemia 1449
treatment of 145t
Mastigophora 1619
Mastocytosis 1449, 1454
bullous 162
classification of 1450
diagnostic criteria of 1452
diffuse cutaneous 146, 146f, 702, 1451, 1452f
erythrodermic 146, 1450
maculopapular cutaneous 1450, 1451f
nodular 694f
pediatric 1455t
skin lesions of 1450
systemic 775, 1449, 1452, 2047
treatment of 1455
Matricaria recutita 2098
Matrix
alterations of 1264
metalloproteinases 661, 1057, 2011
Mattress sutures 2107
Max Joseph's spaces 533
Maxillary bones, shortening of 1927
Maxillary dental arch 1307f
Measles 1761, 1763, 1767
atypical 1727
exanthem 1764f
Mechanical ventilation 1811
Mediterranean fever, familial 417, 835, 854, 2035
Medium-chain triglycerides 881
Medullary thymic epithelial cells 40
Mees’ lines 973
Mefenamic acid 2100
Meissner corpuscles 24
Melaleuca alternifolia 1986
Melanin 1094
synthesis 1095, 1095fc
unit, epidermal 1094
Melanocytes 10, 18, 1093
biology 1096fc
disorders of 1097
light micrograph of 18f
stimulating hormone 926, 1096, 1138
Melanocytic lesion, criteria for 96
Melanocytic nevi 1501, 1502fc
acquired 1507
compound acquired 2084
extensive 2067
junctional acquired 2084
Melanogenesis 1093
Melanoma 1556, 1557f, 1562
histopathology of 1559f
invasive 95f
juvenile 1560
malignant 1574
pediatric 1558f
risk of 1503
Melanonychia, longitudinal 1278
Melanosome 1094, 2074, 2074f
Melasma 1137, 1981
Melioidosis 1733
Melkersson–Rosenthal syndrome 1328, 1329f
Melnick–Fraser syndrome 1543
Membrane attack complex 429
Memory T cells 42
MEN1 syndrome 1519
Mendelian inheritance 303
Mendes da Costa syndrome 346
Meningitis
bacterial 1727
gonococcal 1939
Meningocele 192
rudimentary 192
Meningococcal septicemia 1726f, 1727f
Meningoencephalitis 685
Menkes disease 348, 886, 886f, 1171
protein 1171
Menkes syndrome 886f, 1102
Mental retardation 210, 443, 1277
Menthol 1975
Menzies 11-point scoring method 97
Mepivacaine 2105
Mepolizumab 776
Mercaptobenzothiazole 620
Mercaptopurine 514, 2027
Mercury 1623
Merkel cells 3, 18, 19
Mesenchymal cells 6, 1532f
Mesenchymal stromal cells 2118, 2119
Messenger ribonucleic acid 56, 57, 1984, 2117
Metabolic defects 875t
Metabolic disease 2120
Metabolic disorders 568, 2120, 2122
hereditary 871
Metabolic eczema 630
causes of 630t
Metabolic syndrome 498
Metabolic wasting syndrome 239, 289, 289f
Metacarpophalangeal joint 275f
Metals 603
transport, disorders of 883
Metastasis 1574
Metastatic calcinosis cutis 971, 1021, 1022
Methicillin-resistant Staphylococcus aureus 579, 2017, 2097
Methionine 873
Methotrexate 474, 510, 592, 626, 828, 956, 2025, 2029, 2030
potential uses for 2030t
Methyl aminolevulinate 1998, 2005, 2006
Methylchloroisothiazolinone 606, 620, 2066
Methylene blue 2004
Methylisothiazolinone 599, 606, 620
Methylmalonyl-co-enzyme A epimerase encoded 875
Methylprednisolone 465, 2023
Methyltestosterone 2100
Mevalonate diphosphate decarboxylase 244
Mevalonate kinase 244
deficiency 835, 836
Mibelli, angiokeratoma of 1421
Micaceous scales 74
Micellar water 2069
Michelin tire baby syndrome 1541, 1541f
Miconazole 1839, 1854, 1987
Microbes cell 31
Microciona prolifera 1617
Micrococcus sedentarius 1709
Microdeletion
diagnosis of 55
syndromes 61, 372
Micronychia 1273, 1273f, 1274t
Microphthalmia 386
associated transcription factor 1093, 1096
Microscopic agglutination test 1736
Microsporum 1823, 1829, 1831, 1832, 2020
audouinii 101, 1824
canis 101, 1824
ferrugineum 101
Microthermal zones 2088
Microvilli-covered cells 5
Micruroides euryxanthus 1659
Micrurus fulvius 1659
Middle east respiratory syndrome 1807
Mid-face toddler excoriation syndrome 1635
Midline anterior neck inclusion cyst 181, 181f, 1490
Midline facial lesions, differential diagnosis of 191t
Migrant helminthiasis 1889
Migratory necrolytic erythema 973
Milia 151, 152f, 152t, 1489, 1491f, 1806
classification of 1490t
Miliaria 138, 1253
crystallina 139f, 1254f
rubra 139, 139f, 617f, 1254f
Miliary tuberculosis 1871
Milker's nodules 1795
Millipedes 1651
Millisecond-domain pulses 2089
Milroy's disease 1277
Miltefosine 1885
Mimic wells syndrome 776
Mind-body medicine 2100
Mineralocorticoids 925
Minocycline 1140, 1203, 2012
Minor iodine-starch test 115f
Minus nevus 1169
Mites 1653
biology of 1905
Mitochondria 9
disorders 373, 374t
encephalopathy 374
inheritance 59
Mitogen-activated protein 1096, 1097, 1390, 2025
kinase 32, 351, 391, 436, 839, 1073, 1431, 1675, 2051
Mitral valve prolapse 1065, 1068, 1069
Mitten-band hyperpigmentation 1144f
Mixed connective tissue
disease 790, 803, 852, 852t
disorder 333, 1020
MLS syndrome 314
MMP14 gene 910
Modern disposable diaper 613
Mohr syndrome 1331
Mohs’ micrographic surgery 1554
Molecular analysis 382t, 383t
Molecular tests 104, 106
Molluscipox genus 1804
Molluscum contagiosum 449f, 461, 1804, 1806f, 1961
cytodiagnosis of 106
dermoscopy of 1806f
genital lesions of 1962f
large lesions of 1962f
periocular 2083f
Molluscum dermatitis 1804
Moloney murine leukemia virus 2117
Monepidermolytic keratinocytic nevus 393f
Mongolian spot 1133
Monilethrix 1170, 1170f
autosomal dominant forms of 292
Monoamine oxidase 2021
Monoclonal gammopathy 1251
Monocyte chemoattractant protein 2042
Monogenetic skin diseases 2122
Monogenic diseases 486
Monogenic disorders 2115
Monogenic lipoprotein disorders 879t
Monomorphic lesions 1242f
Monomorphous papules 1240f
Mononuclear cells 844
Mononucleosis, infectious 1776
Mood disorders 500
Moraxella catarrhalis 1696, 1939, 2016
Moriform granulomas 1864
Morphea 795, 797, 1207
active lesions of 798f
broad linear lesions of 800f
late stage 798f
linear 797, 800f, 1120f
plaque-type 1120f
Morquio syndrome 907, 2121
Mosaic epidermal skin diseases 390
Mosaic epidermolytic ichthyosis 218f
Mosaic lesions
arrangement of 379
bilateral 384
Mosaic skin disorder 64
Mosaic Turner syndrome 371
Mosaicism 59
disseminated 379
hypopigmented 371, 1107
nonsegmental 379, 380f
patchy 380
segmental 380
superimposed 383, 383f
Moulin atrophoderma 1048
Mountain spotted fever 1701
Mouth
and genital ulcers with inflamed cartilage syndrome 770
disease 1321f
ulcers 857
Moxibustion 1622
Mucinosis, follicular 910, 910f, 1472, 1473f
Mucinous follicularis 1472
Muckle–Wells syndrome 417, 837, 913
Mucoceles 149
Mucopolysaccharidoses 905, 906t, 908, 2122
Mucor 472, 1871
Mucormycosis 1871, 1871f
Mucosa 1389
Mucosal lesions, prominent 664f
Mucosal vesiculoulcerative syndromes 1320t
Mucositis 684
chlamydia pneumoniae-induced 721
mycoplasma-induced 717
Mucous membrane 943f, 1163
anatomy 1306
diseases 1300
pemphigoid 666
Muehrcke lines 973
Muir–Torre syndrome 1582
Mulberry molars 1927
Multifocal epithelial hyperplasia 1319, 1319f
Multiorgan disease 2036
Multiple endocrine neoplasia 359, 913, 1034, 1333, 1519, 1546, 1588
syndromes 943, 944t
Multiple erythema migrans 693f, 1717
Multiple lentigines 361, 362, 1584, 1586
syndromes 2085
Multiple organ dysfunction syndrome 1610
Multisystem disease 770, 2120
Multisystem inflammatory
disease 417
disorder 837
syndrome 1810
Multisystem organ 1810
Munro nevus 400, 400f
Murray–Puretic–Drescher syndrome 1525
Muscle
benign tumors of 1540
enzymes, elevated 812
weakness, proximal 811
Muscular dystrophy 640, 642
Mutations, mechanisms of 61
MVK gene 244
Myalgia 811
Myasthenia gravis 921
Mycetoma 1855, 1857f
belt 1856
etiological agents of 1856t
Mycetome 1899f
Mycobacteria 1736
atypical 1722
infections, nontuberculous 1741
nontuberculous 1085, 1741, 1745
Mycobacteriaceae 1736, 1746
Mycobacterium 104, 1736
abscessus 1741
avium 1740
complex 1745
bovis 1740
gordonae 1745
haemophilum 1745
indicus pranii 1118
kansasii 1744
leprae 1119, 1736
marinum 989, 1614, 1616, 1621, 1732, 1742
infection 1742f
szulgai 1745
tuberculosis 104, 460, 1081, 1740
ulcerans 1743
Mycophenolate mofetil 467, 593, 2031
Mycophenolic acid 2031
Mycoplasma 1723
infections 742, 2015
pneumoniae 528, 684, 718, 721, 1081, 1930, 2012
Mycosis 104
fungoides 742, 1121, 1121f, 1460, 1461, 1462f
clinical staging of 1461t
hypopigmented 1121, 1460f
plaque type 1460f
superficial 1853
systemic 1861
Myelodysplastic syndrome 436, 761
Myelofibrosis 1435
Myeloid cells, atypical 1472f
Myeloma, multiple 56f, 974
Myocardial infarctions 498
Myoepithelial cells 22f, 23f
Myofibroma 1530f
infantile 1530f
solitary fibrous 1481
Myofibromatosis 1530
Myopathy, idiopathic inflammatory 813
Myositis
lower risk of 817
ossificans 1029
Myroxylon balsamum pereirae 604
Myroxylon pereirae 604
Myxedema 911
congenital 911f
Myxoid
neurofibroma 1128
stroma 1532f
N
N-acetylcysteine 1980
N-acetylethanolamine 633
N-acetylgalactosamine-6-sulfate-sulfatase 907
Naegeli–Franceschetti–Jadassohn syndrome 913
Naegleria 1885
Naftifine 1987
Nagashima's disease 632
Nager syndrome 1543
Nail 20, 533f, 1163
absence of 1273t
apparatus 1261f
bacterial infections of 1285
genetic diseases of 1291
bed 21
discoloration 493f
hemorrhage 1274
biopsy 1291
candidiasis 927f
chewing 1282
clubbing 1271f
isolated congenital 1292
composition 1263
conditions 1279
damage 1639
disease 1261
patterns 1264
disorders 1291
dyschromia, causes of 1276t
dystrophy 297f, 324f, 1264f
median 1267
severe 533f
eczema 1284
fold
capillaries 1262f
proximal 21
fragility 1269f
function 1262
grooves, multiple longitudinal 1266
growth 1263
rate 1263t
hemorrhage 1613
traumatic 1613f
landmarks of 21f
loss of 650
matrix arrest, causes of 1265t
nevi 1514
part of 1279f
patella syndrome 1289, 1289f, 1290, 1291
pitted 1266f
plate 21, 493f
alterations of 1264
separation of 493f
psoriasis 492, 493f, 1283, 1283f
signs 1272t
unit 1264f
anatomy of 1261
biology of 1261
infections of 1284
infestations of 1284
regions of 21f
Naïve T cells 49f
Nakajo–Nishimura syndrome 843, 1085
Nanocapsules 1973
Napkin
area, candidiasis of 1849f
dermatitis 611
psoriasis 492f, 825
Nappy rash 611
Nasal
bleeding 969f
cartilage, loss of 841f
chondritis 856f
crease 1242f
crease, pseudoacne of 1242
glioma 192, 192f
lubricants 969
Natal teeth 150, 1308t
Natamycin 1987
Natroba 1990
Natural killer 50t, 425, 528, 724, 1466, 1666t, 2027, 2122
cell 31, 37, 43
Naxos disease 268
NCSTN gene 764
Neck
flexors, anterior 812
lesions, verrucous 1866f
Necrobiosis lipoidica
diabeticorum 938t
severe 939f
Necrolysis, epidermal 728
Necrolytic acral erythema 963, 963f
Necrolytic migratory erythema 960, 974
Necrosis
central 1432f
epidermal 82f
Neisseria
gonorrhoeae 1935, 1936, 2015
meningitidis 743
Nemolizumab 594
Neodymium-doped yttrium aluminum garnet 2073, 2074, 2078, 2081, 2084, 2087
Neofibularia nolitangere 1617
Neomycin 626
polymyxin b-hydrocortisone 1724
Neonatal disorders 119, 144
Neonatal epidermolysis bullosa acquisita 663
Neonatal herpetic infection, primary 1784
Neonatal ichthyosis sclerosing cholangitis syndrome 299, 300
Neonatal intensive care unit 618, 1846
Neonatal sepsis, late onset 164
Neoplasm, hematological 1449
Neoplastic diseases 745
Nephrogenic systemic fibrosis 805, 971, 1675
Nestor–Guillermo syndrome 1034
Netherton syndrome 226, 237, 238f, 440, 568f, 1175, 1177f, 2115, 2120
Neu–Laxova syndrome 204
Neural crest stem cells 1093
Neural heterotopia, cutaneous 192
Neuroblastoma 1572
metastasis of 1572f
tumors staging of 1573t
Neuroborreliosis 1717
Neurodermatitis 631
Neuroectodermal melanolysosomal disease 1103
Neurofibroma 352, 353f, 357, 1544, 1545f
mucocutaneous 1128
Neurofibromatosis 351, 356, 357, 379, 1129, 1156, 1319, 1441t, 1544, 1546, 1569, 1588
segmental 71f
Neurologic diseases 685, 2045
Neurologic disorder, progressive 340
Neuroma 1546
Neuromuscular diseases, broad variety of 818
Neuromuscular disorders 2047
Neuropathy 270, 348, 1751
Neuropeptides 1250
Neuropsychiatric disorder 360
Neurothekeoma 1546
Neutral lipid storage disease 226, 232
Neutropenia 1324
transient 2048
Neutrophil 31, 37, 502f, 1084f
abundant 677f
extracellular traps 432, 840
gelatinase-associated lipocalin 1234
microabscess of 677
rich dermatoses 760t
Neutrophilia 1810
Neutrophilic diseases 759
Neutrophilic eccrine hidradenitis 1254, 1673
Nevirapine 462
Nevoid basal cell carcinoma syndrome 1551, 2052, 2123
Nevoid hypertrichosis 1180, 1180f
Nevus
anemicus 352
atypia 395
atypical 1511
comedonicus syndrome 400, 400f, 406
dermoscopic patterns, benign 1508t
dynamics of 1502f
eccrine 401
epidermicus verrucosus 404
flammeus 1389
follicular 399
lipomatosus superficialis 1538, 1538f
marginatus 399f
psiloliparus 184f, 1538, 1539f
sebaceus syndrome 404, 1510f, 1582
simplex 1352f, 1388, 1388f
spilus 1509, 1510f, 2084
treatment of 2086f
subtypes 1509
syringocapillaris 402
trichilemmocysticus 401
Next generation sequencing 62, 307, 354, 655, 1066
Nickel
dermatitis, spectrum of 604f
test kit 603
Nicotinamide 695
Niemann–Pick disease 1446
Nifedipine 804
Nijmegen breakage syndrome 420
Nikolsky sign 93
positive 726, 727
Nipple
anomalies 195
diseases 1257
eczema 585f, 1257, 1257f
Nitroblue tetrazolium 434
Nocardia 1703, 1722, 1931
brasiliensis 1856
Nocardiosis 1703
Nodular adrenocortical disease, primary pigmented 928, 1583, 1584
Nodule 72, 72f, 1227, 1311
subcutaneous 755f
Noma neonatorum 148
Nonbullous impetigo, secondary 1685f
Nonepidermolytic keratinocytic nevus 393
Non-Hodgkin's lymphomas 974, 1272, 1459
Noninvasive prenatal diagnosis tests 65
Non-Langerhans cell histiocytoses 1438, 1438t
Nonmelanoma skin cancers 472, 1551, 2025
Nonsteroidal anti-inflammatory
agents 1081
Nontraumatic myositis ossificans circumscripta 1030
Noonan syndrome 65, 361, 362, 363f, 737, 1546, 1569, 1584, 1586
webbed neck in 362f
Normophosphatemic familial tumoral calcinosis cutis 1025f
N-palmitoylethanolamine 633
Nuclear factor kappa B 32, 303, 392, 486, 839, 1975
Nucleic acid amplification tests 1807, 1938
Nucleotide
binding oligomerization domain 33, 843, 858
excision repair 57, 1153
polymorphism 62
reverse transcriptase inhibitors 462
Nutrition 15
Nutritional disorders 918, 943
acquired 630
Nymph, second instar stage of 1899f
Nystatin 1987
ointment 1976
topical 1987
O
Obesity 497
Occipital horn syndrome 886, 888
Ochronosis 874
Ocimum gratissimum essential oil 1986
Ocular mucous membranes
anatomy of 1300f
disorders of 1300
Oculocerebrocutaneous syndrome 314
Oculodentodigital dysplasia 270, 296
Oculoectodermal syndrome 184, 374, 406
Odontoonychodermal dysplasia 304, 305, 314, 315f, 1291
Oenothera biennis 2099
Ofuji's disease 911, 1204
Oligoarthritis 824
Olindias sambaquiensis 1616
Olmsted syndrome 265, 265f
Omalizumab 2046
joint task force 2047
Omenn syndrome 440, 446, 448, 448f, 569f
Onchocerca volvulus 1887, 1888, 1910
Onchocerciasis 1119
control programme 1888
Onion skin appearance 25f, 1750
Onychauxis 1269
Onychmycosis 1840f
Onychodystrophy 444f
factitial 1639
Onychogryphosis 1269, 1269f
Onycholysis 1264f, 1274
Onychomadesis 1265, 1265f
Onychomycosis 1285, 1838
topical therapeutic options for 1841t
Onychophagia 1282, 1282f
Onychorrhexis 1267, 1267f
Onychoschizia 1268
traumatic 1268f
Onychoteiromania 1283
Ophthalmia
neonatorum 1939, 1940, 1951
prophylaxis 1949
Ophthalmopathy 921
Optical cavity 2073
Optical coherence tomography 112
Opuntia ficus-indica 989
Oral candidiasis 1323
acute atrophic 1324
forms of 1849
Oral mucosa 1313
benign tumors of 1311
infectious diseases of 1318
lesions of 1336f
pigmented lesions of 1334t
Oral mucous membranes
disorders of 1306
function of 1306t
keratinization of 1306t
Oral neonatal lesions, benign 149
Oral suction over fontanelle 1622, 1633
Oral thrush 1848f
Organ transplantation 463, 2047
Organogenesis 121
Organoid epidermal nevi 397, 404t, 405
Ornithine transcarbamylase 875
Orofacial granulomatosis 957, 957f
Orphan receptor C, receptor-related 1853
Orthohyperkeratosis 214f
Orthopox variola virus 1794
Osteichthyes 1616
Osteochondrodysplasia 1177
Osteochondroma, subungual 1543
Osteocytes 1028f
Osteogenesis imperfecta 1065, 1076
Osteoma cutis 337, 1544
large plaque of 942f
management of 1029
multiple miliary 1029
plaque of 1028f
plate-like 1026, 1028, 1029f
primary 1026
secondary 1029
Osteomyelitis 1857
chronic multifocal 1243
Osteo-onycho-dysplasia, hereditary 1289
Osteopetrosis 1291
Osteopoikilia 1037f
Ota macules, acquired bilateral nevus of 1135
Ota nevus 1133, 1134, 1135f, 2086f
Otitis externa 1620, 1724
malignant 1620
Otolaryngology 516
OTULIN deficiency 1085
Otulipenia 839
Outer ear, swelling of 856f
Outer root sheath, cells of 20f
Oval nuclei 1528
Ovarian ampulla 1899f
Ovary 930
Overlap syndrome 1065
Oxiconazole 1839
Oxybenzone 1977
P
P5-carboxylate reductase 888
Pachydermodactyly 1525f
Pachyonychia congenita 271, 272, 1268, 1286, 1287, 1287f, 1287t, 1332, 2115
Pacinian corpuscle 25f
Paget's disease 1257
Pain
abdominal 1979
rectal 621
Pale erythema 585f
Palisaded neutrophilic granulomatous dermatitis 827
Pallister–Hall syndrome 1291
Palm, aquagenic wrinkling of 965, 966f, 1621, 1621f
Palmar
eccrine hidradenitis, idiopathic inflammatory 1611f
granuloma annulare 986f
hidradenitis, traumatic 1255f
keratoderma 267f
papules, painful 817
papulosquamous lesions 1921f
Palmoplantar
eccrine hidradenitis, idiopathic inflammatory 1610
erosions 318f
erythrodysesthesia 698
hyperkeratosis 323f
insulated 271f
severe 218f
keratoderma 255, 259t, 268, 270f, 362, 1145, 1167
acquired 276
areata 271
diffuse 255, 256, 264, 269
epidermolytic 256, 2115
inherited 276
linear 273
painful 2115
pediatric aspects of 277
striata 270
keratosis, Nagashima-type 263
pits 1581
psoriasis 489, 490f
pustulosis 492
P-aminobenzoic acid 2017
Panencephalitis, subacute sclerosing 1764
Panniculitis 85, 1080, 1083, 1085
drug-induced 1085
lipoatrophic 1084, 1084f
nodular migratory 1889
pancreatic 1082, 1083f
subcutaneous 1083, 1460, 1466
Pansclerotic morphea 797, 798
Papillary dermis 24f, 25f
Papilloma, verrucous 1312f
Papillomatosis 1143t
confluent 632, 1142, 1845
reticulated 632, 1142, 1845
Papillon–Léage–Psaume syndrome 1331
Papillon–Lefèvre syndrome 268, 268, 1043, 1332, 1333f
Papovaviridae 1796
Papular
acrodermatitis 1779
angiokeratoma 1420
lesions, crusted 1432f
purpuric gloves and socks syndrome 743, 1769, 1771, 1771f
sarcoidosis, juvenile 993
dome-shaped 1023f
erythematous 138f, 1240f, 1790f, 1828f
follicular 1040, 1620f
inflammatory 1228f
scattered 1433f
umbilicated 1433, 1806f
verrucous 80f
Papulonecrotic tuberculid 1738, 1740f
Papulonodules 1017f
Papulosquamous diseases 483, 526
Para-aminobenzoic acid 1232, 2105
Paracoccidioides
brasiliensis 1863
lutzii 1863
Paracoccidioidomycosis 1860, 1863, 1864f
Parainfluenza virus 1773
Parakeratosis 1016f
focal 536f
mounds of 502f
pustulosa 585f, 1283, 1283f
Paraneoplastic pemphigus 664, 959, 974
Paraphenylenediamine 109, 606
Parapoxvirus 684
Parapsoriasis 548
Parasitic disease 173
Parathormone 1029
Parathyroid hormone 941, 1020
Para-toluenediamine sulfate 606
Parechoviruses 170, 1773
Parkes–Weber syndrome 1416, 1419f
Paronychia, acute 1698, 1698f
Parry–Romberg syndrome 797, 799, 1207
Parvovirus
Pasini atrophoderma 1048
Pasteurella 1662, 1734
canis 1662
multocida 1662, 1734
Patau syndrome 61, 370, 371f, 1243f
Patch 71f
test 107, 108f, 110
Patella 415f
Pathergy test 111
Pathogenesis directed therapy 2122
P-cadherin 293
Peanut allergy 578
Pearson syndrome 374, 1446
Pedal papules
bilateral 152f
congenital 152, 195
Pediatric contact dermatitis workgroup 602t
Pediatric dermatology 67, 1969, 2030t, 2104
disorders, surgical management of 2104
Pediatric mastocytosis 1455t
epidemiology of 1450
Pediatric patch testing 601
Pediatric psoriasis 505t
topical therapies for 504t
Pediculosis 1301, 1904
pubis 1904
Pediculus 1898
capitis, life cycle of 1899f
humanus corporis 1711
Peeling 75, 126
skin
disease 290
disorders 239t
syndrome 238, 239, 239f, 290, 290, 645, 1167
Pelvic
examination 930
inflammatory disease 1936
Pelvis syndrome 622
Pemphigoid
childhood 666
bullous 667, 667t
classical bullous 668f
gestationis 663, 946
neonatal 146
infantile bullous 669f
neonatal 663
Pemphigus
childhood paraneoplastic 666
disease area index 665
familial benign chronic 243
foliaceus 661, 665f
neonatal 663
herpetiformis 664
neonatal 663
vegetans 664
vulgaris 661, 664f
neonatal 663
Penicillin allergy 1933
Penicillium 1841, 2031
marneffei 1855
Pentoxifylline 695
Penttinen syndrome 332, 332f
Peptic ulcer disease 2031
Peptidase D 440
Peptidylglycine A-amidating monooxygenase 887
Perforating disorders 939, 1016f
classification of 1015t
Perianal plaque, erythematous 1692
Periderm cells 4
Periflexural exanthema, asymmetric 1781, 1782f
Perilipin 1086
Perineal erythema, toxin-mediated 621, 1703
Perinuclear inclusions, eosinophilic 286f
Periodic acid-Schiff 150, 904, 1483, 1527, 1830
Periodic fever 848, 1325
adenitis pharyngitis aphthosis syndrome 848
aphthous stomatitis, pharyngitis and adenitis syndrome 2035
syndromes 416t, 417, 706, 835, 836, 1727, 2043
Periodic syndrome 836, 1325
receptor-associated 835
Periodontitis 268
Perioral urticarial lesions 705
Periorificial dermatitis, granulomatous 1240f
Peripheral blood mononuclear cells 1772
Peripheral nerve sheath tumor, malignant 354, 1567, 1570, 1571f
Permethrin 1902, 1909
Peroxisomal disorders 208
Peroxisome proliferator-activated receptor 1225
Petechia 75, 153
Petrolatum stripes 614
Peutz–Jeghers syndrome 956, 962, 962f, 1128, 1584, 1585, 1585f, 2085
Phace syndrome 1364, 1366f, 1369
diagnostic criteria for 1365t
Phacomatosis
cesioflammea 385f
pigmentokeratotica 398, 1510f
Phagocytes 37
Phagocytic cells 31
Phakomatosis pigmentovascularis 1392
Pharmacokinetics 2018
Pharmacologic therapy 827
Pharyngitis 848, 1325, 1774
Pharynx, uncomplicated gonococcal infection of 1938
Phenolic glucuronide 2031
Phenylalanine 871
ammonia lyase 872
hydroxylase 871, 875
deficiency 871
Phenylketonuria 871
Phenytoin 1606
Phialophora verrucosa 1859
Phlebectasia 1414
diffuse 1414
Phlebotomus 1880
Phosphatase 392, 403, 1588
Phosphate, inorganic 1062
Phosphatidylinositol 41
bisphosphate 390, 392, 393, 396, 846
kinase 392, 393, 1390, 1588
triphosphate 392
Phosphodiesterase 804, 1975
inhibitor 743
Phosphoglycerate dehydrogenase 346
Phosphoinositide dependent kinase-1 392
Phospholipase 144, 846, 1848
Phospholipid synthesis defects 888
Phosphomevalonate kinase 244
Phosphorus 1029
Photoallergens 1646t
Photoallergy 1646
Photobiomodulation 2089
Photocontact dermatitis 685
Photodermatosis 2028
idiopathic 1641t
Photodynamic therapy 539, 1997, 20042006, 2072, 2080
Photomediated light eruption 1998
Photon emission computed tomography 1598
Photopatch testing 111
Photophobia 240f, 348f, 1167
Photosensitivity 468
diseases 1644, 1645t
idiopathic 1641
Phototherapy 155, 508, 1113, 1997, 1998
clinical studies of 2003
indications of 1997t
types of 1997f
Photothermolysis, selective 2073, 2089
Phototoxic
drugs 2000
reactions 1644, 1645f
Phototrichogram 113
Phthiriasis palpebrarum 1301, 1900, 1904
Phylloid pattern 381
Phylum porifera 1617
Physalia physalis 1615
Physical abuse 1626
Phytanic acid
oxidase deficiency 230
storage disease 230
Phytanoyl-coenzyme A hydroxylase deficiency 231
Phytophotodermatitis 1645
Piebaldism 1106, 1106f
Piedraia hortae 1854
Pierini atrophoderma 1048
Piezogenic papules 1055, 1613
Pigment
application of 1637
demarcation lines 1130, 1131f, 1131t
dilution 873
incontinence 312
network 100f
Pigmentary abnormalities, camouflaging techniques for 2068t
Pigmentation 99f
diseases 1150
disorders of 1097
regulation of 1095
Pigmented nevi, congenital 2084
Pigmented nodular adrenocortical disease 1128
Pile 1936
Pili
annulati 1175, 1176f
canaliculi 1174
torti 1171, 1171f, 1172
trianguli 1174
Piloleiomyoma 112, 1541, 1239, 1479, 1480f
deep 1480f
histopathology of 1480f
Pimecrolimus 802
Pincer nails 1271, 1271f
Pinch purpura, bizarre patterns of 1637
Pinworm infestation 1304
Piperonyl butoxide 1990
Pityriasis
alba 630, 631t, 1117, 1117f
mild 631f
lichenoides 543, 545f, 546f, 1462, 2000, 2002, 2029
acute 82f
chronica 544
et varioliformis acuta 544
rosea 540, 542f, 1833
atypical 1782
variants of 542f
rotunda 543
rubra pilaris 269, 550, 550t, 551f, 565, 565f, 812, 2029
versicolor 1843, 1845f
Pityrosporum
folliculitis 1844, 1845f
ovale 1687
septicemia 1845
Plague 1735
Plakoglobin 284, 640f, 645
junction 284
Plakophilin 285
Plane warts 1799
Plantar
dermatitis 605f
juvenile 585f, 627, 628f
fibromatosis 1524, 1524f
hidradenitis 1255
hyperkeratosis 256f
porokeratotic lesions 245f
wart 1801, 1802f
multiple small 1802f
Plaque 72, 72f, 585f
chronic 2029
erythematous 676
morphea 798f
nummular 583f
psoriasis 487, 488f, 502, 502f, 509f
classic 488f
scaly 841f
Plasma cell 43
Plasminogen activator inhibitor 738
Plasmodium falciparum 2012
Platelet
derived growth factor 331, 803, 1271
disorders 738t
Platyhelminthes 1887
Platyonychia 1270
Playstation thumbs 1610
Plectin gene 648
Pleurodynia 1774
Plexiform
fibrohistiocytic tumor 1533, 1569
neurofibroma 352, 353f, 1183
isolated 1545f
Plexus
subpapillary 7
vascular 25f
Plotosus lineatus 1616
Plummer's nail 921
Pluripotent stem cell 2117
Pneumococcus 990, 1302
Pneumocystis
jirovecii 437, 448, 476
pneumonia 2017
Pneumonia, infant 1951
Pneumonitis, nonspecific interstitial 847
Podofilox 1956
Poikiloderma 75, 329, 337, 338f
alopecia, retrognathism, and cleft palate syndrome 345
congenitale, hereditary 337
nongenetic 1158
sclerosing 345f
Poikilodermatous mycosis fungoides 1460f
Poliosis 1185, 1185t
Polyangiitis 753, 754, 965967, 967t, 1328
microscopic 753, 2047
Polyarteritis nodosa 417, 749, 754, 755f
cutaneous 754, 755f
systemic 699
Polyarthritis 825
nonerosive 959
Polychondritis 968f
relapsing 856, 965, 967
Polycyclic aromatic hydrocarbons 1980
Polycystic kidney disease 357
Polycystic ovarian
disease 930
syndrome 498, 500, 928, 930, 936, 1208f, 1227, 1229
Polydioxanone 2107
Polyendocrinopathy 423, 445
Polyenes 1987, 1988
Polyethylene glycol 872
conjugated bovine adenosine deaminase 2122
Polygenic diseases, mechanism of 58
Polygenic skin disorders 387f
segmental mosaicism of 387
Polyglactin 2107
Polyglycolic acid 2107
Polyglyconate 2107
Polygonal cells 1530f
Polymerase chain reaction 62, 104, 148, 167, 723, 724, 801, 1007, 1284, 1319, 1382, 1562, 1620, 1690, 1711, 1721, 1827, 1884, 1935
Polymorphonuclear leukocytes 1931
Polymorphous light eruption 341, 1641, 1642f, 2033
Polyneuropathy 1251
Polyonychia 1273
Polyostotic fibrous dysplasia 942
Polyp, umbilical 193, 194f
Polypeptide gene 443
Polyposis syndrome, juvenile 962
Polysorbate 2031
Polythelia, bilateral 196f
Pomade acne 1241, 1241f
Pompe disease 2121
Pompholyx 626
Pool palms 1621, 1621f
Popliteal pterygium syndrome 1291
Porcelain nails 1292
Porokeratosis 243, 2004
classification of 244
linear 245f
palmoplantaris et disseminata 276
Porokeratotic adnexal ostial nevus 402, 403f
Porokeratotic eccrine nevus 297, 298f, 402
Poroma 1486f
eccrine 1485
Porphobilinogen deaminase 2120
Porphyria 890, 890t
acute intermittent 896
cutanea tarda 804, 890, 894, 895f, 1672, 2033
erythropoietic 1998
hepatoerythropoietic 892, 894
variegate 897f
Porphyrinemia, transient 145
Port-wine stain 801, 1389, 1389f, 1985, 1391f, 1392f, 2006, 2041, 2075, 2079f, 2080t
laser treatment of 2077, 2079f
Postaxial polydactyly 195f
Posterior brachioclavicular cutaneous nerves 1135f
Post-kala-azar dermal leishmaniasis 1118, 1881, 1884
Poststeroid panniculitis 1085
Post-transplant lymphoproliferative disorder 472
Potassium 2035
dichromate 603
hydroxide 1117, 1828, 1829f, 1845f, 1976
iodide 1859, 2040
titanyl phosphate 2074, 2077
Poxvirus infections 1794
Prader–Willi syndrome 373, 1101
Preauricular pit 179f
Prednisolone 2100
Prednisone 2047, 2100
Pre-engraftment syndrome 463, 464f
Pregnancy 1140, 1934
atopic eruption of 948
cholestasis of 948
disorders of 945, 946
plaque of 947
polymorphic eruption of 947
prurigo of 947
pruritic folliculitis of 948
pustular psoriasis of 948
Preimplantation genetic diagnosis 65, 655
Premature aging syndromes 329, 1168
Pressure ulcer 155, 1608, 1609f, 1609t
European pressure ulcer advisory panel classification of 1608t
Pretibial dystrophic epidermolysis bullosa 652, 653f
Pretibial myxedema 921
Prevotella 1723
intermedia 1322
Prilocaine, eutectic mixture of 1807
Probiotics 2100
Progeroid disorders 804
Progressive bone marrow failure syndrome 341
Prohibitin 1768
Proliferator activated receptor gamma 936
Proline serine-threonine phosphatase interacting protein 1 840
Proopiomelanocortin 1096
processing of 1096
Prophylaxis 471
long-term 713
Propionibacterium growth 618
Propranolol 1366, 2050
Propylthiouracil 920
Prostaglandin 36
cyclo-oxygenase pathway 703
Protective stratum corneum functions 4f
Protein 838
alternative pathway 32
C deficiency 733, 740f
capillary morphogenesis 910, 1527
defects, structural 207
electrophoresis, serum 1598
energy malnutrition 949
eosinophilic cationic 773
homologous 1571
human cationic antimicrobial 268
kinase 41f, 1096
B 392
C 41, 1096
losing enteropathy 1435
nucleolar 341
pancreatitis-associated 966
receptor-interacting 35
replacement therapy 2120
rich cells 14
S deficiency 734
serum interferon-gamma induced 788
synthesis 56f
transmembrane 841
tyrosinase-related 18, 1095, 1096
Proteus syndrome 1397
cerebriform collagenoma of 1522
Prothrombin
thrombophilia 734
time 732, 1396
Protoporphyria
erythropoietic 341, 890, 892, 893f, 1642, 1673
X-linked 892
Prototype immunoglobulin, structure of 48f
Protozoal disease 173, 1880
Prurigo
nodularis 629, 629f
pigmentosa 632, 632f
Pruritic urticarial papules 947, 947f
Pruritus 468, 1692
vulvae 1303
P-selectin glycoprotein ligand-1 46
Pseudoainhum 1041, 1042f
Pseudoangiomatosis, eruptive 1782, 1783f
Pseudocowpox 1795
Pseudo-Darier sign 1182
Pseudodidymosis 273, 384
Pseudohydrocephalic progeroid syndrome, neonatal 331
Pseudohypoparathyroidism 919, 941, 1026
Pseudo-ingrown toenail 1279f
Pseudokeratoderma 258
Pseudolymphoma 1004, 1239, 1459, 1469
cutaneous 1469
Pseudomonal folliculitis 1620, 1725
Pseudomonas 101, 148, 164, 444, 1282, 1614, 1619, 1695, 1725, 1728, 1838, 1847, 1985
aeruginosa 148, 164, 460, 474f, 940, 1304, 1686, 1724, 2097
folliculitis 1620f
hot hand-foot syndrome 1620
infections 164, 1985
Pseudomonilethrix 1170, 1171f
Pseudopelade 1203
Pseudopili annulati 1175
Pseudoporphyria 1672
Pseudopseudohypoparathyroidism 942
Pseudosyndactyly 649
Pseudoverrucous papules, perianal 616, 616f
Pseudoxanthoma elasticum 1061, 1061f, 2122
Psoralen 500, 590, 1644
plus ultraviolet A 1455, 1997, 2003
radiation 1113
Psoriasiform 81
acanthosis 502f
dermatitis 444f
eruptions 486
leishmaniasis 1882
scales 74
Psoriasis 33, 485, 486, 493f, 564, 611, 1264f, 1266f, 1833, 2000, 2001t, 2052
annular 489, 490f
anogenital 491
classic 81f
eczematous 502f
erythrodermic 495, 495f, 503
infantile 565f
inverse 491
linear 489, 491f
manifestation of 585f
micropapular 1781
pediatric 505t
phenomena 94
pustular 492, 494, 494f, 502, 1672
Psoriatic arthritis 496, 764, 820, 825, 2042
classification of 497
diagnostic criteria for 497t
features of 496t
juvenile 825
Psoriatic joint disease 2043
Psoriatic march 498fc
Psoriatic plaques, typical 488f
Psychiatric disorder 2054
Pterois volitans 1616
Pterygium 1273f
inversum 1274, 1275f
Pthirus 1898
pubis 1301, 1898
Ptychodiscus brevis 1619
Ptychotropism 236f
Puberty, precocious 61
Pucked chicken skin 1061f
Pulmonary disease 800, 965, 971, 2122
antituberculosis therapy for 462f
Pulmonary valve stenosis 1128
Pulsed dye laser 361, 1362, 1387, 1485, 2073, 2074, 2080t
resistant port-wine stains 2080
Punctate palmoplantar keratoderma 274, 275,
types of 276
Purified protein derivative 1695, 2025, 2043
Purpura 75, 153, 732
annularis telangiectodes 742f
causes of 734t
exercise-induced 743
extravascular causes of 743
fulminans 739, 740f, 1727f
causes of 740t
neonatal 740f
induction of 1635
infectious 743
causes of 741
linear 1622f, 1633f
Pustular
folliculitis, eosinophilic 140
melanosis, transient neonatal 137, 137f
psoriasis, generalized 494
skin disease 838
Pustule 73, 73f, 1227, 1866
subcorneal neutrophilic 80f
Pustulosis
eosinophilic 140, 141f, 770
neonatal cephalic 138, 139f, 1235, 1236f, 1845
Pyemotes 1913
herfsi 1653
ventricosus 1913
Pyemotidae 1913
Pyloric atresia 640, 646
Pyoderma
bacterial 73f
faciale 1238, 1238f, 2052
gangrenosum 147, 759, 763, 764t, 766t, 825, 840, 841f, 956, 958, 958f, 1237, 2028, 2042, 2112f
Pyogenic granuloma 1239, 1348, 1350, 1350f, 1373, 1378, 1378f, 1557, 2081, 2082f
features of 96
Pyostomatitis vegetans-pyodermatitis vegetans 958
Pyrethrins 1901, 1990
Pyrethroid, synthetic 1902
Pyrophosphate, inorganic 1062
Pyrroline-5-carboxylate 1075
Q
Q fever 1715
QS alexandrite 2085
Quadriplegia, spastic 210, 241
Quaternium 606, 2066
R
Rabson–Mendenhall syndrome 934, 935f
Raccoon eyes 1572
Racket nails 1288, 1288f
Radiation
dermatitis 1266
ionizing 1606
Radioallergosorbent test 1676
Radiofrequency 2072, 2090
Radioimmunoassay 919
Radiotherapy 1606t
Ragged-red fibers 374, 1539
Ramon syndrome 1526
Rapamycin 1985
complex, mammalian target of 392
inhibitor, mammalian target of 2041
mammalian target of 355, 393, 1396, 1675, 1985
topical 1985
Raphe cyst, median 194, 194f, 1494, 1494f
Rapid plasma reagin 788, 1928
Rash 75, 717, 721
mycoplasma-induced 684, 723
petechial 1774f
Rasopathy syndromes 354, 361, 362f, 2123
Raynaud's phenomenon 694, 696f, 803, 825, 969
Raynaud's syndrome 695, 696, 696t
Reactive blistering disorders 683
Reactive oxygen species 49, 432, 1100, 1623
Recalcitrant disease 767, 2026
Recessive disease 648
Recessive dystrophic epidermolysis bullosa 640, 649, 650, 651f, 2118, 2120
Rectum 1938
Red blood cells 938, 1380f, 1436f
Red tide dermatitis 1619
Reed's syndrome 1541
Reflectance confocal microscopy 92
Reflex sympathetic dystrophy 697
Refractory digital vascular disease 804
Refsum disease 230
Regional pain syndrome 697, 2099
Regiscar group scoring system 1670t
Reiter's disease 528
Reiter's syndrome 529, 529f, 768, 1326
Renal cell cancer syndrome 1541
Renal disease 733, 753, 783, 784, 788, 971, 972, 2034, 2039, 2047
chronic 751
end-stage 971
pre-existing 2038
rapidly progressive 2038
severe 789
Renal failure 1139, 2035, 2048
Renal function tests 2012
Renal parenchymal disease 650
Renal tubular acidosis 853
Reoviruses 1767
Respiratory distress syndrome 739, 1660, 2035, 2100
Respiratory system 1899f
Respiratory tract infection, upper 848, 2044, 2122
Restrictive pulmonary disease 812
Retardation 266
Retention hyperkeratosis 209, 213
Reticular erythematous mucinosis 2033
Reticulate capillary malformations 1393
Reticulate erythema 124f, 698, 1769f
Reticulated hyperpigmentation, disorders of 1144
Reticulohistiocytosis
congenital self-healing 142
multicentric 1443
Retiform hemangioendothelioma 1380
Retinal disease 2034
Retinal pigment epithelium, congenital hypertrophy of 1586
Retinitis pigmentosa 2116
Retinoic acid 1980, 2051
receptors 1231, 2052
response element 2052
responsive gene 2052
Retinoid 511, 1980, 2051
oral 1171
topical 1231
X receptors 1231, 1980, 2052
Retinol 2051
Retronychia 1280, 1280f
Reverse transcriptase polymerase chain reaction 1764, 1807
Reversible posterior leukoencephalopathy syndrome 516, 2046
Revesz syndrome 344
Reye's tumor 1529
Rhabdoid tumor 1570
Rhabdomyomatous mesenchymal hamartoma 1542
Rhabdomyosarcoma 1567, 1569, 1570f
Rhagade 75, 1928
Rheumatic diseases 784, 787
Rheumatism, fibroblastic 806
Rheumatoid
arthritis 822, 921, 2029, 2042, 2050
juvenile 820, 854, 2023
factor 497, 820823, 852, 996
serum 530
neutrophilic dermatosis 959
Rheumatologic diseases 736, 2029
Rhinocladiella aquaspersa 1859
Rhipicephalus sanguineus 1714
Rhizomelic chondrodysplasia punctata 204
Rhizomucor 1871
Rhizopus 1871
Rhomboid
flap 2110f
glossitis, median 1316
Ribonuclease H2, components of 847
Ribonucleic acid 58, 104, 424, 970, 1763, 2115
small interfering 1288, 2117
Ribonucleoprotein 842
Ribosomal ribonucleic acid 1233, 1847
Richner–Hanhart syndrome 255, 274
Rickettsia 1710, 1711t
prowazekii 1900
rickettsii 743
typhi 1712
Rickettsial diseases 1652
Rifampicin 2041
Rift valley fever virus 743
Riga–Fede disease 1336f
Ring chromosomes 373
Ringworm 1823
Rituximab 470, 2047
Robinow syndrome 1316
Rocky mountain spotted fever 743, 1651
Rofecoxib 1621
Rombo syndrome 1553, 1582
Rosacea
childhood 1238
pustular 1239f
Rosai–Dorfman disease 1443, 1444f
Roseola 1771f
Rosette pattern 666
Rothmann–Makai panniculitis 1084
Rothmund–Thomson syndrome 314, 332, 337, 338f, 345, 657, 791, 1016, 1077, 1168, 1551
Rough endoplasmic reticulum 9
Rowell syndrome 671
Rower's rump 1612
Rubella 169, 1763, 1765
Rubinstein–Taybi syndrome 1037
Rudimentary hair follicle units 398f
Rudimentary supernumerary digits 195
Rudimentary toe 406
Russell's sign 945
Ruta graveolens 1630
Rutherford syndrome 1526
S
Saber shin 1928
Sabouraud's dextrose agar 1838
Saccharomyces boulardii 2100
Saddle nose 1927
Sagartia elegans 1619
Salicylic acid 213, 1979, 1982
Salivary gland tissue, heterotopic 181
Salivary retention cysts 149
Salmon patch 1352f, 1388f
Salmon spot 1264f
Salmonella 1689, 1722, 1728, 1729
enterica 528, 1728, 1729
enteritidis 1081, 1326
typhi 1729, 1730
Salt split skin technique 661
San Joaquin valley fever 1865
Sanfilippo syndrome 905, 907, 2121
Sarcoid granulomas 996f
Sarcoidosis 970, 991, 993f, 994f, 1121, 1525
associated syndromes 995t
early-onset 970, 993
lesions 993t, 996t
nonspecific 994, 995t
pediatric 996t
preschool 993
Sarcoma 1569
epithelioid 1571, 1571f
pleomorphic 1572
Satellite lesions 1849
Saw-tooth acanthosis 533f
Scab 75
Scabies 173, 1904, 1905
complications of 1911
crusted 1908f
dermoscopy of 1909f
infestation 1286
mite 1908f
neonatal 173f
nodular 1907f
treatment of 1907f
Scale 74
Scalp 1182f
abscess 1689
biopsy, fetal 153
coloring 2070
dissecting cellulitis of 1202
erosive pustular dermatosis of 183
hair, absent 306f
hereditary hypotrichosis simplex of 1165
injury 1168
psoriasis 487, 489f
Scaphoid scapula 1928
Scar 75, 1228, 1552, 2083
tissue 649
Scarlet fever 1702
convalescence 1702f
rash 1702f
Scarring alopecia 1200
irregular patches of 1205f
Schamberg's disease 741, 741f
Schauder syndrome 404
Schimmelpenning syndrome 405, 406f
extracutaneous manifestations of 405t
Schistosoma mansoni 1891
Schistosomiasis 1891
Schnitzler's syndrome 753
School chair sign 599
Schöpf–Schulz–Passarge syndrome 304, 305, 315, 316f
Schwann cell 1545f, 1546
precursors 1093
Schwannian stroma 1572
Schwannoma 357, 1546
Scleredema 805, 939
Sclerema neonatorum 157, 807, 1082
Scleritis 857
Sclerocornea 386
Sclerodactyly 969
Scleroderma 892, 795, 1120
linear melorheostotic 1183
Sclerodermoid diseases 795
Sclerodermoid graft-versus-host disease 2004
Scleromyxedema 805
Sclerosing cholangitis 299
Sclerosing disorders 1034
Sclerosis 75
progressive systemic 802
systemic 33, 797, 805, 1020, 2041
Sclerotherapy 969
Sclerotylosis 266
Scoliosis 406
Scorpaenidae 1616
Scorpions 1653
Scrofuloderma 1737, 1738f
Scrotal calcinosis 1023
Scrotal hair 1181
Scrotum, angiokeratoma of 1421
Scytalidium hyalinum 1838
Sea
nettles 1615
snakes 1616
urchin granuloma 990f
Seabather's eruption 1618
Seaweed dermatitis 1617
Sebaceous duct 21f
Sebaceous gland 10, 10f, 14, 21, 23f, 24f
hyperplasia 151, 151f
products 21f
tumors of 1487
Sebaceous lipids 24
Sebaceous nevus 397, 398f, 406f
Seborrheic dermatitis 526, 528f, 564, 585f, 956
severe 462f
Seborrheic keratosis 395, 1588
criteria for 96
Sebum production 1225
Secukinumab 516, 2045
Sedation, preoperative 2106
Sedimentation rate 853
Segmental keratinocytic nevi 403t
classification of 391t
Selective serotonin reuptake inhibitors 1196, 2021
Sensation 15
Sensitizers, topical 1981
Sentinel lymph node biopsy 1559
Septicemia 164
Sequelae 1791
Serine protease inhibitor kazal-type 5 2120
Serologic tests 104, 106
Serologies, viral 1598
Serpiginous borders 1886f
Serratia marcescens 433, 1238
Sertaconazole 1839
Sertoli cell tumor 1583, 1584
Serum alanine aminotransferase 863
Serum amyloid A 835
protein 913
Serum sickness 702, 712, 1671f
classic 1670
disease 2011
reaction 1666, 1670
Servelle–Martorell syndrome 1396
Sesquiterpene lactones 599
Severe combined immunodeficiency syndrome 40, 415, 446, 569, 1168, 1567, 2118
types of 446t
Sex hormone binding globulin 929, 1229
Sex partners, management of 1938, 1957
Sexual abuse 1626, 1631
mimics of 1632
Sexually transmitted disease 1918, 1945, 1949
spectrum of 1918t
Sexually transmitted infections 1919
viral 1953
Sézary syndrome 1975, 2029
Shagreen patch, large 359f
Shah–Waardenburg syndrome 1105
Shaken baby syndrome 1622, 1633
Shell nails 1272
Shigella flexneri 528, 1326
Short anagen hair syndrome 1196
Short stature 918f
Short-course systemic therapy 2000
Shprintzen–Goldberg syndrome 1069
Shrimp nail 1269f
Shrinking tube technique 114
Shwachman syndrome 241
Shwachman–Bodian–Diamond syndrome 436
Siemens ichthyosis bullosa 218f
Silvery hair 1156f
Simple vascular malformations 1351t
Simpson–Golabi–Behmel syndrome 196, 1543
Simulium 1887
Sinecatechins 1957
Sinus 76
pericranii 1414
superior sagittal 1414f
Sirolimus 1985
treatment 1487f
Six sign atopic dermatitis severity score 2002
Sjögren's syndrome 678, 743, 761, 784, 790, 792, 853, 1056, 1328
maternal 70
Sjögren–Larsson syndrome 204, 211, 229, 230f, 348, 567, 2117
Skeletal abnormalities 888, 1177, 1582
Skin 8f, 10f, 31, 121, 153, 785, 1605, 2013
adnexal polyp of 153
atrophy 340f
biopsy 1021f, 1028f
fetal 153
perilesional 660f, 661f
camouflage techniques 2067
cancer 472, 1100
care 128, 588, 1972
ceramide synthesis 210f
changes 1251
color variation 2067
conditions 1606t
congenital absence of 651f
contour variation 2068
defects 2109
congenital 374
defense, mechanisms of 1683
dermal epidermal junction of 8f
detachment, extensive 725f
development 3, 5, 7, 9
stages of 5
diabetic 939
dimple 188f, 188t
direct immunofluorescence examination of 677f
disease 33, 36, 64, 149, 625, 1972, 1975, 2033, 2096, 2115, 2117
artifactual 1635
frequency of 133
immunobullous 2037
inflammatory 36, 2025, 2029, 2031, 2083
pediatric 2033
persistent 818
primary 598
disorders 269, 275, 939, 2047, 2122, 2123
genetic testing for 64t
hereditary 2115, 2123
inflammatory 2027, 2083
inherited 2117
embryogenesis of 3
erythematous 668f
findings 531
fragility 285
disorders 640f
syndrome 285, 286f, 305, 644
function of 13, 14
genetic diseases of 201
glands of 21f
grafts 2109
histopathology 1453f
hydration 618, 2104
hyperextensibility 1064t
infections 1681, 1684
infestations of 1898, 1913
infiltrations 1459
junctions, diseases of 284
lesions 71, 369f, 722f, 725f, 885f, 956, 963, 965, 971, 1608, 1622, 1905
arrangement of 77t
disseminated 473f
histopathology of 786
terminology of 71
water-related 1614, 1621
lymphoplasmacytic infiltrations of 1004
malignant tumors of 1567
mastocytoma of 1450, 1451
microbiome 2104
necrosis, warfarin-induced 734
ossification 1026
pathology 297
perianal 1305f
phototypes 111t, 1552t
pigmentation, abnormal 324f
prick test 110, 577
primary herpetic lesion of 1785f
reactions 1810t
scales 1834f
direct examination of 1845f
solitary
fibrous tumor of 1528
lesions of 1452f
substitutes 2110
superficial blistering of 218f
tags 1806
test 107, 110, 110t
tight junction in 299f
treatments, topical 1455
vesicles, recurrent 291
Skyline
basal cell layer 396, 405
sign 396
Slapped cheek 1769
Sleep, prolonged periods of 2051
Sly syndrome 905, 2121
Small cell tumor, malignant 1573
Small proline rich proteins 209
Smallpox 1794
Smith–Lemli–Opitz syndrome 65, 233
Smooth muscle
actin 1521
hamartoma 1540
congenital 1182, 1541f
tumors 462, 1540
Sneddon syndrome 699, 734
Sock-line hyperpigmentation 1143
Sodium 2035
antimony gluconate 1118
Soft nails 1269f
Soft ticks 1651
Soft tissue 1422, 1422f
infections 2013
injury 153
tumors 1538
malignant 1567
Solar lentigines 339
Solar radiation 1640
Solar urticaria 708, 710, 2033
Sole, cerebriform collagenoma of 1523
Somatic mosaic mutations 407
Sparganosis 1892
Sparse hair 306f, 348f, 364f
Sphingosine-1-phosphate 46
Spider 1654
angioma 2080
nevus 2080
treatment of 2081f
Spiky hyperkeratoses 298f
Spilorosea 1509
Spina bifida 406
Spinal dysraphism 184, 189t
cutaneous signs of 189
Spinal fusion abnormalities 1181
Spindle cell hemangioma 1377
Spindle myoid cells 1530f
Spinulosus keratosis 585f
Spiny palmoplantar keratoderma 275
Spiny skin 1617
Spiracles, abdominal 1899f
Spiradenoma 1485, 1486f
Spiridurida 1888
Spirillum minus 1732, 1733
Spirochetes 1323
Spitz melanoma 1560
Spitz nevi 98f, 1511, 1557, 1560, 1806
atypical 1560, 1561f, 1562f
classical 1513f
Spitz tumor, atypical 1239, 1511, 1560
Spitzoid melanocytic neoplasms 1560
Spitzoid melanoma 1560
Spitzoid tumor 1560
Split papules 1922f
Sponge Fisherman's disease 1619
Spongiosis 502f
epidermal 81
Sporadic arteriovenous malformations 1415
Sporothrix 1858
schenckii 1695
Sporotrichoid leishmaniasis 1882, 1882f
Sporotrichoid nocardia infection 1704f
Sporotrichoid staphylococcal lymphangitis 163
Sporotrichosis 1857, 1858f
disseminated 1858
lymphocutaneous 1858
Sports injuries 1612
Spot test 603
Spring eruption, juvenile 1642, 1643f
Spun glass hair 1174
Squamous cell carcinoma 315, 472, 649, 797, 1100, 1145, 1551, 1551t, 1552, 1553f, 1578, 1579, 2004
features of 96
invasive 1552f
Squaric acid dibutylester 1192, 1981
Staphylococcal
cassette chromosome 1690
cold abscesses, neonatal 163
impetigo 1285
infection 611
scalded skin syndrome 84f, 102, 163, 163f, 567f, 611, 682, 684, 727, 1684, 1698, 1699f
Staphylococcus aureus 104f, 162, 424, 460, 460f, 616, 621, 883, 928, 966, 1039, 1040, 1201, 1237, 1282, 1300, 1662, 1683, 1684, 1764, 1790, 1791, 1986, 2012
gram-positive 104f
impetigo 625
infection 621
Staphylococcus epidermidis 139, 1056, 1231
Starch-iodine test 1251f
Steatocystoma multiplex 1287, 1491
Steatohepatitis, nonalcoholic 499
Steely hair syndrome 1171
Stem cells
epidermal 2117
factor 1449
postnatal 1094
Sterile alpha motif 316
Sternal defects 193
Sternocleidomastoid muscle 180
Steroid
dependent disease 818
rosacea 1238
sparing drugs 665
sulfatase 65
systemic 922
Stevens–Johnson syndrome 82f, 462, 671, 682, 723, 862, 684, 717, 725f727f, 768, 769, 1666, 1972, 2017
Stewart–Bluefarb syndrome 1419
Stiff skin syndrome 804, 806, 806f
Still's disease 820, 822, 1136, 2043
Stomatitis, ulcerative 1324
Stratum
basale 1093, 1094
granulosum 10, 14, 17, 210f, 682
spinosum 10, 18, 18f, 1094
corneum 10, 17, 122, 210f
Strawberry gums 754
Strawberry tongue 859f
Streptobacillus moniliformis 1732
Streptococcal dermatitis
perianal 621, 1693f
perinatal 1692
Streptococcal disease 1686
Streptococcal intertrigo 1693, 1693f
Streptococcal pyrogenic exotoxins 1700
Streptococcus 1683
pneumoniae 424, 1694, 1764
pyogenes 162, 424, 1683, 1684, 1764, 1906, 1986
viridans 528
Streptomyces
genus 2015
hygroscopicus 2041
somaliensis 1856
Stress 501
Stretch marks 1069
Striae 76, 1043, 2083
Striate palmoplantar keratoderma 287, 287f
Striated muscle
nevus of 1542, 1542f
tumors 1542
Strongyloides stercoralis 1890
Sturge–Weber syndrome 1364, 1390, 1391, 1392f
Subcutaneous tissue 20f, 23, 415f, 797
diseases of 981
Subcuticular sutures 2108, 2108f
Subepidermal calcified nodule 1023, 1023f
Subepidermal vesicle 677f
Sucking blister 150, 151f
Sucking calluses 150
Sugiura's sign 1116f
Sulfamethoxazole 462, 1233, 1686, 1857, 2017, 2025, 2036
Sulfasalazine 828, 2036
Sulfatase deficiency, multiple 231
Sulfonamides 462, 2035
Sulfones 2035
Sulfur ointment 1909
Sun protection 1977
factor 1641, 1977
Superantigens, bacterial 476
Superficial actinic porokeratosis, disseminated 244
Superficial fungal infections 1822, 1822t
topical drugs for 1841t
Surfer's nodules 1612
Surgery 1370
Surgical nasal closure 969
Suturing techniques 2106, 2107
Sweat
glands, eccrine 21, 22f
testing 115
Sweating, eccrine 1250
Sweet syndrome 143, 676, 759, 825, 959, 2035, 2043
classical 759, 761
diagnosis of 763t
drug-induced 759
malignancy-associated 759
Swimmer's ear 1620
Swimmer's itch 1617
Swimmer's periocular purpura 1613
Swollen wrists 994f
Sycosis nuchae 1039
Syndrome of inappropriate antidiuretic hormone secretion 1669
Syndromic arteriovenous malformations 1416
Synovitis, acne, pustulosis, hyperostosis, osteitis syndrome 1202, 1237, 2043
Syphilis 1722, 1918, 1923, 1929fc, 1930fc
condylomata, multiple flat-topped 1921f
congenital 164, 165f, 621, 1924, 1925t, 1934
diagnosis of 1928
early congenital 1924, 1924t, 1926f, 1927f
late 1923
congenital 1927, 1928f
prenatal 1924
primary 1919, 1919f, 1920f
secondary 1920, 1920f1923f
specific pediatric aspects of 1935
treatment of 1931, 1933t
Syringocystadenoma papilliferum 1486
Syringomas 1484, 1485f
histopathology of 1485f
Syringometaplasia, eccrine squamous 1255
Systemic disease 785, 1138, 1328t, 2106
cutaneous manifestations of 956
Systemic inflammatory response syndrome 761
Systemic lupus erythematosus 33, 443, 670, 702, 721, 735, 753f, 783, 784f, 787f, 812, 820, 841, 852, 921, 1010, 1930, 2021
bullous 661
childhood bullous 670
features of 429t
neuropsychiatric 788
Systemic mastocytosis 775, 1449, 1452, 2047
diagnostic criteria of 1453t, 1454
Systemic sclerosis 33, 797, 805, 1020, 2041
overlap syndrome 1022f
Systemic therapies 1232, 1830t
T
Tachycardia 864
Tacrolimus 797, 802
ointment 626
Taenia solium 1892
Taeniolella boppii 1859
Takayusu's arteritis 958
Tamoxifen 969
Tap-binding protein 39
Tarantulas 1656
Tattoo 2084
granuloma 990f
removal 2087t
Tazarotene 508
T-cell 19, 39, 40
cytolytic activity 2027
cytotoxic 44
development 40
function 2027
interferon-gamma release assays 104
lesional 911
leukemia virus 1905
lymphoma 686, 742, 1083, 1460, 1466, 1467
cutaneous 1459, 1975, 1997, 2002, 2041, 2052
medium 1460
lymphotropic virus 563, 633, 634, 1461
receptor 39, 40, 41f, 42, 724, 1461
diversity of 39f
gene rearrangement 537
signaling 41
regulatory 44
subsets 43
Tea tree oil 1986, 2096
Tedania ignus 1617
Teeth, congenital absence of 306
T-effector cells 50f
Tegumentary forms 1881
Telangiectasia 76, 791f, 796f, 1239, 1480f, 1806f, 2080
hereditary hemorrhagic 965, 968, 969f, 1354, 1387
linear 419f
Telogen effluvium 114f, 1185, 1186f
causes of 1186
Telomerase reverse transcriptase 1572
Telomere biology disorder 323
Temporomandibular joints 825
Tendon sheath 1533
fibroma of 1533
Tense blisters 684f
Tensin homolog 392, 403, 1588
Terbinafine 1842, 1987, 2021
Terra firma-forme dermatosis 1143
Terry's nails 973
Teschler–Nicola syndrome 196
Testosterone estrogen binding globulin 929
Tetracaine 2105
Tetracyclines 1203, 1319, 2010
antibiotics 1640
Tetrahydrobiopterin 871
Tetrahydrofolic acid 2017
Tetrathiomolybdate 886
Thayer–Martin medium 1936
T-helper 576, 1204, 1880, 2045
lymphocytes 1324
Thermal
burns 1601, 1603f
injury 1636, 1638f
relaxation time 2073, 2074f
Thiomethyl tetrazole ring 2014
Thiopurine methyltransferase 593, 789, 20272029
Thoracic aortic aneurysms, familial 1069
Thoracic spiracle 1899f
Three-M syndrome 196
Three-prime repair exonuclease 847
Threonine protein kinase 11 962
Thrombocytopenia 788, 1364, 1422, 1810
neonatal 739
Thrombocytopenic purpura, idiopathic 921
Thrombophlebitis 1694
Thromboplastin, partial 1396
Thrombosis, venous 769
Thrombotic disorders 732
Thrombotic thrombocytopenic purpura 736
Thumb
Beau's lines of 1265f
sucking 1240
Thymine 56
Thymus activation regulated chemokine 588, 1470
Thyroglossal duct cyst 179, 180f
Thyroid
binding globulin 919
disease 795, 2040
disorders 918
dysfunction 2039
medullary carcinoma of 944
stimulating hormone 912, 919, 996, 2040
Thyrotropin-releasing hormone 919
Thyroxine, serum 919
Tietz syndrome 1102
Tilbury fox 648
Timolol maleate gel 1369
Tinea 1823
capitis 101f, 1207, 1824, 1826f, 1828f, 1830t
epidemiology of 1825t
noninflammatory 1828f
corporis 86f, 1782, 1832, 1833f
diagnosis of 1834f
cruris 1835, 1836f
faciei 1834, 1835f
imbricata 1834, 1834f
incognita 1835f
manuum 1836, 1838f
nigra 1855, 1855f
nondermatophyte causes of 1838
pedis 1836, 1836t, 1837f
typical features of 1835f
versicolor 1118, 1118f
Tissue
expansion 2111
nonlymphoid 46
nonspecific alkaline phosphatase 2122
plasminogen activator 154, 1598
resident memory T cells 46
toxicity 1659
T-lymphocytes 2089
Tocopherol 2066
Toe web intertrigo 1724
Toenail loss 647f
Togaviridae 169, 1765, 1767
Toll-like receptor 416, 1225, 1804
Tolnaftate 1987, 1988
Tolypocladium inflatum 2025
Tongue
benign papular lesions of 1311t
dorsum of 1312f
erythema of 859f
fibroma on 1312f
melanotic macule of 1336f
ventral surface of 1312f
Topical therapy 503, 585f, 1909
Torsion, irregular 320
Torticollis 1037
Tortuous vessels 502f
Townes–Brocks syndrome 1543
Toxic epidermal
necrolysis 102, 462f, 670, 682, 684, 717, 723, 726f, 727f, 1664, 1699, 2017
necrosis, score of 726
Toxic erythema 134, 473
Toxic oil syndrome 804, 805, 805f
Toxic shock syndrome 1699, 1701
Toxicity, hematologic 1659
Toxins 621
bacterial 83f
Toxocara canis 1889
Toxocariasis 1893
Toxoplasma 173
gondii 173
Toxoplasmosis, congenital 173f
Trachoma 1944t
Trachyonychia 1267, 1267f
Tralokinumab 594
Tranexamic acid 713, 969
Transcription activator-like effector nucleases 56f, 2116
Transcutaneous oxygen 154
Transducer, suppress signal 829
Transepidermal water loss 122, 576, 618, 1612, 1973
Transferrin immunoelectric focusing 1074
Transforming growth factor 32, 210, 1037
Transglutaminase 4, 222, 257, 674, 2117
gene 645
Transient myeloproliferative disorder 142, 370
Transmission electron microscope 91
Tranylcypromine 437
Trauma 743
Trench
fever 1723
foot 1598
Treponema
carateum 1157
pallidum 164, 1119, 1157, 1918, 1931
hemagglutination assay 166, 1119
particle agglutination 166
Treponematoses 1119
nonvenereal 1932t
Tretinoin 1980
Triamcinolone 797
Triangular delta structure 100f
Triazoles 1987, 1988
Trichilemmal cyst 1490
nevus 401
Trichilemmomas 316
Trichinella spiralis infestation 818
Trichloroacetic acid 1957
Trichoblastoma 1482
Tricho–dento–osseous syndrome 1331
Trichodiscoma 316
Trichodysplasia spinulosa 471, 471f
Trichoepithelioma 1482, 1482f
multiple familial 1482
Trichofolliculoma 1481, 1481f
Trichogram 113
Trichohepatoenteric syndrome 1104
Tricholemmoma 1483, 1483f
Trichomycosis
axillaris 1709
pubis 1709
Trichophyton 1823, 1831, 1832, 1842
interdigitale 1824
mentagrophytes 1081, 1286
rubrum 1286, 1823
schoenleinii 101
soudanense 1286
tonsurans 1823
violaceum infection 460f, 1824
Trichorhinophalangeal syndrome 61, 1292
Trichorrhexis
invaginata 1175, 1177f
nodosa 1172, 1173f
Trichoscopy 115
Trichosporon 1849, 1853, 1854
infections 1853
Trichosporum 1851
Trichothiodystrophy 269, 335, 347, 347f, 347t, 348f, 1172, 1173
diseases, group of 339
Trichotillomania 1194, 1195f
Trientine 886
Triglyceride 878, 881
metabolism 881
Triiodothyronine 919
Trimethoprim 462, 1233, 1302, 1686, 1857, 2017, 2025, 2036
Trinucleotide repeat disorders 63
Tris nitromethane 606
Trombicula autumnalis 1914
Trombiculidae 1014
Tropical diseases 1891
Tubercle 76
Tuberculids 1739
Tuberculoid
disease 1119, 1748, 1750
leprosy 1748, 1748f
Tuberculosis 511, 2043, 2050
acute miliary 1738
colliquative 1857
congenital 1738
periorificial 1738
primary inoculation 1737
verrucosa cutis 1738
warty 1738
Tuberous sclerosis 65, 351, 357, 358f360f, 392, 393, 944, 1101, 1319, 1519f
collagen hamartoma of 359f
complex 357, 357t, 1519, 2041, 2123
facial angiofibromas of 358f
Tubular ducts 22f
Tularemia 1722, 1731, 1731f
francisella 1081
Tumoral fibroblasts 1568f
Tumors 76, 462, 1479, 1484, 1574, 1579, 1584, 1588
cutaneous 1050t
Ewing family of 1573
fibroblastic 1519
inflammatory myofibroblastic 1532
intradermal 1562
lysis syndrome 2048
malignant epidermal 1551
melanocytic 1560, 1562
myofibroblastic 1519
necrosis factor 32, 210, 305, 417, 438, 835, 983, 1232
receptor 32, 836, 1325
node, metastasis 1461
ovarian 839, 840
primitive neuroectodermal 1573
solitary fibrous 1528
testicular 1583
thickness 1560
vascular 1348, 1373
Turcot syndrome 961
Turner's syndrome 371, 372f, 922, 1041f
dermatologic features of 371t
Twenty-nail dystrophy 1267f
Twin-twin transfusion syndrome 744
Tyrosine 871
aminotransferase 274
kinase
inhibitors 1671
receptors 1096
Tyrosinemia 274
oculocutaneous 274
Tzanck test 102, 103f
U
Uchthyoses 1167
Ulceration 1361, 1557, 1560
oral 444f
Ulcers 74
diabetic 939
multiple 1941f
necrotic 750f
vulvar 1777f
Ulerythema ophryogenes 1051f
Ullrich–Turner syndrome 922
Ulnar mammary syndrome 322
Ultra-long-chain-ceramides 15
Ultrasonography, cutaneous 112
Ultraviolet 57, 330, 470, 590, 1465, 1501, 1551, 1572, 1579, 1611, 1829, 1977, 2074, 2089
A 101, 155, 500
A1 therapy 2004
B 16, 1043
light excimer laser 2089
phototherapy 1998
protection factor 1977
radiation 1093, 1640, 1997
Uncinaria stenocephala 1890
Universal melanosis 1142
Unna boots 631
Upadacitinib 2049
Urbach–Wiethe disease 1332
Urban–Rifkin–Davis syndrome 1070, 1075
Ureaplasma 1723
urealyticum 528, 1326
Urethra 1938
Urethritis, nongonococcal 1943
Uric acid 1461
Uroporphyrinogen
decarboxylase 894
synthase 890
Ursodeoxycholic acid 948, 964
Urticaria 702, 705f, 1669, 2037
acute 73f
annular lesions of 705
aquagenic 711
cholinergic 711
chronic spontaneous 703, 706, 960
concomitant lesions of 705f
delayed pressure 709
multiforme 702, 705f
papular 706
physical 707
pigmentosa 1449
vasculitis 752f, 753f
vibratory 707, 711
Ustekinumab 436, 2045
Uveitis 497
acute anterior 826
V
Vaccination, complications of 1740
Vaccinia 1795
virus 1795
Vaginosis, bacterial 1723
Varicella 168, 1789, 1806
syndrome
congenital 168
fetal 169f
virus live vaccine 1791
zoster
immunoglobulin 169, 2024
infections 1322, 1789
virus 106, 168, 461, 683, 1303, 1322, 1771, 1989, 2009, 2024
Variegate porphyria 892, 896
Variola 1794
virus 1961
Vascular anomalies 1345, 1355, 1355t
classification of 1347
multifocal 1364t
overview of 1347t
Vascular cell adhesion molecule 46, 2018
Vascular disease 802
complications of 333
proliferative 2039
Vascular endothelial growth factor 486, 803, 1063, 1094, 1138, 1985, 2012
Vascular lasers, nonvascular indications of 2082
Vascular lesion
criteria for 96
laser therapy of 2072
treatment of 2077
Vascular malformations 1351, 1387, 1574, 2081
Vascular tumors 1348, 1373
benign 1373
malignant 1382
subcutaneous 1481
Vasculitides 699, 958
classification of 749t
management of 755
Vasculitis 83, 743, 748, 753, 1754, 2037
classification of 748
cutaneous 960
granulomatous 966
lymphomatoid 966
medium vessel 754
necrotizing 966
nodular 1081
urticarial 706, 751
Vasculopathy 840
sting-associated 840
Vasoactive intestinal peptide 1250
Vaso-occlusive disease 694, 1574
Vater-Pacini corpuscles 24
Vellus hair 306
cysts 1981
Veno-occlusive diseases, life-threatening 2028
Venules, postcapillary 25f
Verardinelli–Seip syndrome 1086
Vernix caseosa 123
functions 10
Verruca vulgaris 1588, 1797, 1989, 2004
Verrucosis 1803
Verrucous hyperkeratotic lesions 1859
Verrucous venous malformation 1355, 1355f, 1413, 2110f
Vesicles 73
hemorrhagic 1785f
intracellular 35f
Vesicular nucleotide transporter 244
Vesicular palm lesions 1774f
Vesiculobullous diseases 637, 682
neonatal 134, 134t
Vesiculopustular eruption 142
Vessel 2074
catheterization 154
vasculitis 753, 755
Viannia subgenus 1885
Vibrio 1614
vulnificus 1616, 1619, 1620, 1697
Vincent's disease 1322
Vincent's gingivostomatitis 1322
Vincristine 2047
Vinyl chloride 1623
Violaceous nodules 1568f
Violaceum 1286
Viral diseases 106
treatment of 2037
Viral exanthems 1761, 1806
Viral genome 1768
Viral infection 567, 682, 1284, 1761
mucocutaneous 2010t
types of 2009
Virus 1663
Visceral disease 802
Visceral leishmaniasis 1118, 1880, 1881, 1883
Vitamin
alcohol 2051
B12 603, 735, 889
B6 735
C 742
deficiency 744
D 591, 789
activated 1982
analogs 507
dependent rickets, hereditary 945
receptor 945
resistance 945
D3 945
analogs 1982
K deficiency 738
responsive disorders 888
supplementation, oral 1114
Vitiligo 1111f, 1114, 1120f, 2002, 2002f, 2003
childhood 1109, 1110
extensive 1111f
nonsegmental 1110, 1111f, 1112
perilimbal 1116f
perineal 1111f
repigmenting 1113f
segmental 1110, 1112f, 1114
susceptibility 1112t
treatment of 1112
Vogt–Koyanagi–Harada syndrome 1101, 1114, 1115f, 1116f
Vohwinkel keratoderma 264f
Vohwinkel syndrome 258, 264
Vomiting 926f
von Willebrand
disease 737
factor 737, 738
Voriconazole 1640
Vulva, angiokeratoma of 1421
Vulvovaginal candidiasis 1850
W
Waardenburg syndrome 1099, 1101, 1104, 1105, 1105f
diagnostic criteria of 1104t
Wangiella dermatitidis 1859
Warts 2082
extensive 444f
multiple 1798f, 1802f
perianal 1800f
periungual 2083f
viral 1282f
Washboard nails 1265
Waterhouse-Friderichsen syndrome 1726
Waxy keratosis 553
Waxy skin 938
Weber–Christian panniculitis 1084
Wegener's granulomatosis 753, 857, 966, 1525, 2042, 2047
Weill–Marchesani syndrome 1069
Wells syndrome 770, 772
Werner syndrome 331, 332, 1022, 1168
Westerhof syndrome 1153
White adipose tissue 25
White atrophic papules 796f
White blood cell 343, 835, 863
White piedra 1854f
White strawberry tongue 1702
Whitfield's ointment 1979
Whole exome sequencing 62, 1066, 1084
Whole genome sequencing 63, 1066
Wiedemann–Beckwith syndrome 920
Wiedemann–Rautenstrauch syndrome 331
Wiedemann–Steiner syndrome 1181
Wildervank syndrome 1543
Williams syndrome 196
Wilms tumor 1373, 1574
Wilson's disease 885, 1171
Winchester syndrome 910, 1525
Winter syndrome 1157
Wiskott–Aldrich syndrome 436, 440, 450, 450f, 569, 728, 1807, 2118
Witkop syndrome 1291
Wolf–Hirschhorn syndrome 374
Wolman disease 1446, 2122
Wood's lamp examination 101, 102f
Wool wax alcohols 605
Woolf syndrome 1154
Woolly hair 268, 1173, 1174f
Worn–Down nail syndrome 1283
Wound 76
chronic 1552
closure techniques 2106, 2108
therapy, negative-pressure 2111
Wrinkly skin 1074
Wuchereria bancrofti 1695, 1887, 1888
Wyburn–Mason syndromes 1419
X
Xanthogranuloma juvenile 83f, 352, 353f, 362, 1439, 1441f, 1442f, 1470, 1806
Xanthoma
disseminatum 1443, 1443f
eruptive 939
Xanthomatosis 1861
X-chromosome 308, 923, 924, 925
diseases, mosaicism of 59
Xenopsylla cheopis 1735
Xeroderma pigmentosum 62, 334, 339, 340f, 892, 1145, 1153, 1173, 1552, 1552f, 1556, 1582, 1998, 2004, 2052
Xerostomia 1325
etiology of 1326t
syndrome 300
X-linked dominant disease 60
X-linked ichthyosis 62
recessive 213, 372
X-linked syndrome 445
XP disorders 336
Xylol scraping 1908f
Y
Yamamoto sign 579
Yellow nail syndrome 1277, 1292
Yersinia
enterocolitica 528, 1326, 1694
pestis 1705, 1735
Yttrium aluminum garnet 1253, 1481
Z
Zidovudine 462
Zika virus 743, 1768
infection 1650
Zimmermann–Laband syndrome 1526
Zinc
deficiency 147, 956
transient neonatal 883
supplementation 884
Zinsser–Cole–Engman syndrome 323, 341
Ziprkowski–Margolis syndrome 1154
Zosteriform 381, 1133, 1882
leishmaniasis 1882
Z-plasties 1041
Zummer cooler device 2078f
×
Chapter Notes

Save Clear


1Basic Science2

Embryogenesis of the SkinCHAPTER 1.1

Maria I Morasso
 
INTRODUCTION
The skin is the largest constantly renewable organ in the body. It is a complex tissue from which specialized structures such as hair, glands, and nails develop during embryogenesis. Several of the structures renew throughout life and recapitulate morphological processes and molecular and cellular events that are established during embryogenesis.
The skin is composed of the underlying dermis of mesodermal embryonic origin that is separated from the multilayered overlaying epidermis of ectodermal origin by a basement membrane. The epidermis is primarily composed of cells termed keratinocytes, due to the presence of the epidermal characteristic intermediate filaments, the keratins. Other cell types present in the skin are the Langerhans cells, melanocytes, and the sensory Merkel cells. The epidermis is organized into layers that correlate with stages of keratinocyte differentiation. During the differentiation process, proliferative keratinocytes of the basal layer divide and move upward, differentiating to spinous cells. These cells then differentiate to granular cells and ultimately culminate in a cornified, anucleated, nonviable cell of the stratum corneum. Stratification is concurrent with the layer-specific expression of structural and enzymatic markers. The cornified cell is the product of covalent cross-links of cornified envelope precursors by Ca++-dependent transglutaminases and attachment of lipid molecules. The cornified layer provides the protective and water barrier functions between the body and the environment.1,2 The endpoint of epidermal differentiation in both fetus and adult is keratinization, but there are differences in how this is accomplished. In the adult, keratinization requires a relatively short time. A cell that leaves the basal layer moves into the lowest cornified cell layer in about 14 days. The fetal epidermis requires 22–24 weeks to keratinize. Some of the properties of adult skin are established during embryogenesis and are maintained throughout life. Fetal skin has additional, unique characteristics outlined below.
 
SKIN DEVELOPMENT
During early embryogenesis, the conceptus undergoes gastrulation, a process that leads to the establishment of the three primary embryonic layers: the ectoderm, mesoderm, and endoderm. Ectoderm and endoderm are formed at 10–12 days estimated gestational age (EGA) and the mesoderm (origin of the dermis) forms around 18–19 days EGA. It is shortly after that the epidermis originates from the ectodermal cells covering the embryo.
Epidermis starts as a one-cell layer epithelium, which differentiates and stratifies during development to ultimately form the skin, a water-impermeable structure that protects us from dehydration and infection. The gestational period can be divided into distinct embryonic/fetal developmental stages—the embryonic period (0–60 days), the early fetal period (2–5 months), and the late fetal period (5–9 months) (Fig. 1). In epidermal cells, each of these stages is characterized by specific biochemical and immunohistochemical markers for morphogenetic and differentiation processes.3
Embryonic and fetal epidermis is characterized by the presence of the periderm, a transient epidermal layer of the developing skin. It is the outermost layer of the embryonic and fetal epidermis (Fig. 2). Periderm is ectodermal in origin and contains a single population of cells. Similarities in the cytoplasmic keratins, cell surface morphology, and antigens of the periderm support the hypothesis that it is the first layer of the skin, which divides and gives rise to the single layer of the epidermis.48 The periderm persists as a single layer of cells that remains on the surface of the developing skin until keratinization of cells in the underlying epidermal layers is complete.9 At that point, the periderm is sloughed in sheets and individual cells from the skin surface are shed into the amniotic fluid (Fig. 2). Loss of a certain number of periderm cells occurs throughout the second trimester, as determined from the composition of cells in the amniotic fluid.4
zoom view
FIG. 1: Schematic summary of embryonic and fetal developmental stages and timing through gestation. The initiation of specific landmarks of epidermal differentiation are indicated (epidermal stratification, follicular keratinization, and interfollicular keratinization). Timing of different techniques utilized for prenatal testing are highlighted.
zoom view
FIG. 2: Schematic diagram of the distinct stages of epidermal development during gestation. Epidermis develops from a single layer of undifferentiated ectoderm (embryonic stage) to form a multilayered differentiated epidermis (late fetal stage). The gestation-specific periderm layer appears in the embryonic stage, with blebbing and final shedding occurring before birth. The intermediate epidermal layer appears at the onset of epidermal stratification and differentiation in the embryonic/fetal transition stage. From the early fetal stage onward, the epidermis continues to undergo proliferation and differentiation programs that ultimately culminate in the formation of the cornified layer. The protective stratum corneum functions as a protective barrier against infection and dehydration by the time of birth.
The periderm cells cease to divide during the first trimester and do not appear to undergo any further steps in differentiation, but they continue to expand markedly in size and volume as the embryo/fetus grows. Characteristic changes in morphology (e.g., blebbing) and expression of markers characteristic of apoptotic cells [e.g., transglutaminases and deoxyribonucleic acid (DNA) fragmentation] suggest that the periderm undergoes a sequence of programmed cell death.10 The shape and surface characteristics of periderm cells are used to define stages of epidermal development.9 Monoclonal antibodies have been made that recognize only the periderm cells among the epidermal cell populations,11,12 some recognizing stage-specific periderm cells.
The function of the periderm is unknown, but it has been suggested that in early stages of development it protects the basal epidermal layer. The extensive microvilli and blebbing of the periderm cell surfaces that face the amniotic cavity suggest that these cells play a role in some type of exchange between the fetus and the amniotic fluid. Evidence for this function includes: (1) The observation that periderm cells share antigens in common with other absorptive fetal and adult epithelial cells; (2) The demonstration that periderm in the sheep fetus is involved in the uptake of substances from the amniotic fluid;13 and (3) The observation that the plasma membrane of human periderm cells has the morphologic characteristics of epithelia involved in water transport.14,15 The periderm may also be a secretory epithelium, contributing material to the amniotic fluid.16
 
Development of Epidermal Appendages
In the mammalian embryo, the surface ectoderm envelopes the embryo during gastrulation and neurulation, forming a simple epithelium comprised of a single cell layer. During embryonic development and organ formation, a series of signals between epithelial ectodermal cells and underlying mesenchymal cells are the basis for the formation of the epidermal appendages.17 Skin appendages in mammals include hair, nail, and sweat, sebaceous and mammary glands.
The first morphologically distinguishable event is the thickening of the surface ectoderm to form a placode or anlage 5that subsequently invaginates to form a bud. Similar sets of intersecting signaling pathways are involved in patterning the epithelium for placode formation and controlling bud invagination. Despite initial similarities, subsequent events in appendage development are different.17,18 Findings in the last decade have helped elucidate the molecular and cellular mechanisms controlling early steps in the development of these organs and human genetic diseases that affect appendage morphogenesis.18 Disruption in the signalling that leads to anomalies in epithelial/mesenchymal-derived organs are features of a group of human pathological conditions defined as ectodermal dysplasias (EDs).19 In the last two decades, the molecular basis of some EDs has been characterized with the identification of mutations in transcription factors (i.e., p63, DLX3, MSX1) and effectors of signalling pathways (i.e., ectodysplasin, NF-κB) with important roles during developmental organogenesis.20,21
 
Specialized Nonkeratinocyte Cells within the Skin
The epidermis has contributions from cells derived not only from the surface ectoderm but from other embryological origins such as neural crest. The three major nonkeratinocyte cell types present in the skin are Langerhans cells, melanocytes, and Merkel cells. All three cell types are detected within the epidermis by the end of the embryonic stage and can be easily distinguished by their nuclear morphology, cytoplasmic density, orientation in the tissue, and antigenic properties.
Langerhans cells function as antigen-presenting dendritic cells and are evident in embryonic epidermis as early as 43 days EGA.22 The appearance of Langerhans cells before the onset of bone marrow function and recent studies have determined the contributions of yolk sac and fetal liver hematopoiesis to the formation of Langerhans cells. Langerhans cell precursors are identified in the embryonic epidermis based on the expression of CD45, CD1c, HLA-DR, and ATPase.22,23 The expression of langerin and CD1a, present in adult human epidermal Langerhans cells, is detectable only after 11 weeks EGA.2224 The density of these cells is low (65 cells/mm2) in the epidermis during the first two trimesters of pregnancy, after which their numbers increase several fold in the third trimester and after birth.22 Langerhans cell granules are evident in the cytoplasm around 80 days EGA, suggesting that the cells already may be involved in antigen processing and presentation.23,24
The neural crest-derived melanocytes, responsible for pigmentation, migrate into the embryonic epidermis around 50 days EGA. Although they do not contain melanosomes or produce distinguishable quantities of pigment until mid-pregnancy, they are easily detected using the HMB-45 monoclonal antibody that recognizes an antigen common to melanoblasts and melanomas. Even at this early age, melanocytes are dendritic, high in density (~1,000 cells/mm2), and distributed uniformly throughout the epidermal tissue.25 Melanocytes reach a remarkably high density (~3,000 cells/mm2) in the fetal epidermis at about 80 days EGA.25 Melanosomes first appear in the cytoplasm of melanocytes around 65 days EGA depending on the region of the body. The eyelids, external auditory meatus, and labial mucosa appear to have melanin-producing melanocytes before they are evident in the skin in other regions,26 but the cells are present only transiently in these structures. Melanocytes begin to transfer melanosomes to keratinocytes in the fifth month of gestation. Studies of HMB-45 immunostained epidermal sheets have revealed that the density of immunopositive cells decreases toward birth, probably reflecting the growth of the fetus. The total cutaneous numbers at this time appear to be similar to the total numbers of the melanocytes in newborn epidermis.27
The third cell type, the mechanoreceptor Merkel cells have an epidermal origin.2833 Adult Merkel cells are easily recognized by characteristic neuropeptides, but in the fetal epidermis, detection of these cells relies on the presence of keratins specific to Merkel cells (K8, K18, and K20). Merkel cells are known to be plentiful in adult palmar skin. Merkel cells have been demonstrated at 8 weeks EGA in fetal palmar and plantar skin,29,32 although the density of cells at this stage was low and quite variable.32 No other morphologic markers (e.g., dense-core granules) are apparent at this stage. By 80–90 days EGA, the density was as great as 1,400 cells/mm2 and by 22–24 weeks EGA increased to 1,700 cells/mm2.4,5,29,32 At both ages, the cells were organized specifically along the primary epidermal ridges. This is the expected location because Merkel cells in adult skin are commonly found in association with hair follicles and sweat glands and both of these appendages are beginning to form during this stage of fetal development. Merkel cells were first seen in hairy skin at 75 days EGA where they were located in the infundibulum and bulge regions of the developing hair pegs and bulbous hair pegs.32,34
Cytochemical evidence suggests that Merkel cells may also function as neuroendocrine cells and may serve as target structures for the ingrowth of nerve fibers or they may attract other cells such as the smooth muscle cells of the arrector pili muscle that are associated with nerve fibers in the skin.34,35
 
STAGES OF HUMAN SKIN DEVELOPMENT
 
Skin Development during the Embryonic Period
A single-layered epithelium covers the human embryo from gastrulation and a cuboidal ectoderm overlying undifferentiated mesenchyme is recorded by 5 weeks of development. By 40 days gestation, the skin consists of an epidermis, dermal-epidermal junction (DEJ), dermis, and subcutaneous connective tissue (Fig. 3). The epidermis includes basal and periderm layers. The periderm is a simple pavement epithelium composed of hexagonally shaped, microvilli-covered cells. Periderm and basal cells are similar morphologically; both contain large amounts of glycogen, few organelles, and small quantities of keratin filaments that are organized into fine networks and associated with desmosomes (Fig. 3). The species of keratins in periderm and basal cells are characteristic of simple and glandular epithelia K19, K18, and K8.4,5,36 Basal cells also contain the keratins K5 and K14 that are markers of the basal layer keratinocytes of adult epidermis.4,5,37 K18 is found in periderm cells and in Merkel cells. A planar, microfilamentous network is present internal to the plasma membrane of basal cells adjacent to the basement membrane. 6This assembly may promote adhesion and reinforce the cell before hemidesmosomes are organized in sufficient numbers to maintain the structural integrity of the dermal-epidermal interface.
zoom view
FIGS. 3A TO C: Light, transmission, and scanning electron micrographs of the human embryonic skin. (A) Histology of the two-layered embryonic epidermis consists of glycogen-filled basal and periderm cells, where large vascular channels are detected. (B) Transmission electron micrograph of human embryonic skin. (C) Scanning electron micrograph of the periderm of human embryonic 70-day estimated gestational age (EGA), note the microvilli present in the surface correct magnifications for panels B and C.Courtesy: (Part A) Dr Karen Holbrook.
(B) 3500×; (C) 2500×.
The epidermis is associated with a basement membrane at the DEJ at all embryonic and fetal ages. Ultrastructural images show the basal keratinocytes physically separated from the lamina densa by a clear zone known as the lamina lucida. Several molecules that are characteristic of all basement membranes (e.g., type IV collagen, laminin, heparan sulfate proteoglycan) regardless of the epithelia with which they are associated, are also present in the embryonic DEJ. Skin-specific antigens are added to various regions of the DEJ coincident with epidermal stratification at the embryonic-fetal transition of development.38 Early stages of hemidesmosome formation are evident morphologically, but these structures are sparse and incomplete in structure.39 Occasional strands of fine filamentous material (anchoring filaments) can be seen crossing the lamina lucida.39
The embryonic dermis is a loose network of mesenchymal cells with little intervening fibrous connective tissue matrix.40,41 The high water content and hyaluronic-acid rich environment promotes cell migration during all phases of active tissue morphogenesis.42 Types I, III, V, and VI collagens are detected in early embryonic skin, but the fiber bundles contain few fibrils and are associated primarily with the surfaces of fibroblastic cells and in the zone subjacent to the DEJ.36,40,41 The latter zone, sometimes called the compact mesenchyme, is also a site that contains sulfated proteoglycans and is rich in growth factors. At later stages, the collagens become distributed in accord with the adult pattern of deposition.40 Elastic fibers are not present in embryonic dermis, while microfibrillar structures are seen by electron microscopy.1
Small capillary-like vessels are evident in the embryonic dermis.43 They are sparse and do not appear to be organized into patterns. Nerve fibers are recognized by immunostaining embryonic skin with antibodies to the p75 low-affinity nerve growth factor receptor. Fine fibers in the dermis connect with large nerve trunks located at the dermal-subcutaneous junction. It is difficult to distinguish subcutaneous tissue from dermis in the embryonic skin because the cells are quite similar and adipose tissue is synthesized considerably later in development. There is frequently, however, a difference in the density and/or orientation of the mesenchymal cells in the two 7regions and large, dilated channels, organized in the plane of the skin form an arbitrary boundary (Fig. 3). In some regions of the body, there is also a greater density of fibrous connective tissue in the subcutaneous tissue compared with the dermis. There is no morphologic evidence that epidermal appendages have begun to form in embryonic skin.
 
Skin Development at the Early Fetal Stage
By the end of the second month gestation, hematopoiesis has switched from the extraembryonic sac to the bone marrow and remarkable changes in the structure and biochemistry of the skin occur during the embryo/fetal transition period (Fig. 1). From this time to the end of the first trimester, all regions of the skin acquire features that establish a template of adult skin.
The first obvious change in the structure of the skin in this transition stage is the stratification of the epidermis to basal, intermediate, and periderm cell layers (Figs. 2 and 4). The cells of the intermediate layer show little difference in morphology from the basal cells; they have high glycogen content (Fig. 4) and few organelles are positioned around the nucleus and at the cell borders. There are larger and more densely staining bundles of keratin filaments located in the peripheral cytoplasm where they are associated with desmosomes (Fig. 4). Intermediate cells stain with antibodies that recognize the differentiation-specific keratins K1 and K10, of the adult stratified keratinized epidermis.4,5 This indicates that as soon as the basal keratinocytes divide and a layer of intermediate cells is added, the tissue is “differentiated” in terms of the expression of adult epidermal keratins. Other markers of differentiation present in the intermediate layer cells are involucrin and loricrin.1 Once the intermediate layer is formed, the basal layer begins to lose some of its glycogen content and thus appears to begin to acquire more of the adult features. Glycogen is common in cells of fetal tissues where it may serve as an energy source; it occupies a significant volume of fetal keratinocytes and fibroblasts through the first and second trimester but diminishes in later stages of development toward birth.
The epidermis continues to stratify by additional cell layers during the second trimester of development (Fig. 4). All cells of the fetal epidermis, including the periderm, can divide during the first trimester, but around the end of the third month this ability appears to become restricted primarily to basal keratinocytes.44,45 Periderm cells at this stage have a large volume of cytoplasm and appear rounded. At later ages within the same period one or more blebs project from the surfaces of periderm cells (Figs. 2 and 4) and remain densely covered by microvilli.
Changes in the structure and composition of the DEJ parallel epidermal stratification. The basal keratinocytes synthesize the components of the hemidesmosomes, anchoring filaments, and anchoring fibrils. Fibroblasts of the papillary dermis contribute collagens and components of elastic fibrils to the connective tissue matrix of the sublamina densa.2 Hemidesmosomes are now complete in structure and anchoring filaments and anchoring fibrils organize in relation to these sites (Fig. 4).39 It has been suggested from studies of chick cornea that there may be an interdependent relationship between hemidesmosomes and anchoring fibrils during morphogenesis.46 However, in humans, patients with junctional epidermolysis bullosa (EB) who lack hemidesmosomes do not lack anchoring fibrils,47 and vice-versa in the case of individuals with recessive dystrophic EB who do not have anchoring fibrils but whose hemidesmosomes assemble normally.48 Several of the antigens that correlate with these structures are expressed in the DEJ at the time of the embryonic fetal transition.49,50
During the remainder of the first trimester, the mesenchymal cells differentiate into fibroblastic cells and the dermis becomes less cellular and watery as more fibrous connective tissue accumulates in the interstitial spaces. By the end of this period, papillary and reticular regions can be distinguished on the basis of differences in cell density and orientation, fibril diameter, and fiber bundle size.40,51 A decrease in hyaluronic acid parallels the transition of the dermis from a cellular to a fibrous tissue; the water content of the dermis still remains >80%. Like adult dermis, the proteoglycan is composed largely of sulfated molecules.
Around 70 days EGA, the basic pattern of the adult vasculature is evident in fetal dermis.43 Horizontal plexuses are present within the dermis (subpapillary plexus) and separate the dermis from the subcutaneous tissue. The structure of the vessel wall is simple, making identification of vascular segments difficult. Nerve patterns are also well developed by the mid- to later first trimester and generally follow the vascular pattern.
Thus, the beginning of the fetal period is characterized by epidermal stratification and the histogenesis of various tissues of the skin. Epidermal stratification coincides with the onset of tooth, nail, and follicle morphogenesis, the addition of antigens and adhesive structures at the DEJ, regionalization of the dermis via the organization of fibrous extracellular matrix and patterns of nerves and vessels, and the expression of surface and cytoplasmic markers by melanocytes and Langerhans cells. Merkel cells are established in both hairy and glabrous skin.
There can be a hiatus of as much as 10 weeks between keratinization of the epidermal appendages and keratinization of the interfollicular epidermis. Keratinization of the follicle begins around 15 weeks EGA. At the beginning of the second trimester, the follicle is an elongated cord of cells consisting of a cellular core and an outer cellular layer. In general, the core cells are similar to intermediate layer epidermal cells and the cells of the external layer are more like cells of the basal epidermal layer. The hair peg grows and differentiates to become the bulbous hair peg (a structure named for the terminal bulb of the follicle), around 12–14 weeks EGA when primordia of the sebaceous gland, bulge, and the apocrine gland are recognized.52,53 Lipid is synthesized in the sebaceous gland around 15 weeks EGA. Simultaneously smooth muscle cells of the arrector pili muscle grow toward and attach to the follicle in the region of the bulge.54 The apocrine gland grows as a short cord of cells that originates from the infundibular portion of the follicle; apocrine glands persist and continue to develop only in specialized regions of the body. The mechanisms for establishing these precisely positioned structures are unknown. The terminus of the bulbous hair peg has a concavity within which cells of the dermal papilla are sequestered.8
zoom view
FIGS. 4A TO G: Light, transmission, and scanning electron micrographs of early fetal human skin. (A) Histology of normal human skin at the embryonic fetal transition stage 76-day estimated gestational age (EGA), and (B) at the early fetal stage 107-day EGA, with identification of the intermediate layer after stratification starts. (C) The intermediate layer cells contain abundant glycogen (arrows) and keratin filaments are evident at the periphery of the cell. (D) Note the presence of complete hemidesmosomes and anchoring fibril-like structures (arrows) in the dermal epidermal junction of skin from a 70-day EGA fetus. (E and F) Hair follicle bud and peg at 87-day and 101-day EGA development respectively. (G) Scanning electron micrograph of the surface periderm at 112-day EGA. Note the microvilli and blebs. ×2500.Courtesy: (Part A, B, E and F) Dr Karen Holbrook.
 
9Skin Development during the Late Fetal Stage
By 15 weeks gestation, the interfollicular epidermis is stratified with one or two additional layers of intermediate cells, but until the end of the second trimester there is no evidence of keratinization (Fig. 1). The adult pattern of keratins is maintained in the basal cells (K5 and K14), and the suprabasal keratinocytes of all intermediate layers express K1 and K10. Keratin filaments have continued to increase in quantity in the intermediate layers. Glycogen remains a significant component. The surface of the skin is still covered by a complete layer of periderm. The nondividing, periderm cells have attained a peak stage of structural modification in which one or more simple or complex blebs project from the surface; all portions of the periderm cells facing the amniotic cavity are covered with microvilli.55 The internal morphology of the cells, however, is variable. Some of the cells contain the organelles associated with active metabolic processes (e.g., mitochondria, rough endoplasmic reticulum, Golgi); others have few organelles and are filled with filaments. The latter cells have a thickened cell envelope, which is morphologically and biochemically equivalent to the cornified cell envelope. Involucrin and loricrin have been identified at the boundary of the periderm cell56 and an active epidermal transglutaminase is present that appears able to cross-link the envelope proteins.2,56 At later stages of this period (~18 weeks) the periderm cells flatten, the blebs regress to small, button-like protrusions,2 and the subcellular morphology is indicative of a nonfunctional, perhaps nonviable, apoptotic remnant of this tissue.9
Between 22 and 24 weeks EGA, the interfollicular epidermis begins to keratinize; the exact timing depends on the region of the body.8 Early evidence for keratinization is the appearance of lamellar granules and small keratohyalin granules in the uppermost intermediate cell layer (Fig. 5). This is the first age at which filaggrin is expressed in the fetal interfollicular epidermis;4 thus the onset of filaggrin synthesis appears to correlate precisely with the morphologic appearance of keratohyalin granules. The first few layers of cells that keratinize are a combination of “regressed” periderm cells that contain primarily filaments and have a cornified cell envelope, and incompletely keratinized keratinocytes; the latter cells are characterized by a condensed nucleus, dense organelles, cornified cell envelope, and flattened shape of the stratum corneum cell. The numbers of layers of keratinized cells and the size of keratohyalin granules gradually increase so that the epidermis of the third trimester fetus appears similar to that of the neonate and adult with the exception that glycogen remains in the cytoplasm of the keratinocytes. Coincident with keratinization, the periderm is sloughed from most of the skin surface revealing the underlying keratinized epidermis (Figs. 2 and 5).
zoom view
FIGS. 5A TO C: Light, transmission, and scanning electron micrographs of late fetal human skin. Histology of normal human skin at the late fetal stage (A) 143-day estimated gestational age (EGA), and (B) 189-day EGA. Note the stratification and the keratinization of the epidermis as well as the complex structural organization of the dermis. (C) Scanning electron micrograph of the periderm of human skin 160-day EGA, note the periderm sheet sloughed from the skin surface.
The surface of the skin is coated with the lipid-rich material of the vernix caseosa, a combination of sebum secreted from the 10sebaceous gland of the follicle, epidermal lipids, desquamated cells, hair, and other tissue debris.57,58 Like sebum, the vernix contains a significant level of triglycerides and wax esters, and like cornified cells it has a high proportion of sterols. Other lipids that are not characteristic of either of these sources contribute to the unique content of this material.57 Vernix caseosa is often apparent on the skin at birth.
The second trimester dermis contains an extensive amount of fibrous connective tissue, including elastic fibers. The elastic microfibrils are synthesized early in development but the elastin gene does not appear to be expressed until approximately 15 weeks EGA.59 Elastic fiber networks are seen in the skin by histochemical and immunohistochemical methods around 20 weeks EGA.51,60 These fibers are immature in structure, more similar to adult elaunin fibers, and thus it is unrealistic to consider using the structure of the elastic fibers to identify a fetus at risk of a genetic disorder of elastic connective tissue such as cutis laxa. Even at birth, the amount of elastin associated with elastic fibers is minimal.
Coarse fiber bundles of the deep dermis clearly distinguish it from the fine connective tissue of the hypodermis. This pattern is reversed from the situation in younger skin where the density of matrix in the subcutaneous tissue is greater than that of the dermis. The organization of the hypodermis is readily apparent at 15 weeks EGA, and by 18 weeks EGA there is a small accumulation of subcutaneous fat.
By late fetal stage, the hair follicle morphogenesis has proceeded and the hair canals can be seen as elongated ridges visible at the epidermal surface. The integrity of the periderm is disrupted along the tops of the ridges where the hair canal will rupture and open to the surface. The length of the canals, the time of hair release, and the density of the hair are dependent on the region of the body.61 The position of eyebrow and scalp hairs can be recognized as early as 15 weeks EGA by the presence of short, closely positioned, periderm-covered hair canals. At 21 weeks, the hair canals on the trunk begin to rupture, interrupting the continuity of the periderm over the body surface and releasing a fully elongated hair.61 The eccrine sweat glands develop on the body late in the second trimester, >2 months after their development initiated on the palms and soles.
By birth, the skin has the final structure that it will maintain through life (Fig. 6). The detailed characterization of the skin structure, composition, and function, as well as the epidermal appendages will be the focus of the next section of this chapter.
 
SKIN DEVELOPMENT IN IMMATURE/PREMATURE SKIN
The skin of the premature infant is that of the third trimester fetus. During this period, the skin increases in bulk, primarily by the addition of connective tissue to the dermis, the epidermis is keratinized, all of the epidermal appendages are formed, and the dermis contains all of the matrix proteins characteristic of the newborn and adult. Nonetheless, the skin is still immature in both structural and physiologic properties.
zoom view
FIGS. 6A AND B: Architecture of normal human skin at birth. (A) Schematic representation of normal human skin at birth. Magnification delineates the distinct layers of the epidermis, cellular components, and hair morphology. (B) Light micrograph of a developing hair follicle at 15-week estimated gestational age (EGA). The regions of the follicle, sebaceous gland, and bulge are indicated. Note the keratinization of the developing hair and of the lining of the hair canal in the region of the infundibulum and within the epidermis (×400).(B: stratum basalis; Bu: bulge; C: stratum corneum; DP: dermal papilla; EGA: estimated gestational age; G: stratum granulosum; HS: hair shaft; LC: Langerhans cell; M: melanocyte; S: stratum spinosum; SG: sebaceous gland)
The epidermis has all of the layers of the adult epidermis, but it is thinner. The cells retain a substantial amount of glycogen, and the stratum corneum forms a less formidable barrier. The relatively poor barrier properties of the preterm infant are of great importance when considering topical application of various pharmacologic and cleansing compounds.62,63 The uptake of pharmacologic compounds applied topically to the skin is much more rapid in the 28- to 34-week premature newborn than in older newborns and the loss of water through the skin and evaporative water loss from the surface decreases exponentially with increasing gestational age.64,65 The amount of transepidermal water loss through the skin of a 25- to 30-week EGA infant can be so substantial that death can result from dehydration. In the premature infant, it is suggested that the vernix caseosa functions to augment the poorly established 11barrier properties of the epidermis or serve as a natural emollient. The skin of the premature infant is more resistant to desquamation than that of the term newborn.
The structure of the DEJ of the premature infant correlates with gestational age. As the age increases, the contours (rete ridges and dermal papillae) become more prominent. In the youngest (26–34 weeks EGA) premature infants, the DEJ is relatively flat, although the structural components of the DEJ that anneal the epidermis and dermis are well established. The papillary dermis immediately underlying the DEJ is edematous and the bundles of collagen fibrils are smaller and more widely spaced than those of the term newborn or adult, and thus the epidermal–dermal integrity might be expected to be more easily compromised than in the term newborn.66
The dermis of the premature infant is ~3 quarters of the thickness of adult dermis and comparable in connective tissue organization. Fine collagen fibrils and the small-sized collagen fiber bundles give the dermis a highly cellular and delicate appearance. The water content of the dermis remains high in premature babies, but this, like many properties of the premature and newborn skin depends on the nutritional status of the fetus in addition to gestational age.
All of the adult epidermal appendages are established in premature skin. The fully formed, hair-synthesizing lanugo follicles of fetal skin are equivalent to those of the term newborn or adult; however, the eccrine sweat glands have formed only a few coils of the glandular segment and the light and dark cells are not easily distinguishable.66 Sweat ducts are partially occluded until the end of the seventh month of gestation. The sweating response is limited or absent in premature infants67 and appears to have a strong correlation with gestational age; there is a tendency toward total anhidrosis in the premature neonate,68 although this dysfunction rapidly resolves after a few days of extrauterine life.
A summary of all the major morphological events that occur through the embryogenesis of the human skin is presented in Table 1.
TABLE 1   Summary of timing of major morphological events occurring during epidermal development.
Embryonic
Early fetal
Late fetal
Periderm
X
  • Shedding of periderm
X
Epidermis
  • Basal layer
X
  • Intermediate layer
X
  • Granular layer
X
  • Cornified layer
X
Cell junctions
  • Desmosomes
X
  • Tight junctions
X
  • Hemidesmosomes
X
Appearance of specialized non-keratinocyte cells
  • Langerhans cells
X
  • Melanocytes
X
  • Merkel cells
X
Epidermal appendages
  • Hair follicle
X
  • Sebaceous gland
X
  • Apocrine gland
X
  • Sweat glands
X
  • Nails
X
Dermis
  • Structural organization
X
  • Dermal papillae
X
  • Connective tissue
X
 
REFERENCES
  1. Kalinin A, Marekov LN, Steinert PM Assembly of the epidermal cornifies cell envelope. J Cell Sci. 2001;114:3069-70.
  2. Holbrook KA. Structure and function of the developing human skin. In: Goldsmith LE (Ed). Physiology, Biochemistry and Molecular Biology of the Skin, 2nd edition. New York: Oxford University Press; 1991. p. 63.
  3. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol. 2005;6:328-40.
  4. Dale BA, Holbrook KA, Kimball JR, Hoff M, Sun TT. Expression of the epidermal keratins and filaggrin during fetal human development. J Cell Biol. 1985;101:1257-69.
  5. Moll R, Moll I, Wiest W. Changes in the pattern of cytokeratin polypeptides in epidermis and hair follicles during skin development in human fetuses. Differentiation. 1982;23:170-8.
  6. Akiyama M, Smith LT, Yoneda K, Holbrook KA, Hohl D, Shimizu H. Periderm cells form cornified cell envelope in their regression process during human epidermal development. J Invest Dermatol. 1999;112:903-9.
  7. M'Boneko V, Merker H-J. Development and morphology of the periderm of mouse embryos (days 9–12 of gestation). Acta Anat (Basel). 1988;133:325-36.
  8. Richardson RJ, Hammond, NL, Coulombe PA, Saloranta C, Nousiainen HO, Salonen R, et al. Periderm prevents pathological epithelial adhesions during embrogenesis. J Clin Invest. 2014;124:3891-900.
  9. Holbrook KA, Odland GF. The fine structure of developing human epidermis: light, scanning and transmission electron microscopy of the periderm. J Invest Dermatol. 1975;65:16-38.
  10. Polakowska RR, Piacentini M, Bartlett R, Goldsmith LA, Haake AR. Apoptosis in human skin development: morphogenesis, periderm and stem cells. Dev Dyn. 1994;199:176-88.
  11. Lane AT, Negi M, Goldsmith LA. Human periderm: a monoclonal antibody marker. Curr Probl Dermatol. 1987;16:83-93.
  12. Schofield OMV, McDonald JN, Fredj-Reygrobellet D, Hsi BL, Yeh CJ, Ortonne JP, et al. Common antigen expression between human periderm and other tissues identified by GB1-monoclonal antibody. Arch Dermatol Res. 1990;282:143-8.
  13. Mears GJ, Van Petten GR. Fetal absorption of drugs from the amniotic fluid. Proc West Pharmacol Soc. 1977;20:109-14.
  14. Parmely TH, Seeds AE. Fetal skin permeability to isotopic water (THO) in early pregnancy. Am J Obstet Gynecol. 1970;108:128-31.
  15. Riddle CV. Intramembranous response to cAMP in fetal epidermis. Cell Tissue Res. 1985;241:687-9.
  16. Lind T, Kendal A, Hytten FE. The role of the fetus in the formation of amniotic fluid. J Obstet Gynaecol Br Commonw. 1972;79:289-98.
  17. Pispa J, Thesleff I. Mechanisms of ectodermal organogenesis. Dev Biol. 2003;262:195-205.
  18. 12Mikkola ML. Genetic basis of skin appendage development. Semin Cell Dev Biol. 2007;18:225-36.
  19. Priolo M, Lagana C. Ectodermal dysplasias: a new clinical-genetic classification. J Med Genet. 2001;38:579-85.
  20. Priolo M. Ectodermal dysplasias: An overview and update of clinical and molecular-functional mechanisms. Am J Med Genet A. 2009;149A:2003-13.
  21. Itin PH. Etiology and pathogenesis of ectodermal dysplasias Am J Med Genet A. 2014;164A:2472.
  22. Foster CA, Holbrook KA. Ontogeny of Langerhans cells in human embryonic and fetal skin: expression of HLA-DR and OKT6 determinants. Am J Anat. 1989;184:157-64.
  23. Schuster C, Vaculik C, Fiala C, Meindl S, Brandt O, Imhof M, et al. HLA-DR+ leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigen-presenting cells. J Exp Med. 2009;206:169-81.
  24. Schuster C, Mildner M, Mairhofer M, Bauer W, Fiala C, Prior M, et al. Human embryonic epidermis contains a diverse Langerhans cell precursor pool. Development. 2014;141:807-15.
  25. Holbrook KA, Underwood RA, Vogel AM, Gown AM, Kimball H. The appearance, density and distribution of melanocytes in human embryonic and fetal skin revealed by the anti-melanoma monoclonal antibody, HMB-45. Anat Embryol. 1989;180:443-55.
  26. Barla-Szabo L. Ejection of melanocytes and melanin from fetuses and newborn mammalian animals. Acta Morphol Acad Sci Hung. 1970;18:213-25.
  27. Hamada H. Age changes in melanocyte distribution of the normal, human epidermis. Jpn J Dermatol. 1970;82:223-32.
  28. Moll I, Moll R, Franke WW. Formation of epidermal and dermal Merkel cells during human fetal skin development. J Invest Dermatol. 1986;87:779-87.
  29. Moll R, Moll I, Franke W. Identification of Merkel cells in human skin by specific cytokeratin antibodies: changes in cell density and distribution in fetal and adult plantar epidermis. Differentiation. 1984;28:136-54.
  30. Moll I, Lane A, Franke W, Moll R. Intraepidermal formation of Merkel cells in xenografts of human fetal skin. J Invest Dermatol. 1990;94:359-64.
  31. Moll I, Moll R. Early development of human Merkel cells. Exp Dermatol. 1992;1:180-4.
  32. Kim D-G, Holbrook KA. The appearance, density and distribution of Merkel cells in human embryonic and fetal skin: their relation to sweat gland and hair follicle development. J Invest Dermatol. 1995;104:411-6.
  33. Narisawa Y, Hashimoto K. Immunohistochemical distribution of nerve–Merkel cell complex in fetal human skin. J Dermatol Sci. 1991;2:361-70.
  34. Narisawa Y, Hashimoto K, Nakamura Y, Kohda H. A high concentration of Merkel cells in the bulge prior to the attachment of the arrector pili muscle and the formation of the perifollicular nerve plexus in human fetal skin. Arch Dermatol Res. 1993;285:261-8.
  35. Sharp F. A quantitative study of the glycogen content of human fetal skin in the first trimester. J Obstet Gynaecol Br Commonw. 1971;78:981-6.
  36. Moll R, Franke WW, Schiller DL. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31:11-24.
  37. Tseng SCG, Jarvinen M, Nelson WG, Huang JW, Woodcock-Mitchell J, Sun TT. Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell. 1982;30:361-72.
  38. Yin T, Green KJ. Green, Regulation of desmosome assembly and adhesion. Semin Cell Dev Biol. 2004;15:665-77.
  39. McMillan JR, Eady RAJ. Hemidesmosome ontogeny in human fetal skin. Arch Dermatol Res. 1996;288:91-7.
  40. Smith LT, Holbrook KA, Madri JM. Collagen types I, III and V in human embryonic and fetal skin. Am J Anat. 1986;175:501-21.
  41. Smith LT. Patterns of type VI collagen compared to types I, III and V collagen in human embryonic and fetal skin and in fetal-skin derived cell cultures. Matrix Biol. 1994;14:159-70.
  42. Breen M, Weinstein HG, Johnson RL, Veis A, Marshall RT. Acid glycosaminoglycans in human skin during fetal development and in adult life. Biochim Biophys Acta. 1970;201:54-60.
  43. Johnson CL, Holbrook KA. Development of human embryonic and fetal dermal vasculature. J Invest Dermatol. 1989;93:10S-17S.
  44. Bickenbach JR, Holbrook KA. Proliferation of human embryonic and fetal epidermis in organ culture. Am J Anat. 1986;177:97-106.
  45. Bickenbach JR, Holbrook KA. Label-retaining cells in human embryonic and fetal epidermis. J Invest Dermatol. 1987;88:42-6.
  46. Gipson IK, Spurr-Michaud SJ, Tisdale AS. Hemidesmosomes and anchoring fibril collagen appear synchronously during development and wound healing. Dev Biol. 1988;126:253-62.
  47. Tidman MJ, Eady RAJ. Hemidesmosome heterogeneity in junctional epidermolysis bullosa revealed by morphometric analysis. J Invest Dermatol. 1986;86:51-6.
  48. Tidman MJ, Eady RAJ. Evaluation of anchoring fibrils and other components of the dermal-epidermal junction in dystrophic epidermolysis bullosa by a quantitative ultrastructural technique. J Invest Dermatol. 1985;84:374-7.
  49. Fine J-D, Horiguchi Y, Couchman JR. 19-DEJ-1, a hemidesmosomal-anchoring filament complex associated monoclonal antibody: definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa. Arch Dermatol. 1989;125:520-3.
  50. Smith LT, Sakai LY, Burgeson RE, Holbrook KA. Ontogeny of structural components at the dermal-epidermal junction in human embryonic and fetal skin: the appearance of anchoring fibrils and type VII collagen. J Invest Dermatol. 1988;90:480-5.
  51. Smith LT, Holbrook KA, Byers PH. Structure of the dermal matrix during development and in the adult. J Invest Dermatol. 1982;79:93s-104s.
  52. Holbrook KA, Minami SA. Hair follicle morphogenesis in the human: characterization of events in vivo and in vitro. NY Acad Sci. 1991;642:167-96.
  53. Pinkus H. Embryology of Hair. In: Montagna W, Ellis RA (Eds) The Hair Growth. New York: Academic Press; 1958. p. 1.
  54. Akiyama M, Dale BA, Sun TT, Holbrook KA. Characterization of hair follicle bulge in human fetal skin: the human fetal bulge is a pool of undifferentiated keratinocytes. J Invest Dermatol. 1995;105:844-50.
  55. Nanbu Y, Fujii S, Konishi I, Nonogaki H, Mori T. CA 125 in the epithelium closely related to the embryonic ectoderm: the periderm and the amnion. Am J Obstet Gynecol. 1989;161:462-7.
  56. Holbrook KA, Underwood RA, Dale BA, Thacher SM, Wuepper KD, and Banks-Schlegel S. Cornified cell envelope (CCE) in human fetal skin: involucrin, keratolinin, loricrin and transglutaminase expression and activity. J Invest Dermatol. 1991;96:542.
  57. Kurkkainen J, Nikkari T, Ruponen S, Haahti E. Lipids of the vernix caseosa. J Invest Dermatol. 1965;44:333-8.
  58. Nazarro-Porro M, Possi S, Boniforti L, Belsito F. Effects of aging on fatty acids in skin surface lipids. J Invest Dermatol. 1979;73:112-7.
  59. Sephel GC, Buckley A, Davidson JM. Developmental initiation and elastin gene expression by human fetal skin fibroblasts. J Invest Dermatol. 1987;88:732-5.
  60. Deutsch TA, Esterly NB. Elastic fibers in fetal dermis. J Invest Dermatol. 1975;65:320-3.
  61. Holbrook KA, Odland GF. Structure of the hair canal and the initial eruption of hair in the human fetus. J Invest Dermatol. 1978;71:385-90.
  62. Nachman RL, Esterly NB. Increased skin permeability in preterm infants. J Pediatr. 1971;79:628-32.
  63. West DP, Worobec S, Solomon LM. Pharmacology and toxicology of infant skin. J Invest Dermatol. 1981;76:147-50.
  64. Hammarlund K, Sedin G. Transepidermal water loss in newborn infants. Acta Paediatr Scand. 1979;68:795-801.
  65. Faranoff AA, Wald M, Gruber HS, Klaus MH. Insensible water loss in low birth weight infants. Pediatrics. 1972;50:236-45.
  66. Holbrook KA. A histologic comparison of infant and adult skin. In: Maibach HI, Boisits EK (Eds). Neonatal Skin. New York: Marcel Dekker; 1981. p. 3.
  67. Sinclair JC. Thermal control in premature infants. Annu Rev Med. 1972;23:129-48.
  68. Green M. Comparison of adult and neonatal skin eccrine sweating. In: Maibach HI, Boisits EK (Eds). Neonatal Skin. New York: Marcel Dekker; 1981 p. 35.